Automated tissue processing and analysis platform, implements therefor and methods for use thereof

The automated robotic platform integrates freezing, sectioning, and imaging with adaptive thermoelectric cooling and AI to address labor-intensive and cross-contamination issues, providing rapid and dual-output histological analysis.

WO2026239385A1PCT designated stage Publication Date: 2026-11-19GERON SHAY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IL2026/050399
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-15
Filing Date
2026-05-13
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing histological tissue processing methods are labor-intensive, time-consuming, prone to cross-contamination, and lack the ability to provide both immediate intraoperative analysis and downstream preservation from a single biopsy specimen.

Method used

An automated robotic platform that integrates tissue freezing, sectioning, staining, and imaging, utilizing thermoelectric cooling, disposable blades, and artificial intelligence for adaptive tissue processing, ensuring consistent quality and reducing manual intervention.

Benefits of technology

The platform significantly reduces processing time, minimizes cross-contamination, and enables both immediate diagnostic output and preserved specimens, enhancing geographic accessibility and diagnostic capabilities.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IL2026050399_19112026_PF_FP_ABST
    Figure IL2026050399_19112026_PF_FP_ABST
Patent Text Reader

Abstract

An automated biopsy platform comprising a cooling module configured for receiving a tissue sample and lowering its temperature to form a cooled tissue sample; a cutting module configured for at least partially cutting a histological section of the cooled tissue sample; and a sampling module configured for applying the histological section to a slide to form a histological slide; the automated biopsy platform also comprises an automated actuation mechanism associated with each of the cooling module, cutting module, and sampling module, and configured for automatically facilitating at least one of the following: transfer of the tissue sample to the cooling module, engagement between the cutting module and the cooled tissue sample, and application of the histological section to the slide.
Need to check novelty before this filing date? Find Prior Art

Description

AUTOMATED TISSUE PROCESSING AND ANALYSIS PLATFORM, IMPLEMENTS THEREFOR AND METHODS FOR USE THEREOFTECHNOLOGICAL FIELDThe present invention is in the field of medical diagnostic instrumentation and biomedical robotics, in particular, autonomous robotic platforms for cryosectioning, staining, imaging, and artificial-intelligence-assisted diagnostic analysis of histological tissue samples.BACKGROUND OF THE INVENTION

[0001] The present invention relates to medical diagnostic instrumentation and biomedical robotics. More particularly, the present invention relates to a fully autonomous robotic platform for the preparation, staining, imaging, and diagnostic analysis of histological tissue sections utilizing the frozen section method, incorporating adaptive tissue characterization, thermoelectric cryogenic control, mechanical blade alignment, consumable contamination-prevention architecture, and artificial intelligence-assisted diagnostic engines.

[0002] Histological examination of tissue specimens obtained during surgical procedures may involve the preparation of thin tissue sections suitable for microscopic analysis. One technique employed for intraoperative pathological consultation is the frozen section method, in which a fresh tissue specimen is frozen and cryosectioned into thin slices that are then stained, mounted on a microscope slide, and examined microscopically.

[0003] A frozen section workflow may comprise, without limitation, one or more of receiving a fresh tissue specimen; embedding the specimen in an embedding medium, such as without limitation an optimal cutting temperature (OCT) compound; freezing the specimen; sectioning the frozen tissue block to produce one or more histological sections; transferring an individual histological section onto a microscope slide; applying one or more histological stains to the section; and microscopic examination of the stained section.

[0004] Tissue specimens for which intraoperative or near -intraoperative histological examination may be sought include, without limitation, biopsy specimens, surgical resection specimens, oncological margin specimens, and dermatological specimens, including without limitation specimens prepared for Mohs micrographic surgery.

[0005] Different tissue types — including without limitation adipose tissue, parenchymal tissue, fibrous connective tissue, lymphatic tissue, and dermatologicaltissue — exhibit different thermophysical characteristics, and may be processed under different cryogenic parameters.

[0006] In some clinical applications, a tissue specimen workflow may yield both a frozen section suitable for immediate intraoperative analysis and a preserved tissue specimen suitable for downstream tissue preservation processing, including without limitation formalin-fixed paraffin-embedded (FFPE) histology, immunohistochemistry, and molecular analysis such as next-generation sequencing (NGS) and companion diagnostic assays.

[0007] Histological staining of a tissue section may employ one or more staining protocols, including without limitation hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) staining. Microscopic evaluation of stained sections may be performed in person by a pathologist or remotely via digital whole-slide imaging.

[0008] Computer-aided image analysis, including without limitation classical imageprocessing algorithms, machine-learning classifiers, and convolutional neural networks, may be applied to digital images of stained histological sections to provide one or more diagnostic indications.

[0009] The present invention provides automated platforms, implements therefor, and methods for the foregoing tissue processing applications, as described herein.Acknowledgement of the above references herein is not to be inferred as meaning that these are in any way relevant to the patentability of the presently disclosed subject matter.GENERAL DESCRIPTION

[0010] The automated biopsy platform of the present invention advantageously consolidates the complete intraoperative tissue-section workflow — placement of a fresh tissue sample, freezing, sectioning, transfer to a microscope slide, staining, imaging, and artificial-intelligence-assisted diagnostic analysis — into a single, autonomous, software-orchestrated device that operates without continuous skilled-operator intervention. The integrated architecture provides, among other technical benefits and gains: (i) a substantial reduction of the elapsed time from tissue receipt to diagnostic output, by eliminating manual transfer steps between stand-alone instruments; (ii) reproducibility of section quality independent of individual operator technique, by replacing manual cryotome operation with closed-loop, sensor-guided automation; (iii) a substantial reduction of cross-contamination risk between successive specimens, by employing a single-use cartridge that contains the tissue throughout the freeze and section operations and that, in some embodiments, also contains the disposable blade; (iv) extended geographic accessibility of intraoperative pathology, by enabling the platform to be deployed at sites that lack a co-located trained histotechnologist or pathologist; (v) a per-section automated quality decision that supersedes the manual accept / reject step and prevents resources from being expendedon sections that would later be discarded; and (vi) a dual -output capability in which the same single specimen yields both an intraoperative section and a tissue core preserved for downstream paraffin-embedded preservation and molecular analysis, thereby preserving full options for definitive diagnosis and biobanking from the same biopsy. The further aspects and embodiments below recite specific structural and functional features of the platform, and where appropriate identify the technical benefit, gain, or problem solved by each such feature.

[0011] In accordance with one aspect of the present invention, there is provided an automated tissue processing platform, hereinafter also referred to as the "automated biopsy platform", comprising: a cooling module configured for receiving a tissue sample and lowering its temperature to form a cooled tissue sample; a cutting module configured for at least partially cutting a histological section of the cooled tissue sample; a sampling module configured for applying the histological section to a microscope slide to form a histological slide; and an automated actuation mechanism associated with each of the cooling module, the cutting module, and the sampling module, and configured for automatically facilitating one or more of: transfer of the tissue sample to the cooling module, engagement between the cutting module and the cooled tissue sample, and application of the histological section to the microscope slide.

[0012] In some embodiments, the platform further comprises a housing accommodating at least the cooling module, the cutting module, and the sampling module, the housing comprising a sample inlet configured for introduction of a tissue sample into the platform. The integrated housing-and-inlet arrangement provides the technical benefit of a defined, controlled-environment workspace for all tissue handling, supporting consistent thermal and humidity control across the freezing, sectioning, and slidehandling regions of the platform, and providing a single regulated entry point that supports specimen identification and orientation validation prior to admission.

[0013] In some embodiments, the cooling module comprises a cooling arrangement configured for lowering the temperature of the tissue sample, the cooling arrangement being configured to achieve at least partial freezing of the tissue sample, optionally to a temperature in the range of approximately negative ten degrees Celsius to negative seventy degrees Celsius. In further embodiments, the cooling module is configured for freezing the entire tissue sample; in further alternative embodiments, the cooling module is configured for freezing a peripheral portion of the tissue sample while leaving a central portion thereof unfrozen. The optional partial-freezing mode, in which a peripheral portion of the tissue sample is frozen while the central portion remains unfrozen, enables the platform to deliver a frozen section for immediate intraoperative analysis while preserving an unfrozen tissue core for downstream tissue preservation processing — a dual-output capability that, in some embodiments, supports both rapid surgical decision making and definitive paraffin-embedded histology, immunohistochemistry, and molecular analysis from the same biopsy specimen.

[0014] In some embodiments, the cooling module is associated with a tissue chamber configured for containing the tissue sample. The tissue chamber is, in some embodiments, an individual chamber sized and shaped for accommodating a single tissue sample; in further embodiments, integrated into the platform; in alternative embodiments, an external unit introduced into the platform; and is configured to contain a thermal fluid in some embodiments. The platform further comprises, in some embodiments, an extraction mechanism configured for removing the cooled tissue sample from the tissue chamber. Containing the tissue sample within a tissue chamber throughout the cooling cycle advantageously enables the tissue to be transported, positioned, and engaged by downstream subsystems without operator handling, supporting an autonomous workflow and reducing the risk of operator-tissue contact and cross-contamination between specimens.

[0015] In some embodiments, the cooling module includes a monitoring unit configured for one or more of assessing a size, shape, or volume of the tissue within the tissue chamber; assessing the temperature of the tissue within the tissue chamber; and assessing the level of freezing of the tissue within the tissue chamber. The cooling arrangement is, in some embodiments, associated with the monitoring unit and configured to change cooling characteristics based on the assessments. Real-time monitoring of tissue size, temperature, and freezing level enables closed-loop adaptation of the cooling characteristics to the individual specimen, providing the technical benefit of consistent block hardness and morphology across specimens with widely varying geometry, water content, and thermophysical properties — without requiring per-specimen operator parameter tuning.

[0016] In some embodiments, the cooling arrangement is configured for cooling the tissue sample by conduction and comprises a thermoelectric cooling (TEC) unit. In further embodiments the cooling module comprises two or more TEC units arranged for cooling the tissue sample from two different directions, including a first TEC unit and a second TEC unit. The TEC is cooled, in some embodiments, using a secondary cooling system, optionally a fluid cooling system. Cooling the tissue sample by conduction with thermoelectric cooling modules, optionally from two opposing directions, achieves rapid and uniform freeze across the tissue mass; the use of a secondary fluid cooling system to remove heat from the TEC hot side enables the platform to sustain the heatpumping rate required for intraoperative time budgets without ambient heat loading, providing the technical benefit of repeatable freeze times across consecutive specimens.

[0017] In some embodiments, the cooling module further comprises a hierarchical adaptive freezing protocol implementing three layers: a first layer in which an operator selects a tissue class designation from a predefined enumerated list of tissue classes, each tissue class being associated with stored thermophysical parameters; a second layer in which the platform automatically measures one or more tissue geometry parameters using an imaging sensor and one or more position encoders, computing a tissue volume estimate; and a third layer comprising a thermal response observer configured tomonitor a real-time cooling curve of the tissue sample using one or more temperature sensors thermally coupled to the cooling module sampling at a rate of at least ten hertz, comparing the observed cooling rate against an expected thermal signature for the selected tissue class, and automatically correcting the active freezing profile if the observed cooling rate deviates from the expected thermal signature by more than a defined threshold. The hierarchical adaptive freezing protocol advantageously provides per-specimen freezing optimization across a wide range of tissue classes, geometries, and water contents, achieving consistent ice-block hardness and morphology suitable for high-quality cryosectioning without operator-dependent parameter tuning, and adapting in real time to inter-specimen variability that would otherwise require manual intervention.

[0018] In some embodiments, the cooling module comprises a two-stage cascaded thermoelectric architecture wherein a first stage of one or more chiller thermoelectric modules pre-cools a circulating liquid coolant, and a second stage comprising one or more tissue thermoelectric modules and a knife thermoelectric module operates with the pre-cooled liquid coolant on its hot sides. In some embodiments, the cooling module further comprises a thermally conductive coupling element interposed between each thermoelectric cooler cold face and a corresponding contact surface of the cartridge, the coupling element comprising a truncated conical body fabricated from a material having a thermal conductivity of at least approximately 200 W / (m K), the truncated conical body having a base dimensioned to substantially overlap the corresponding TEC cold face and a tip dimensioned to match the corresponding cartridge interface, and being configured to be pre-cooled to a sub-zero temperature prior to tissue engagement to store thermal capacity exceeding the energy required to freeze the tissue specimen. The cascaded architecture and pre-cooled thermal-capacitor coupling element advantageously achieve a low cold-face working temperature with high thermal capacity and low thermal resistance into the tissue, enabling rapid and uniform tissue freezing within the time budget required by intraoperative use; the pre-cooled coupling element absorbs the freeze-energy peak and decouples the per-specimen freezing time from the steady-state pumping capacity of the thermoelectric stack, providing reproducible freeze times across consecutive specimens.

[0019] In some embodiments, the cooling module further comprises multiple temperature sensors comprising at least: a first sensor thermally coupled to a lower thermoelectric cold plate; a second sensor thermally coupled to an upper thermoelectric cold plate; a third sensor thermally coupled to a cold plate of the knife thermoelectric module; and a fourth sensor thermally coupled to a coolant reservoir of the cooling system; the platform configured to sample the temperature sensors at a rate of at least ten hertz from cartridge insertion through final slide output, and to place a corresponding thermoelectric module in a fail-safe state responsive to any sensor reporting an out-of-range value. Multi-point temperature sensing across the lower TEC cold plate, upper TEC cold plate, knife TEC cold plate, and coolant reservoir enablescomprehensive thermal supervision and the platform's fail-safe response on out-of-range readings; this provides the technical benefit of catching thermal faults before they affect tissue integrity and supports unattended operation by triggering automatic recovery rather than requiring operator intervention.

[0020] In some embodiments, the cutting module comprises at least one blade configured for cutting a histological slice from the cooled tissue sample. The blade is, in some embodiments, configured for removing a section of the tissue sample to form a planar surface appropriate for cutting a histological slice; in alternative or additional embodiments, the platform comprises a planing mechanism configured for creating a planar surface, the planing mechanism comprising a planar surface configured for applying pressure to the tissue before or during cooling. Forming a planar tissue surface — by removal-based blade trimming or by an active planing mechanism applying pressure during cooling — provides the technical benefit of presenting a flat reference plane to the cutting blade, enabling consistent section thickness and reducing the rate of partial-thickness or torn sections that conventionally arise when sectioning a non-planar frozen surface.

[0021] In some embodiments, the cutting module is associated with a blade cooling arrangement configured for lowering the temperature of at least one blade. The blade cooling arrangement is, in some embodiments, configured to lower the blade temperature between subsequent cuts; in further embodiments, the cooling module is configured to lower the tissue sample temperature between subsequent cuts. Pre-cooling the blade between successive cuts and pre-cooling the tissue between successive cuts together control the thermal recovery time of both the blade and the block, supporting reproducible section quality across multiple sections from the same specimen and across rapid intraoperative section sequences.

[0022] In some embodiments, the cutting module is configured to maintain a knife thermoelectric cold plate at an operational setpoint continuously during cartridge processing, including during idle intervals between successive sectioning strokes and between successive specimen cartridges, such that, upon engagement of a blade and blade-receiving insert at a temperature warmer than said setpoint, the blade and insert assembly attains operational temperature primarily by thermal mixing with the precooled cold plate; and wherein the operational setpoint is selected such that the blade temperature is at least approximately five degrees Celsius colder than the operational setpoint of the cooling module so that net thermal flux during sectioning flows from the tissue section into the blade. Maintaining the knife thermoelectric cold plate at the operational setpoint continuously throughout cartridge processing — including idle intervals — eliminates per-section blade re-cooling delays and supports a deterministic per-section time budget; the warmer-blade-than-tissue convention ensures net thermal flux flows from tissue into blade, advantageously preventing blade-induced tissue thaw at the cutting interface.

[0023] In some embodiments, at least one blade is disposable. In further embodiments, the platform is configured such that a blade is used only to cut a single tissue sample and is disposed thereafter. The cutting module is, in further embodiments, associated with a stack of disposable blades, or alternatively configured for insertion of at least one external blade into the cutting module. Use of a single-use blade per tissue specimen advantageously eliminates blade-mediated cross-contamination between successive specimens and removes the operator burden of inter-specimen blade cleaning and resharpening; the disposable-blade architecture supports unattended operation and reduces the variability in section quality that conventionally tracks with blade wear.

[0024] In some embodiments, the cutting module further comprises a control arrangement configured for controlling movement of at least one blade during a cutting operation, including: bringing the blade into contact with the tissue sample and monitoring resistance to blade movement during cutting; verifying that the blade is aligned with the cooled tissue sample before a cutting operation; and controlling movement of the blade to determine a thickness of the histological slice. The control arrangement is, in some embodiments, associated with at least one imaging unit configured for obtaining visual data of the tissue sample before, during, and after a cutting operation. Closed-loop monitoring of blade-movement resistance and visual confirmation of blade alignment before each cutting operation provide automated equivalents of the manual feel-and-look checks conventionally performed by a trained histotechnologist, enabling the platform to detect and respond to blade misalignment, dulling, or unexpected resistance without operator intervention.

[0025] In some embodiments, the cutting module is configured to execute a mechanical blade alignment cycle prior to the first sectioning stroke per cartridge, the alignment cycle comprising: (i) loading the blade in a compliant grip permitting angular compliance of the blade relative to a blade housing; (ii) advancing the blade into physical contact with a surface of the frozen tissue block such that the blade self-aligns to the surface plane by the compliant grip; (iii) locking the blade in the self-aligned orientation by a self-locking lead screw mechanism wherein the resulting clamping force is maintained passively without continued motor energization; and (iv) retracting the blade by an overshoot distance plus the first-section thickness, positioning the blade for an initial sectioning stroke. The mechanical blade alignment cycle advantageously eliminates the need for the operator-dependent visual blade-tilt adjustment that historically governs section uniformity in manual cryosectioning; the self-locking, mechanically-referenced alignment is reproducible across cartridges and across operators, and the passive locking maintains the alignment without standing motor current, reducing electrical load and avoiding alignment drift caused by motor heating.

[0026] In some embodiments, at least one blade is configured for partially cutting the histological slice such that it remains attached to the tissue sample, and the cutting module is configured for sliding the blade underneath the histological slice and for retracting the blade after cutting, leaving the histological slice on the tissue sample. Thecutting module further comprises, in some embodiments, a slice scoop configured for receiving the at least partially cut histological slice during cutting, the slice scoop being angled to at least one blade and being optionally disposable or integrated with at least one blade. Partial cutting and slide-mediated section pickup — wherein the section remains attached to the tissue block until the slide engages it, optionally with a slice scoop — provides the technical benefit of preserving section flatness during transfer and avoiding the section-curl artifact that conventionally arises when a fully detached frozen section is moved between blade and slide.

[0027] In some embodiments, the platform further comprises a Slicing Quality Control System configured to acquire image data of each tissue section immediately following sectioning and prior to tissue-to-slide transfer, the Slicing Quality Control System comprising an imaging sensor, an illumination source, and one or more imageprocessing modules executing a classifier selected from one or more of: a computer vision algorithm, a classical image-processing algorithm, a machine learning classifier, and a convolutional neural network classifier; the classifier configured to determine whether the tissue section satisfies one or more diagnostic-quality criteria, sections satisfying the criteria being routed by the tissue-to-slide transfer unit onto a microscope slide and sections failing the criteria being routed to a Waste Management System without transfer to a slide. The pre-transfer Slicing Quality Control System advantageously replaces the human accept / reject decision conventionally performed by a trained histotechnologist on each freshly cut section; the automated decision is uniform across operators, occurs in situ at the cutting region within the per-section time budget, prevents downstream resources (slide, staining reagents, imaging time, pathologist attention) from being expended on a defective section, and enables a reslicing stroke to be triggered automatically when the section is rejected, thereby supporting truly autonomous unattended operation of the platform.

[0028] In some embodiments, the sampling module comprises at least one slide configured for placing thereon a histological slice. The slide is, in some embodiments, provided with a barcode configured for being indexed according to the tissue sample. The sampling module is, in some embodiments, configured for bringing at least one slide into contact with the at least partially cut histological slice such that contact causes attachment of the histological slice to the slide, the attachment being based in some embodiments on electrostatic forces. The sampling module is, in some embodiments, configured for distancing at least one slide from the tissue sample to detach the histological slice from the tissue sample. Direct tissue-to-slide transfer by adhesion — including by electrostatic adhesion in some embodiments — and controlled slide-to-block separation enable a clean, fast, and reproducible section pickup without manual paint-brush manipulation, supporting per-section transfer times within the intraoperative budget.

[0029] In some embodiments, at least one slide is engageable with a cover configured for covering at least one slide and the histological slice thereon, the cover beingconfigured for creating a closed chamber containing the histological slice. The cover is, in some embodiments, slidable between a first, open position allowing attachment of the histological slice to the slide, and a second, closed position in which it forms the closed chamber, and is integrated with at least one slide. The closed chamber comprises, in some embodiments, at least one inlet configured for introduction of a staining agent and at least one outlet configured for egress of the staining agent, the inlet and / or outlet being provided in some embodiments with a one-way valve. The cover is, in some embodiments, made of a material allowing imaging of the histological slice through the cover. The integrated slide-and-cover assembly with sealed staining chamber advantageously enables in-place staining of the deposited tissue section directly on the imaging-ready slide, eliminating manual coverslipping and the conventional sequence of separate dipping baths; the sealed chamber confines reagent volume, reduces the perslide reagent consumption, contains chemical fumes within the platform, and provides an immediately imageable optical path through the transparent cover.

[0030] In some embodiments, the sampling module is provided with a stack of slides and a dispensing mechanism configured for drawing a slide from the stack and preparing it for engaging the tissue sample. Provision of a slide stack with an automated dispensing mechanism enables continuous unattended operation across multiple sections and across multiple specimens; in some embodiments, slides are pre-loaded with barcodes that the platform reads at dispensing, automatically associating each slide with the source cartridge and supporting end-to-end specimen-slide-image traceability.

[0031] In some embodiments, the platform further comprises a staining module configured for applying at least one staining agent to the histological slide to generate a stained histological slide. The automated actuation mechanism is, in some embodiments, configured for bringing the histological slide into engagement with the staining module. The staining module is, in some embodiments, configured for introducing at least one staining agent into the closed chamber of the histological slide, optionally through at least one inlet, and / or for removing a staining agent from the closed chamber by introducing a different staining agent or a replacement fluid (e.g., air, water, alcohol, buffer solution, or other inert fluid compatible with the staining reagents). The staining module is, in some embodiments, provided with a pump configured for introducing the staining agent under pressure, and is provided with at least one staining agent outlet configured for engaging with the inlet of the closed chamber.

[0032] In some embodiments, the staining module is provided with two or more staining agents and includes a dispensing unit configured for controlling the release of each onto the slide. The dispensing unit is, in some embodiments, configured for determining a staining protocol determining one or more of dispensing order, dispensing duration, temperature, or mixture of the two or more staining agents. The staining protocol is, in some embodiments, determined according to the tissue sample introduced into the platform.

[0033] In some embodiments, each modular core tissue processing unit of a multi-core platform is provided with its own dedicated staining module, the per-core staining architecture eliminating inter-core scheduling conflicts and enabling parallel staining of specimens across cores. In an alternative embodiment, two or more cores share a centralized reagent supply with per-core distribution valves.

[0034] In some embodiments, the platform further comprises an imaging module configured for obtaining at least one image of the stained histological slide, optionally a high-resolution image obtained through a transparent cover of the stained histological slide. The automated actuation mechanism is, in some embodiments, configured for transferring the stained histological slide from the staining module to the imaging module. In some embodiments, the imaging module comprises an imaging objective positioned beneath the slide and fitted with a calibration correction collar adapted to compensate for spherical and chromatic aberrations introduced by an approximately one-millimeter-thick slide substrate, such that diffraction-limited optical performance is achieved through the slide substrate without requiring a separate cover glass.

[0035] In some embodiments, the platform further comprises an artificial intelligence (Al) diagnostic engine configured to receive a whole-slide image of an H&E-stained histological slice acquired by the imaging module and to produce, in a single inference cycle, one or more diagnostic outputs comprising any one or more of: a malignancy classification, a cancer-subtype or tissue-of-origin classification, and one or more genomic mutation status predictions. The Al diagnostic engine optionally further comprises a confidence-based referral module configured to flag low-confidence predictions for pathologist review. The platform is, in some embodiments, configured to complete acquisition of the tissue specimen, freezing, sectioning, transfer, staining, imaging, and production of the Al diagnostic output within an intraoperative interval suitable to inform intraoperative surgical decision-making while the surgical procedure is ongoing, in some embodiments within approximately ten minutes of tissue specimen receipt. The on-platform Al diagnostic engine advantageously delivers diagnostic information at the point of care within the intraoperative time budget and the confidence-based referral mechanism preserves pathologist oversight for the small subset of cases that benefit from human review, providing actionable diagnostic output to the surgeon without removing the pathologist from the loop.

[0036] In some embodiments, the platform is configured for receiving a cartridge containing the tissue sample, the platform comprising a hatch for introduction of the cartridge. The automated actuation mechanism is, in some embodiments, configured for transferring the cartridge from the hatch to the cooling module and for bringing the cartridge into engagement with the cutting module.

[0037] In some embodiments, the cartridge defines a cavity configured for receiving the tissue sample. The cartridge is, in some embodiments, provided with a lid configured for transposing between a first, open position allowing introduction of the tissue sample into the cavity, and a second, closed position in which the tissue sample is sealed withinthe cartridge. The lid is, in some embodiments, formed with a planar surface configured for applying pressure to the tissue sample at least in the closed position, deforming the tissue sample into having at least one planar surface. The cartridge further comprises, in some embodiments, a pressure mechanism comprising a pressure plate biased toward the lid, optionally perforated, for pushing the tissue sample against the lid to facilitate forming the planar surface. The cartridge is, in some embodiments, provided with a thermal fluid in which the tissue sample is configured for being submerged.

[0038] In some embodiments, the cartridge includes an identification code configured for being associated with the tissue sample placed therein. The cartridge is, in some embodiments, made of a low thermal resistance material allowing the cooling module to lower the temperature of the tissue sample contained therein when engaged, the cartridge being configured for engagement with a first and second TEC of the cooling module. The lid is, in some embodiments, removable to allow access to the tissue sample. The cartridge further comprises, in some embodiments, an extraction mechanism configured for at least partially extracting the tissue sample from the cartridge cavity, the extraction mechanism utilizing in some embodiments the pressure mechanism. The platform is, in some embodiments, configured for gradually extracting a cooled tissue sample from the cavity for a cutting operation.

[0039] In some embodiments, the cartridge comprises a geometric design facilitating alignment of the cartridge upon introduction into the platform and through subsequent transitions within the platform. The cartridge is, in some embodiments, disposable. A defined geometric alignment design on the cartridge enables the platform to passively register the cartridge upon introduction and through subsequent transitions, providing the technical benefit of repeatable cartridge orientation across specimens and supporting deterministic engagement by the freezing, slicing, and transfer subsystems without requiring operator alignment.

[0040] In some embodiments, the cartridge is integrated with at least one blade engageable with the cutting module. The cutting module includes, in some embodiments, a grip configured for gripping the blade. The blade is, in some embodiments, detachable from the cartridge during a cutting operation; in alternative embodiments, the blade is capable of performing a cutting operation without being detached. The automated actuation mechanism is, in some embodiments, configured for bringing the blade into engagement with the grip. Both the cartridge and the blade are, in some embodiments, disposable; and in some embodiments, the cartridge and the blade are configured for being cooled simultaneously, with the cartridge being cooled by the cooling module while the blade is simultaneously cooled by a cooling mechanism of the cutting module.

[0041] In some embodiments, the cartridge comprises an anti-fold arrangement configured for preventing folding of the tissue sample within the cavity, the anti-fold arrangement comprising in some embodiments a polytetrafluoroethylene (PTFE) sheet integrated into the lid. The cartridge further comprises, in some embodiments, athermally conductive open-cell metallic foam stabilization element configured to perform dual functions of mechanical retention of the tissue and thermal conduction between the cooling module and the tissue, optionally an aluminum foam material having a thermal conductivity of at least five watts per meter-kelvin.

[0042] In some embodiments, the cartridge comprises a fresh-blade holster and a spent-blade receptacle as distinct and spatially-separated features, the cutting module's gripper assembly configured to execute exactly one extraction transition and exactly one release transition per cartridge lifecycle, the extraction transition occurring upon removal of a blade-and-insert assembly from the fresh-blade holster and the release transition occurring upon deposition of the spent assembly into the spent-blade receptacle, with the gripped state being maintained throughout all intervening cutting, depth-advance, slicing-quality-control, and section-transfer operations. The spent-blade receptacle comprises, in some embodiments, one or more features selected from the group consisting of a one-way ramp, retention barbs, a sprung latch, and a closure cap, said features permitting insertion of the blade-and-insert assembly into the receptacle but resisting or preventing extraction therefrom. A lifecycle state of the cartridge, comprising one of (i) ready for sectioning and (ii) spent and ready for disposal, is encoded in a physical position of the blade-and-insert assembly within the cartridge independently of any electronic, software, or supervisory state record.

[0043] In an alternative blade-disposal embodiment, the platform further comprises a Waste Management System configured to receive the spent blade-and-insert assembly upon completion of sectioning, the cartridge in this embodiment being configured without a cartridge-side spent-blade receptacle. In a further alternative hybrid embodiment, the cartridge comprises a non-irreversible blade-receiving feature, and the cutting module's gripper selectively deposits the spent blade-and-insert assembly into either the Waste Management System or the cartridge- si de blade-receiving feature, the selection being determined by one or more of a configuration parameter, a deploymentcontext setting, and a per-cycle operator selection.

[0044] In some embodiments, the platform further comprises a waste disposal bin configured for containing disposable items, staining agents, and / or biological samples disposed of during operation, the disposable items including in some embodiments at least one blade and / or at least one cartridge.

[0045] In some embodiments, the platform is configured for outputting a sealed and stained histological slide, the slide being indexed and the indexing corresponding to the indexing of a cartridge containing the original tissue sample. In some embodiments, the platform utilizes a disposable cartridge containing the tissue sample and at least one disposable blade configured for cutting the cooled tissue sample, such that the cartridge and the blade come into contact with a single tissue sample, thereby reducing the risk of cross-contamination.

[0046] In some embodiments, the platform comprises one or more imaging devices configured for monitoring the process along the platform, the monitoring including oneor more of: alignment of the tissue sample within the cooling module; size, shape, or volume of the tissue sample; a cutting operation by the cutting module; and quality of the histological slice.

[0047] In some embodiments, the automated actuation mechanism comprises a transport arrangement configured for displacing the tissue sample and / or a container containing the tissue sample along x, y, and z axes. The transport arrangement comprises, in some embodiments, a dedicated XY motion and positioning system having either a single XY stage or, in alternative embodiments, a dual XY stage architecture comprising a first Y-axis carriage plate dedicated to cartridge transport and a second Y-axis carriage plate dedicated to slide transport, with respective cartridge X / Y motors and slide X / Y motors enabling truly simultaneous cartridge and slide handling without serial bottleneck.

[0048] In some embodiments, the platform further comprises a heat regulation unit configured for controlling the cooling of any thermal element within the platform to provide frost mitigation, the heat regulation unit comprising in some embodiments a four-layer architecture including a firmware TEC polarity-reversal defrost cycle, an active dehumidification subsystem, an XY-actuated sealing pad on the cartridge holder, and closed-cell elastomeric foam insulation on sub-dew-point surfaces.

[0049] In some embodiments, the platform is completely autonomous, the platform comprising an inlet for introducing the tissue sample and being configured for performing cooling, cutting, slide application, and analysis of the histological slide without intervention of a human user. The analysis of a tissue sample within the platform does not exceed approximately ten minutes from specimen receipt to availability of diagnostic output, suitable for use during a surgical procedure to inform intraoperative surgical decision-making.

[0050] In some embodiments, the platform further comprises a processing unit associated at least with the cooling module, the cutting module, the sampling module, and the automated actuation mechanism, and optionally with one or more of: a staining module, an imaging module, and an analysis module. The processing unit is, in some embodiments, configured for regulating the operation of any module within the platform. Centralizing operation of all subsystems under a processing unit provides the technical benefit of single-point software-defined orchestration of the complete workflow, enabling per-specimen protocol selection, per-step verification and recovery, and integrated logging of every action taken across the platform.

[0051] In some embodiments, the platform implements a hierarchical two-tier control architecture comprising a platform-level main control unit and software user interface responsible for cross-core scheduling and coordination of platform-shared subsystems, and a per-core control unit within each modular core tissue processing unit responsible for real-time coordination of subsystems internal to that core. The platform further comprises, in some embodiments, a per-core user interface providing a per-core operator status display distinct from the platform-level main user interface.

[0052] In some embodiments, the platform further comprises a user interface configured for providing a user with one or more of: indication of a pathological analysis of the tissue sample; indication on the stage of the process within the platform; indication of an error; and operation instructions.

[0053] In some embodiments, the platform constitutes part of a modular system including two or more automated tissue processing platforms configured for operating in parallel.

[0054] In accordance with a second aspect of the present invention, there is provided a method for analyzing a tissue sample using the platform of any preceding aspect, the method comprising: receiving a tissue sample; transferring the tissue sample to a freezing module; lowering the temperature of the tissue sample in the freezing module to form at least a partially frozen tissue sample; engaging the frozen tissue sample by a cutting module to at least partially cut a histological section of the frozen tissue sample; collecting the histological section by a collecting module and applying it to a slide to form a histological slide; applying a marking material to the histological slide by a staining module to generate a stained histological slide; and using an imaging module, obtaining at least one image of the stained histological slide. The recited method, by integrating receipt, freezing, sectioning, transfer, staining, and imaging into a single sequence performed within a single device, eliminates manual transfer steps between conventional stand-alone instruments and provides the technical benefit of a deterministic intraoperative-timeframe workflow that can be executed without skilled-operator intervention.

[0055] In accordance with a third aspect of the present invention, there is provided an automated tissue processing platform comprising: a cooling module configured for receiving a tissue sample and lowering its temperature to form a cooled tissue sample; a cutting module configured for at least partially cutting a histological section of the cooled tissue sample; a sampling module configured for applying the histological section to a slide to form a histological slide; a staining module configured for applying at least one staining agent to the histological slide to generate a stained histological slide; an imaging module configured for obtaining at least one image of the stained histological slide; an image processing module configured for processing at least one image and providing at least one pathological indication relating to the tissue sample; and an automated actuation mechanism associated with each of the cooling module, cutting module, sampling module, staining module, and imaging module, configured for automatically facilitating the foregoing transfers and engagements and the output of the stained histological slide.

[0056] In accordance with a fourth aspect of the present invention, there is provided a method for dual-output intraoperative tissue processing from a single tissue specimen, the method comprising: receiving the tissue specimen within a disposable cartridge; applying thermoelectric cooling from at least two opposing sides of the cartridge to form a shell-freeze tissue block — i.e., a frozen outer shell of defined depth surroundingan unfrozen tissue core; producing one or more tissue sections from the frozen outer shell of the shell-freeze tissue block; and recovering the tissue block comprising the unfrozen core for subsequent tissue preservation processing, whereby the method concurrently yields a tissue section suitable for immediate intraoperative histological analysis and a tissue core suitable for downstream formalin-fixed paraffin-embedded preservation and / or molecular analysis. The dual-output Shell-Freeze method advantageously preserves a non-frozen tissue core for definitive paraffin-embedded histology and downstream molecular characterization, removing the conventional tradeoff in which a single biopsy may be used for either intraoperative frozen-section analysis or for high-quality preservation but not both; the method thereby improves the diagnostic and molecular value extracted from any given specimen and, in particular, supports cases in which surgical decision-making and downstream targeted-therapy selection both depend on the same biopsy.

[0057] In some embodiments of the dual-output method, the depth of the frozen outer shell is estimated in real time by a shell-depth estimator module applying a thermal model parameterized by tissue class, tissue geometry, and observed thermal response data, and thermoelectric cooling is terminated when the estimated frozen shell depth meets or exceeds a minimum threshold depth sufficient for cryosectioning. The method further comprises, in some embodiments, enforcing a cumulative Z-axis advance limit on the blade assembly during sectioning, the Z-axis advance limit being set as a fraction of the estimated frozen shell depth, in some embodiments fifty percent or less of the estimated frozen shell depth, thereby preventing the blade from advancing into the unfrozen tissue core. The method further comprises, in some embodiments, monitoring blade cutting resistance using a force sensor and automatically retracting the blade and generating an alert signal if the cutting resistance decreases by more than a defined threshold indicative of blade penetration past the frozen outer shell. The method further comprises, in some embodiments, applying a cryogenic spray to the cutting surface of the frozen outer shell at intervals of two seconds or less between sectioning strokes.

[0058] In accordance with a fifth aspect of the present invention, there is provided a disposable cartridge for introduction into an automated tissue processing platform of any preceding aspect, the cartridge defining a cavity configured for receiving the tissue sample. The cartridge is, in further dependent embodiments, provided with a lid configured for transposing between an open and a closed position, the lid optionally formed with a planar surface for applying pressure to the tissue. The cartridge further comprises, in further dependent embodiments: a pressure mechanism comprising a pressure plate biased toward the lid, optionally perforated; a thermal fluid in which the tissue sample is submerged; an identification code; a low-thermal-resistance material; a configuration for engagement with first and second TECs of the cooling module; a removable lid; an extraction mechanism utilizing the pressure mechanism; a geometric design facilitating alignment; and an anti-fold arrangement preventing folding of the tissue sample within the cavity. The cartridge is, in further dependent embodiments,integrated with at least one blade engageable with the cutting module, the blade being detachable from the cartridge or alternatively performing the cutting operation without detachment, both the cartridge and the blade being disposable and configured for being cooled simultaneously. The disposable cartridge advantageously contains the tissue specimen — and, in some embodiments, the disposable blade — throughout the freeze and section operations, providing a single-use, single-patient consumable that eliminates the conventional cross-specimen sharing of blade, chamber, and embedding-medium hardware and that supports operator-free disposal as a unified biohazard unit.

[0059] In some embodiments of the cartridge, the cartridge comprises both a fresh-blade holster and a spent-blade receptacle as distinct and spatially-separated features as recited above with respect to the system aspect, the cartridge thereby constituting a unified biohazard-sharps consumable in which a contained spent blade is mechanically prevented from inadvertent re-deployment, and a lifecycle state of the cartridge is encoded in a physical position of the blade-and-insert assembly within the cartridge independently of any electronic, software, or supervisory state record. Encoding the cartridge lifecycle state in the physical position of the blade-and-insert assembly within the cartridge — independent of any electronic, software, or supervisory state record — provides the technical benefit of a tamper-evident, mechanically self-validating consumable in which a contained spent blade is mechanically prevented from inadvertent re-deployment, addressing the safety concern of accidental reuse of a blade that has contacted a prior patient's tissue.

[0060] In accordance with a sixth aspect of the present invention, there is provided a non-transitory computer-readable storage medium storing instructions that, when executed by one or more processors, cause the processors to coordinate operation of two or more of: a thermoelectric freezing unit, a tissue slicing unit, a slicing quality control system, a tissue-to-slide transfer unit, a staining module, an imaging module, and an artificial intelligence diagnostic engine, to process a tissue sample from initial placement to diagnostic output without requiring continuous human intervention. The non-transitory computer-readable storage medium enables the integrated platform's coordinated multi -sub system operation to be supplied as a software product distinct from the hardware platform itself, supporting field updates, validation versioning, and regulatory submission of the orchestration software as an independent component of the system.

[0061] In further embodiments of any preceding aspect, the disposable cartridge further comprises a cartridge lid pivotable about a rotatable lid axis between an open position permitting introduction of the tissue sample into the cartridge cavity and a closed position in which the tissue sample is sealed within the cartridge. The cooling module comprises an upper TEC assembly carried on an upper vertical Z-axis drive and a lower TEC assembly carried on a lower vertical Z-axis drive, the lower drive being operable independently of, or in coordination with, the upper drive to engage the underside of the cartridge and provide controlled bilateral compression of the cartridge between an uppercopper cone and a lower copper cone for uniform heat extraction from opposing faces of the cartridge. The upper TEC assembly carries one or more plungers that engage the cartridge lid during descent and perform three sequential mechanical functions in a freezing cycle: (i) urging the lid into the closed position during descent of the upper TEC assembly; (ii) locking the lid in the closed / sealed configuration during the freezing dwell, maintaining a sealed envelope chamber surrounding the tissue sample and intimate thermal contact between the upper copper cone and the lid; and (iii) releasing the lid for extraction after freezing.

[0062] In further embodiments, the platform further comprises lid-extraction pins fixed to an XY stage base plate of the XY motion system at a lid-drop position above a waste management system. When the cartridge holder is translated by the XY motion system to the lid-drop position, the lid-extraction pins enter proximal ends of the plungers from below and urge the plungers into an open / release configuration, thereby releasing the cartridge lid so that the lid drops by gravity into a cartridge-lid compartment of the waste management system. The lid-extraction pins are stationary platform-level features and eliminate the need for a dedicated lid-release actuator on the upper TEC assembly — the existing motion of the XY system provides all relative motion required for plunger release. This passive, motion-driven lid release advantageously simplifies the upper-TEC assembly, reduces moving parts, and provides a deterministic, gravity-driven lid disposal path into the segregated cartridge-lid compartment of the waste bin without requiring active operator handling of a contaminated cartridge lid.

[0063] In further embodiments of the cartridge aspect and any preceding aspect, the disposable cartridge further comprises a blade-insert assembly — a reusable, thermally conductive carrier that releasably retains a disposable microtome blade — held within the cartridge in a fresh-blade holster at the start of cycle and, in a first cartridge embodiment, irreversibly retained in a spent-blade receptacle at the end of cycle, thereby converting the cartridge into a unified biohazard-sharps disposal unit. The blade-insert assembly integrates an MBA spring leaf — a compliant leaf-spring element — that, when a slicing-unit gripper closes on the blade-and-insert sub-assembly (110a + lOx), accommodates manufacturing tolerances and seats a cutting edge of the disposable blade in a precise, repeatable Z-position relative to a flat reference surface of the cartridge under confirmation of a locked clamping position by a limit switch. Holding the blade-insert assembly within the cartridge — and integrating the MBA spring leaf into the blade-insert — provides the technical benefit of mechanical alignment compliance that travels with each disposable cartridge, ensuring per-cartridge bladeposition reproducibility without per-cartridge platform calibration; the blade-and-insert sub-assembly is gripped and translated as a unit, simplifying the platform-side gripper and reducing contamination paths between the cartridge and the platform.

[0064] In further embodiments of any preceding aspect, the blade-insert assembly further comprises a section-receiving pivotable surface on which a freshly cut tissue section comes to rest immediately after the cutting stroke, and an antifold sheetoverlying the section-receiving surface and configured to constrain the freshly cut frozen section from curling or folding. The platform further comprises a sectiondisposal flip actuator integrated in the blade housing and gripper assembly and configured, in response to a reject classification of the freshly cut section by a slicing quality control system, to engage a pivot interface on the section-receiving surface and rotate and the overlying antifold sheet about a flip axis to release the rejected section into a QC-reject compartment of the waste management system; on an accept classification, the section is instead handed off to the tissue-to-slide transfer unit by an accept path. The flip actuator is platform-mounted and reusable across cartridges; only the cartridge- si de parts (lOz + 10z') are consumed per cycle. The pivotable sectionreceiving surface with overlying antifold sheet advantageously preserves section flatness during the brief residence between cutting and downstream handling — a known failure mode of frozen sections — and the flip-based reject path converts the QC accept / reject decision into a single mechanical action without requiring a separate reject-pickup actuator, providing a clean per-cycle consumable interface (lOz + 10z' are renewed with the cartridge) and minimizing platform-side cross-contamination.

[0065] In further embodiments of the staining-module aspect and any preceding aspect, the staining sequence executed by the staining module terminates with a final reagent step in which a retention reagent — selected from a mounting medium, an aqueous glycerol solution, a buffered preservation fluid, an antifade medium, an optical-clearing fluid, or a combination thereof — is delivered into the sealed envelope chamber of the consumable slide assembly through the inlet diza, and the retention reagent is intentionally NOT aspirated by the outlet diza at the end of the sequence, so that the retention reagent remains within the sealed envelope chamber after retraction of the slide-engagement head and after closure of the self-sealing inlet and outlet ports (125d, 125e) of the cover member. The retained retention reagent serves one or more of the following functions: (i) facilitating subsequent slide handling, transport, and storage by maintaining a fluid-immersed environment around the tissue section; (ii) preserving the histological integrity of the section against post-staining degradation, autolysis, and reagent washout; (iii) providing optical index-matching between the cover member, the retention reagent, and the slide substrate to improve image quality during whole-slide imaging by the imaging module; and (iv) preventing dehydration of the tissue section during the interval between staining and imaging and during long-term archive. Retaining a final reagent within the sealed envelope chamber after staining provides the technical benefit of (a) maintaining the tissue section in a fluid-immersed state that preserves histological integrity during slide handling, transport, and archive; (b) optical index-matching that improves whole-slide imaging quality through the cover member; (c) prevention of section dehydration during the interval between staining and imaging; and (d) supporting downstream re-imaging or repeat-immunohistochemistry workflows from the same archived slide.

[0066] In further embodiments of any preceding aspect, the disposable blade of the tissue slicing unit is provided in one of two architectural configurations: (a) a cartridge-confined configuration, in which the disposable blade — together with the blade-insert assembly — is held captive within the disposable cartridge, specifically in the freshblade holster at the start of the cycle, and, in a first cartridge embodiment (Embodiment B), is irreversibly retained in the spent-blade receptacle of the same cartridge at the end of the cycle, and in a hybrid embodiment (Embodiment C) is routed at end of cycle to either or to the minimal blade-receiving feature under supervisory routing, the cartridge-confined configuration converting the cartridge into a unified biohazard-sharps disposal unit; and (b) a platform-confined configuration (Embodiment A), in which the disposable blade and the blade-insert assembly are not held within the cartridge but are instead handled exclusively by the slicing-unit gripper of the tissue slicing unit, which receives a fresh blade-and-insert sub-assembly from a platform-side blade magazine and discharges the spent blade-and-insert sub-assembly into a platform-side waste receptacle of the waste management system without any blade-handling features being integrated into the cartridge. The cartridge-confined configuration (a) and the platform-confined configuration (b) are alternative architectures within the scope of the present invention; the platform automatically detects, via the cartridge identifier read at the cartridge shutter, which configuration is in use and routes the blade accordingly. The cartridge-confined blade configuration converts the cartridge into a unified biohazardsharps disposal unit and eliminates platform-side blade handling between specimens; the alternative platform-confined configuration supports use cases in which a higher blade-cycle throughput is required and the cartridge is to be kept minimal; supporting both configurations within the same platform provides the technical benefit of operator selection per use case without redesign of the slicing-unit gripper.

[0067] In further embodiments of the staining-module aspect and any preceding aspect, the staining module further comprises a staining plate carrying one or more heating elements and one or more temperature sensors for closed-loop temperature regulation of the staining region during reagent dwell, with staining-plate inlet ports opening through a working face of the plate; the staining module further comprises an inlet diza and an outlet diza configured to releasably engage, respectively, an inlet valve port and an outlet valve port of a consumable cover member of a consumable slide assembly, to establish fluid-tight ingress and egress paths to a sealed envelope chamber of the consumable slide assembly when a slide-engagement head of the staining module advances toward the consumable slide assembly. The staining plate is positioned below the consumable slide assembly and provides protocol-controlled heating to the sealed envelope chamber through a slide substrate (125a / 120d) under closed-loop control of the one or more sensors. Establishing fluid-tight reagent ingress and egress through the inlet and outlet diza into the sealed envelope chamber provides the technical benefit of contained, low-volume reagent delivery directly to the sectioned tissue without bath dipping, eliminating reagent crossover between specimens and reducing per-slide reagent consumption; closed-loop heating by the staining plate enables protocol-controlled temperature elevation of the chamber for IHC and similar temperaturesensitive protocols, with reagent containment supporting consistent staining outcomes.

[0068] In further embodiments of any preceding aspect, during sectioning of the ice tissue block by the tissue slicing unit, the tissue block is held in fixed XY position relative to the slicing-unit reference frame by one or more of: (a) a friction-based axial hold in which the lower vertical Z-axis drive is mounted on a stiff structural frame and applies an axial preload force urging the lower TEC cold plate into frictional engagement with the movable conductive base of the disposable cartridge, the friction force exceeding the in-plane component of the cutting force from the blade; (b) an inner-diameter pressure coupling in which a coupling element integrated into the lower TEC cold plate is actuated, after engagement of with the inner diameter of the movable conductive base and after freezing of the tissue sample, to change the effective outer diameter of to establish a positive pressure fit between and the inner diameter of — the coupling element optionally taking the form of a collet, an expanding mandrel, an elastomeric O-ring expanded by axial compression, a hydraulic or pneumatic chuck, or a shape-memory-alloy ring; and (c) an external tissue-block coupling separate from the lower TEC and from the movable conductive base, configured to engage the frozen tissue block directly or to engage the exterior of the cartridge, as a peripheral clamp, retainer ring, side-engaging fixture, or vacuum -actuated face plate. The friction-based hold (a), the inner-diameter coupling (b), and the external coupling (c) may be employed alone or in any combination to ensure rigid registration of the frozen tissue block to the slicing-unit reference frame throughout the cutting stroke. Providing alternative tissue-hold mechanisms — friction-based axial hold, inner-diameter pressure coupling, and external block coupling — supports the wide range of cartridge geometries and cutting forces encountered across tissue types and section thicknesses; combination of two or more hold mechanisms provides the technical benefit of redundant block registration during sectioning, eliminating tissue-block movement that conventionally causes section thickness variability and chatter artifacts.

[0069] In further embodiments of any preceding aspect, the tissue sample is provided as a tissue sample with cut relief, the cut-relief tissue sample comprising one or more preformed peripheral cut reliefs configured as entry paths for the cutting blade of the tissue slicing unit. The cut reliefs enable complete epidermal sectioning of the tissue periphery in a single continuous histological section, capturing the diagnostic-critical peripheral epidermis intact and without edge tear-off or partial-thickness loss. In some embodiments, the cut reliefs are pre-formed manually by the surgeon at the time of sample harvest; in other embodiments, the cut reliefs are formed automatically by an integrated tissue-prep stage of the platform prior to placement of the cut-relief tissue sample in the disposable cartridge. The cut-relief tissue sample is particularly suited to Mohs micrographic dermatological surgery, in which the cancer margin lies along the entire epidermal perimeter of each excised layer and must be assessed in its entirety on a single section to support the per-layer accept / reject decision of the Mohs procedure.The cut-relief preparation advantageously brings autonomous-platform processing into the Mohs workflow, where the central diagnostic question is whether any cancer remains anywhere along the peripheral epidermal margin of the excised layer; the single continuous epidermal section eliminates the manual reconstruction of multiple partial sections that conventionally accompanies frozen-section Mohs interpretation.

[0070] In further embodiments of any preceding aspect, the tissue-to-slide transfer unit further comprises one or more suction needles integrated into a slide-engagement head of the transfer unit, each suction needle comprising a thin-bore lumen connectable to a vacuum source and terminating at a contact tip engaging a peripheral region of a microscope slide or of a consumable slide assembly at a contact location selected so as not to overlap the tissue-bearing region of the slide. A control unit actuates the suction needles into a holding mode at the start of slide extraction from the slide cassette — to retain the slide against the slide-engagement head as the slide-pushing solenoid advances the slide out of the cassette onto the slide holder — and again during the controlled descent of the slide-engagement head toward the freshly cut tissue section presented at the cartridge tissue block, to maintain positional registration of the slide as the tissue-bearing face makes adhesion contact with the section; the suction needles are switched to a release mode after tissue-to-slide adhesion is established. Holding the slide against the slide-engagement head by suction needles during cassette extraction and during descent toward the tissue block provides the technical benefit of positional registration of the slide throughout the transfer operation, eliminating slide drift that conventionally causes inconsistent tissue placement on the slide and ensuring repeatable tissue-bearing-region location across slides; the peripheral contact pattern of the suction needles avoids contact with the diagnostic-critical tissue-bearing region.

[0071] In further embodiments of any preceding aspect, the platform further comprises a shutter and entry management subsystem comprising two independently-controlled shutters: (i) a cartridge shutter configured to admit the disposable cartridge assembly carrying the unfrozen tissue sample to the cartridge holder of the XY motion system following barcode / RFID identification and orientation validation against a cartridge groove and the flat reference surface; and (ii) a slide shutter configured to admit the consumable slide assembly and / or a slide cassette to a slide holder of the tissue-to-slide transfer unit following barcode / RFID identification through a transfer-unit scanning interface. The cartridge shutter and the slide shutter are independently coordinated by a control unit, physically separating a cryogenic processing region — comprising the thermoelectric freezing unit and the tissue slicing unit — from a slide-handling region — comprising the staining module and the imaging module — and preventing crosscontamination between the two regions. The two-shutter architecture advantageously partitions the platform into a cold zone and a warm zone with independent thermal and humidity environments, supports parallel admission of new specimens and new slides without temporary cross-zone exposure, and reduces frost migration into the slidehandling region — a reliability concern in single-shutter cryosectioning architectures.

[0072] The foregoing aspects and embodiments are illustrative and non-limiting. Unless otherwise specified, embodiments are not mutually exclusive and may be combined in any technically compatible manner. The recitation of a range of values includes all subranges and individual values subsumed therein. Where an element is described using the term "comprising," additional elements not explicitly listed are not excluded.BRIEF DESCRIPTION OF THE DRAWINGSIn order to better understand the subject matter that is disclosed herein and to exemplify how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:

[0073] Fig. 1 A is an illustration of the platform in the operating room;

[0074] Fig. IB is a schematic block diagram of a multi-core autonomous tissue processing platform;

[0075] Fig. 2 is a schematic block diagram of the subsystem architecture of a single autonomous processing core unit;

[0076] Fig. 3 is a perspective schematic diagram of a complete autonomous processing core unit;

[0077] Fig. 4 is a perspective schematic diagram of a complete autonomous processing core unit in an alternative (less preferred) embodiment with laser surface profiling, without cross-contamination mitigation, with slides without a cover, and with the blade integrated as part of the slicing unit;

[0078] Fig. 5 is a perspective schematic diagram of a complete autonomous processing core unit with staining performed using a consumable slide assembly with cover, and imaging;

[0079] Fig. 6 is a perspective schematic diagram of a complete autonomous processing core unit with staining performed using reusable staining chambers, and imaging;

[0080] Fig. 7 is a top-view schematic of an autonomous processing core unit with a single XY motion and positioning system;

[0081] Fig. 8 is a top-view schematic of an autonomous processing core unit with the dual XY motion and positioning system (150') comprising the cartridge Y plate (150c1), the slides Y plate (150c"), the cartridge XY plate (150f), the slides XY plate (150g), and respective cartridge X / Y motors (150i' / l 50h') and slide X / Y motors (150i" / 150h") for parallel operation;

[0082] Fig. 9 is a cross-sectional process drawing of an alternative open-cartridge insertion workflow;

[0083] Fig. 10 is a cross-sectional process drawing of cartridge insertion in the closed configuration;

[0084] Fig. 11 is a cross-sectional process drawing of the freezing unit prior to cartridge engagement;

[0085] Fig. 12 is a cross-sectional process drawing of the full thermoelectric engagement with both faces of the cartridge;

[0086] Fig. 13 is a cross-sectional process drawing of frozen tissue block extraction from the cartridge;

[0087] Fig. 14 is a cross-sectional view illustrating disposal of the cartridge lid into the waste bin;

[0088] Fig. 15 is a cross-sectional view of the gripper holding the blade at the start of blade freezing;

[0089] Fig. 16 is a cross-sectional view of the gripper lifting the blade while cooling, with the gripper loosening blade tightening and the blade preloaded by a leaf spring;

[0090] Fig. 17 is a cross-sectional view illustrating blade alignment by contacting the blade with the tissue block surface;

[0091] Fig. 18 is a cross-sectional view of the gripper locking the blade in position;

[0092] Fig. 19 is a cross-sectional view illustrating cutting of a histological section, with the quality control camera capturing the section;

[0093] Fig. 20 is a cross-sectional view of the quality control cameras capturing the section on the block before transfer, two cameras being employed;

[0094] Fig. 21 is a cross-sectional view illustrating section disposal in response to a reject classification by the slicing quality control system;

[0095] Fig. 22 is a cross-sectional view illustrating spray freezing;

[0096] Fig. 23 is a cross-sectional view illustrating laser surface profiling;

[0097] Fig. 24 is a cross-sectional view illustrating tissue-to-slide transfer;

[0098] Fig. 25 is a cross-sectional view illustrating three successive tissue transfers to a slide following respective successive sectioning strokes;

[0099] Fig. 26 is an enlarged detailed view of Fig. 25 illustrating the sealing element in the slide cover and the outlet port;

[0100] Fig. 27 is a cross-sectional view illustrating closing of the slide cover using a rack-and-pinion mechanism to form a sealed chamber;

[0101] Fig. 28 is a cross-sectional view of slide-assembly placement by engaging the XY rack slide holder and the barcode scanning of the slides;

[0102] Fig. 29 is a cross-sectional view of placement of the slide assembly in the XY (slides) plate;

[0103] Fig. 30 is a cross-sectional view illustrating disposal of the blade into the waste bin;

[0104] Fig. 31 is a top view of four slides placed in the XY (slides) plate before staining;

[0105] Fig. 32 is a cross-sectional view illustrating the inlet diza and the outlet diza engaging, respectively, the inlet port and the outlet port of the slide cover;

[0106] Fig. 33 is a top view of the staining plate with its heating elements engaged with the four consumable chambers;

[0107] Fig. 34 is a top view of four slides placed in the XY (slides) plate after staining;

[0108] Fig. 35 is a top view of the imaging module scanning slides;

[0109] Fig. 36 is a cross-sectional view of the imaging module;

[0110] Fig. 37 is a cross-sectional view of slides collection by the user;

[0111] Fig. 38 is a cross-sectional view of Cartridge Version 1 in the open state;

[0112] Fig. 39 is a cross-sectional view of Cartridge Version 1 in the closed state;

[0113] Fig. 40 is a cross-sectional view of Cartridge Version 1 with the freezing-unit cold plates engaged;

[0114] Fig. 41 is a cross-sectional view of Cartridge Version 1 following block extraction;

[0115] Fig. 42 is a cross-sectional view of Cartridge Version 2 in the open state;

[0116] Fig. 43 is a cross-sectional view of Cartridge Version 2 in the closed state;

[0117] Fig. 44 is a cross-sectional view of Cartridge Version 2 following freezing-unit engagement;

[0118] Fig. 45 is a cross-sectional view of Cartridge Version 2 following tissue freezing;

[0119] Fig. 46 is a cross-sectional view of Cartridge Version 3 in the open state;

[0120] Fig. 47 is a cross-sectional view of Cartridge Version 3 in the closed state;

[0121] Fig. 48 is a cross-sectional view of Cartridge Version 3 following block extraction;

[0122] Fig. 49 is a cross-sectional view of Cartridge Version 4 in the open state;

[0123] Fig. 50 is a cross-sectional view of Cartridge Version 4 in the closed state;

[0124] Fig. 51 is a cross-sectional view of Cartridge Version 5 in the open state;

[0125] Fig. 52 is a cross-sectional view of Cartridge Version 5 in the closed state;

[0126] Fig. 53 is a cross-sectional view of Cartridge Version 6 in the open state;

[0127] Fig. 54 is a cross-sectional view of Cartridge Version 6 in the closed state;

[0128] Fig. 55 is a cross-sectional view illustrating Shell-Freeze freezing of the tissue sample;

[0129] Fig. 56 is a schematic process and instrumentation diagram of a first independent fluidic unit (Unit A) of an FLD-003B dual independent fluidic units architecture of the staining module;

[0130] Fig. 57 is a schematic process and instrumentation diagram of a second independent fluidic unit (Unit B) of the FLD-003B dual independent fluidic units architecture of the staining module;

[0131] Fig. 58 is a schematic process and instrumentation diagram of a singlepump staining-module fluidic architecture; and

[0132] Fig. 59 is a schematic process and instrumentation diagram of the FLD-003A preferred staining-module fluidic architecture comprising a single reagent cartridge and a four-way distribution valve.It will be appreciated that the drawings are not shown to scale. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.DETAILED DESCRIPTION OF EMBODIMENTS Attention is first drawn to the accompanying drawings.Part 1: Overview Through Cross-Contamination Architecture

[0133] The following detailed description is presented to enable any person skilled in the art to make and use the invention. For purposes of explanation, specific details are set forth to provide a thorough understanding of the present invention. However, it will be apparent to one skilled in the art that these specific details are not required to practice the invention. Descriptions of specific embodiments and applications are provided only as examples. Various modifications to the disclosed embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. The present invention is not intended to be limited to the embodiments shown, but is to be accorded the widest possible scope consistent with the principles and features disclosed herein.

[0134] Among the technical advantages, gains, and benefits achieved by one or more embodiments of the present invention are, without limitation: (a) consolidation of the complete intraoperative tissue-section workflow — placement of a fresh tissue sample (5), freezing, sectioning, transfer to a microscope slide (125a), staining, imaging, and artificial-intelligence-assisted diagnostic analysis — into a single, autonomous, software-orchestrated device, providing a substantial reduction of elapsed time from tissue receipt to diagnostic output; (b) reproducibility of section quality across specimens and across operators, by employing closed-loop, sensor-guided automation in place of operator-dependent manual technique; (c) processing of multiple tissue specimen s (5) in parallel, supporting multi-sample intraoperative protocols including,without limitation, oncological margin assessment and Mohs micrographic surgery, and reducing the cumulative intraoperative interval associated with multi-sample workflows; (d) deployability of intraoperative pathology to surgical sites that may not have a co-located trained histotechnologist or pathologist, including without limitation field medical facilities and ambulatory surgical centres; (e) per-section automated diagnostic-quality decision making, prior to slide transfer, that supports unattended autonomous operation; (f) a comprehensive single-use contamination-prevention architecture in which the disposable cartridge (10) contains the tissue specimen — and, in some embodiments, the disposable blade (110a) — throughout the freeze and section operations, so that no platform component that contacts patient tissue is reused between specimens; (g) tissue processing within a thermally isolated, closed controlled envelope, with the cooling, equilibration, sectioning, and transfer operations performed inside the same controlled environment; (h) tissue-aware adaptive freezing, in which platform parameters are tuned per specimen based on operator-supplied tissue class designations and on real-time observed thermal response, providing reproducible block hardness and morphology across the wide range of tissue types encountered intraoperatively; and (i) a dual-output capability in which the same single tissue specimen yields both an immediately analyzed frozen section and a preserved tissue core suitable for downstream paraffin-embedded preservation, immunohistochemistry, and molecular analysis. The further embodiments described below recite specific structural and functional features that achieve and contribute to these advantages.

[0135] As used herein, the term "autonomous" refers to operation without requiring continuous human intervention during tissue processing. An operator may initiate processing by inserting a tissue sample (5) and entering metadata, and may optionally receive and review output; all intermediate processing steps are performed by the platform without requiring human action.

[0136] As used herein, the term "frozen section method" refers to the cryosectioning technique in which fresh tissue is frozen and sectioned into thin slices for histological staining and microscopic examination, as distinguished from paraffin-embedded (FFPE) processing.

[0137] As used herein, the term "tissue class" refers to a designator selected from a predefined enumerated list of tissue types, each associated with a corresponding set of stored thermophysical parameters, as further described herein.

[0138] As used herein, the term "consumable cover member (125b)" refers to a singleuse cover element configured to form a sealed chamber over the tissue-bearing face of a microscope slide (125a), as further described herein. In some embodiments the consumable cover member (125b) comprises a transparent polymethyl methacrylate (PMMA) material; however, other optically transparent, chemically compatible materials are contemplated within the scope of this term.

[0139] Reference numerals used throughout this description correspond to those shown in the accompanying drawings. Where a reference numeral is followed by a letter (e.g.,100a, 100b), the letter designates a specific component within the subsystem identified by the numeral.General Platform Architecture and Process Overview

[0140] Referring to FIG. 1 A — an illustration of the platform in the operating room — , FIG. IB — a schematic block diagram of a multi -core platform comprising the platform overall (1), the main control unit and software user interface (la), and a plurality of processing core units (lb) — , FIG. 3 — a perspective schematic of a complete autonomous processing core unit showing the disposable cartridge (10), the thermoelectric freezing unit (100), the tissue slicing unit (110), the tissue-to-slide transfer unit (120), the staining module (130), the imaging module (140), the XY motion system (150), the cooling-loop inlet / outlet / reservoir / cold-plate (160a, 160b, 160c), the environmental control unit (170) with UV (170a) and dehumidifier (170b), the shutter (180), the slicing quality control system (200), the spray freezing system (210), the control unit (220), the user interface (230), and the waste management system (240) — , and FIG. 4 — a perspective schematic of a less-preferred alternative embodiment of the core unit, in which the laser tissue mapping subsystem (190) replaces the slicing quality control system (200), no cross-contamination mitigation is provided, slides are without a cover, and the blade is integrated as part of the slicing unit (110) — , in some embodiments the autonomous tissue processing platform (1), hereinafter also referred to as the "automated biopsy platform (1)", comprises one or more autonomous processing core unit s (lb) housed within a common platform enclosure (lb). In some embodiments, multiple processing core unit s (lb) operate in parallel, each independently processing a separate tissue specimen (5), thereby enabling concurrent multi-sample processing within a single clinical deployment. The platform is operable by individuals with no specialized histological training, such as a nurse, surgeon, or clinical technician.

[0141] In some embodiments, the platform comprises a hierarchical two-tier control architecture. A platform-level main control unit (220) and software user interface (la) is responsible for: (i) operator-facing user interaction; (ii) cross-core scheduling, dispatch, and load balancing across the plurality of modular core tissue processing unit s (lb); (111) platform-level networking via the network interface (245); and (iv) coordination of platform-shared subsystems including, without limitation, the Al Diagnostic Engine (250), the Remote Pathologist Interface (260), the Automated Diagnostic Report Generator (270), and / or shared utilities (e.g., the TEC cooling liquid system (160), the environmental control unit (170), and the Waste Management System (240)). A percore control unit (220) within each modular core tissue processing unit (lb) is responsible for the real-time coordination of the subsystems internal to that core, including, without limitation, the cartridge holder (150a), the thermoelectric freezing unit (100), the tissue slicing unit (110), the tissue-to-slide transfer unit (120), the staining module (130), the imaging module (140), and / or the in-core XY motion components. The main control unit (la) and the per-core control unit s (220)communicate via a platform-internal data bus or network. In some embodiments, the per-core user interface (230) provides a per-core operator status display distinct from the platform-level main user interface (230) integrated within the main control unit (la).

[0142] Referring to FIG. 2, in some embodiments, operation of the platform comprises one or more of the following sequential stages, each performed autonomously: (a) tissue sample (5) placement within a disposable cartridge assembly (10); (b) cartridge transport and registration; (c) tissue characterization; (d) thermoelectric freezing; (e) blade alignment; (f) tissue cryosectioning; (g) tissue-to-slide transfer; (h) staining; (i) imaging; and (j) Al-assisted diagnostic analysis. The platform is configured to complete processing of a single tissue block from tissue placement to diagnostic output within approximately ten minutes, and in some embodiments within a shorter timeframe, without requiring human intervention during processing.

[0143] In some embodiments, the core processing unit is configured to occupy a volume of less than approximately 60 * 60 * 60 cm, although larger or smaller configurations are contemplated. The platform is configured for deployment in any of: an operating theater, a surgical suite, a pathology laboratory, a remote clinic, a field medical unit, or any other clinical or research setting.

[0144] In some embodiments, the platform further comprises, without limitation, a user interface (230) for operator metadata entry and status display, a network interface (240) for transmission of digital image data and diagnostic outputs to a remote pathologist or clinical information system, and / or a control unit (220) configured to coordinate all subsystem operations.Disposable Cartridge Assembly (10)

[0145] Referring to FIG. 9 — a cross-sectional process drawing of an alternative opencartridge insertion workflow showing the cartridge (10) being inserted past the shutter (180) into engagement with the cooling-loop interface plate (160c) — , FIG. 10 — a cross-sectional process drawing of cartridge insertion in the closed configuration, showing the cartridge (10), shutter (180), and cooling-loop interface plate (160c) — , and FIG. 38 through FIG. 54, in some embodiments the disposable cartridge assembly (10) comprises a plastic insulating body (10a), the disposable cartridge assembly (10) hereinafter also referred to as the "tissue chamber (10)" or "cartridge", (10a) defining the structural shell of the cartridge, an overfill chamber (10b) for accommodating excess embedding medium (10g), a sealing ring (10c) such as a gasket and / or O-ring positioned between the upper lid and the cartridge body (10a) to prevent leakage of embedding medium during filling and freezing, a lid rotatable about a rotatable lid axis (lOd) and engageable by a self-locking snap mechanism (lOe), a flat reference surface (lOf), a preloaded embedding medium (10g) such as optimal cutting temperature (OCT) compound or comparable cryogenic embedding medium, a thermal conductive sponge (lOh) or foam (lOh), one or more thermal gap filler pad s (lOi) configured to enhance thermal coupling between the cartridge and the cooling interface, a movable conductivebase (IQj), and one or more alignment and engagement features. The flat reference surface (lOf) is manufactured to an optical flatness of two micrometers or less, and in some embodiments is fabricated from one or more of: polished glass, polished copper, polished aluminum, or other thermally conductive material capable of achieving the specified surface flatness. The flat reference surface (lOf) defines the datum plane from which the blade Z-height origin is referenced, and to which the frozen tissue block (10s) surface conforms upon freezing, as further described herein. The cartridge assembly (10) further comprises, without limitation, a thin, heat-conductive metal wall (lOn), in some embodiments black-matte coated to minimize thermal reflection, and / or in some embodiments a knurled lid grip (lOo) for operator handling. The cartridge assembly (10) may further comprise a cartridge groove (lOr) configured to mechanically couple the cartridge to a lower thermoelectric cooling unit (100b) by aligning with a corresponding feature on the cartridge holder (150a) when inserted. The frozen tissue block (10s) resulting from freezing of the tissue sample (5) together with the embedding medium (10g) is referred to herein as the ice tissue block (10s).

[0146] In some embodiments, the stabilization element within the cartridge interior is configured to perform dual functions: mechanical retention of the tissue sample (5) in a fixed orientation during freezing, and thermal conduction assistance between the thermoelectric cold plate and the tissue mass. In some embodiments, the stabilization element comprises a thermally conductive open-cell metallic foam material, and in certain embodiments an aluminum foam material having a thermal conductivity of at least five watts per meter-kelvin (W / m K). In some embodiments, the foam material is an open-reticulated aluminum foam, such as Duocel® aluminum foam or equivalent, having a porosity of 85-95% and a thermal conductivity of approximately 5-10 W / m K.

[0147] In some embodiments, the cartridge assembly (10) further comprises an antifolding member (10z') integrated into the lid of the cartridge. In some embodiments, the anti-folding member (10z') comprises, without limitation, a flexible, low-adhesion sheet material positioned to overlie the tissue section immediately following each sectioning stroke, preventing the cut section from curling, folding, and / or adhering to the blade. In some embodiments, the anti-folding member comprises a polytetrafluoroethylene (PTFE) sheet. By integrating the anti -fol ding function into the disposable cartridge (10) lid (lOw), consistent anti-folding performance is achieved on every use without requiring maintenance or recalibration of a reusable platform component.

[0148] In some embodiments, the platform supports multiple disposable cartridge (10) variants ("Cartridge Version 1" through "Cartridge Version 6"), each optimized for a different specimen class or workflow constraint. All variants share the common cartridge sub-components recited in

[0114] and differ principally in the tissue-pressing mechanism, the embedding-medium delivery, and the lid-retention features. Cartridge Version 1 (FIG. 38 — open; FIG. 39 — closed; FIG. 40 — freezing-unit engaged; FIG.41 — post-extraction) is a pre-filled cartridge having a movable conductive base (lOj)for tissue-height compensation and an internal thermal conductive sponge (lOh) or foam (lOh) functioning as an upper pressing element, with closure maintained by the selflocking snap mechanism (lOe) and the rotatable lid axis (lOd). Cartridge Version 2 (FIG. 42 — open state; FIG. 43 — closed state; FIG. 44 — following freezing-unit engagement; FIG. 45 — following tissue freezing) employs a movable base plate together with a parabolic mesh and / or spring pressing element (101) applying a distributed pressing force, and is configured to receive a tissue sample (5) and, in particular, a tissue sample (5) with cut relief (5') — i.e., a tissue sample (5) carrying one or more pre-formed peripheral cut reliefs (notches, slits, or wedge cuts) along the epidermal perimeter. The cut reliefs of the tissue sample (5') provide entry paths through which the cutting blade (110a) of the tissue slicing unit (110) enters the tissue from the periphery toward the centre, enabling complete epidermal sectioning in a single continuous histological section in which the entire diagnostic-critical peripheral epidermis is captured intact and without edge tear-off or partial-thickness loss. Cartridge Version 2 is therefore particularly suited for skin specimens bearing relaxation cuts and for Mohs micrographic surgery, in which the cancer margin lies along the entire epidermal perimeter of each excised layer and must be assessed in its entirety in a single section to support the per-layer accept / reject decision of the Mohs procedure; the parabolic mesh / spring pressing element (101) ensures that the epidermis of the tissue sample (5') conforms to the flat reference surface (lOf) in substantially planar orientation following freezing. Cartridge Version 3 (FIG. 46 — open state; FIG. 47 — closed state; FIG. 48 — post-extraction) employs a fixed static knurling surface (10m) and an elastic stabilization element (101) selected from a mesh, net, spring, foam, or sponge material, accommodating varied specimen thicknesses without active compression of a movable base; the static knurling (10m) increases friction and helps secure the ice tissue block (10s). Cartridge Version 4 (FIG. 49 — open state; FIG. 50 — closed state) incorporates an embedding-medium injection port (lOp) for in-process injection of additional embedding medium (10g) following tissue placement and a knurled lid grip (lOo) on the lid exterior for operator handling. Cartridge Version 5 (FIG. 51 — open state; FIG. 52 — closed state) is a pre-contained-embedding-medium variant with knurled lid grip (lOo), and in some embodiments includes a sapphire window in the base enabling through-base optical scanning. Cartridge Version 6 (FIG.53, 54) incorporates protrusions or ribs (lOq) on the lid interior for mechanical tissue engagement and increased friction with the frozen block, in addition to features of Versions 4 and 5. In some embodiments, two or more features from the foregoing variants are combined within a single cartridge configuration; the variant designations are illustrative and non-limiting, and the platform automatically detects and adapts to the inserted cartridge variant via the cartridge identifier read at the entry shutter. Cartridge Version 2 further comprises a movable knurled surface (10k) on the cartridge interior wall, configured to mechanically engage the embedded tissue sample so as to constrain in-plane motion of the frozen tissue block during sectioning by the cutting module (110).

[0149] In some embodiments, the cartridge assembly (10) further comprises a disposable blade (110a) insert pre-loaded within or attachable to the cartridge assembly (10). The blade insert (lOx) constitutes a single-use element discarded together with the cartridge following tissue processing, such that no blade component that has contacted patient tissue is reused between specimens. The integration of the blade insert (lOx) within the cartridge assembly is further described in Section 6 below.Thermoelectric Freezing Unit (100)

[0150] Referring to FIG. 11 through FIG. 13, in some embodiments the thermoelectric freezing unit (100) comprises a lower TEC assembly (100a), the thermoelectric freezing unit (100) hereinafter also referred to as the "cooling module (100)" or "cooling arrangement (100)", and an upper TEC assembly (100c) configured to apply cryogenic cooling to opposing faces of the cartridge assembly (10) simultaneously. The lower TEC assembly (100a) is mounted to the freezing station base (150a) and comprises a lower cold plate (100b) in thermal contact with the underside of the cartridge. The upper TEC assembly (100c) is mounted on a vertical Z-axis drive (lOOd) and comprises an upper cold plate (100g) and a plunger (lOOh) configured to engage the cartridge lid (lOw) and, in some embodiments, to close the lid by descent. Upper TEC plunger (lOOh) guides (lOOf) are chamfered to facilitate alignment with the cartridge lid (lOw) during descent. The TEC cooling liquid system (160) further comprises a cooling-loop inlet and outlet (160a) that connect the lower TEC assembly (100a) and upper TEC assembly (100c) to a liquid cooling reservoir (160b), and a cooling -loop interface plate (160c) configured to thermally couple the TEC cold side to the circulating coolant.

[0151] In some embodiments, the upper TEC plungers (lOOh) perform three sequential mechanical functions during a freezing cycle. First, during descent of the upper TEC assembly (100c) on the upper Z-axis drive (lOOd), the plungers (lOOh) engage the cartridge lid (lOw) and urge it into the closed position over the tissue chamber. Second, during the freezing dwell, the plungers (lOOh) maintain a controlled compressive load on the lid (lOw), locking the cartridge in the sealed configuration so that the sealed envelope chamber is preserved against vapor escape or lid lift-off, and ensuring intimate thermal contact between the upper copper cone (1001) and the lid surface. Third, on completion of freezing and after sectioning operations are concluded, the cartridge holder (150a) is translated by the XY motion system (150) to a lid-drop position above the waste management system (240); at this position, lid -extraction pins (150j) integrated into the XY stage base plate (150b) engage the proximal ends of the plungers (lOOh) from below and urge the plungers into an open / release configuration, thereby releasing the cartridge lid (lOw) from the upper TEC assembly. The released lid (lOw) drops by gravity into the segregated cartridge-lid compartment of the waste management system (240). Because the extraction pins (150j) are stationary features of the platform-level base plate (150b), no additional actuator is required at the upper TEC assembly to release the lid — the existing XY motion of the cartridge holder (150a)provides all required relative motion between the plungers (lOOh) and the extraction pins (150j).

[0152] In some embodiments, the upper TEC plunger s (lOOh) perform three sequential mechanical functions during a freezing cycle. First, during descent of the upper TEC assembly (100c) on the upper Z-axis drive (lOOd), the plungers (lOOh) engage the cartridge lid (lOw) and urge it into the closed position over the tissue chamber (10). Second, during the freezing dwell, the plungers (lOOh) maintain a controlled compressive load on the lid (lOw), locking the cartridge in the sealed configuration so that the sealed envelope chamber ( 125f) is preserved against vapor escape or lid lift-off, and ensuring intimate thermal contact between the upper copper cone (1001) and the lid surface. Third, on completion of freezing and after sectioning operations are concluded, the cartridge holder (150a) is translated by the XY motion system (150) to a lid-drop position above the waste management system (240); at this position, lid-extraction pins (150j) (FIG. 14 — a cross-sectional view illustrating disposal of the cartridge lid (lOw) into the waste bin via the lid-extraction pins (150j) — ) integrated into the XY stage (150) base plate (150b) engage the proximal ends of the plungers (lOOh) from below and urge the plungers into an open / release configuration, thereby releasing the cartridge lid (lOw) from the upper TEC assembly (100c). The released lid (lOw) drops by gravity into the segregated cartridge-lid compartment of the waste management system (240). Because the extraction pins (150j) are stationary features of the platform -level base plate (150b), no additional actuator is required at the upper TEC assembly (100c) to release the lid — the existing XY motion of the cartridge holder (150a) provides all required relative motion between the plungers (lOOh) and the extraction pins (150j).

[0153] In some embodiments, the lower TEC assembly (100a) is mounted on a lower vertical Z-axis drive (lOOe) that translates the assembly upward into engagement with the underside of the cartridge (10) and downward to release. The lower drive (lOOe) operates independently of, or in coordination with, the upper Z-axis drive (lOOd), enabling controlled bilateral compression of the cartridge between the upper and lower copper cone s (100k) (1001, 100k) for uniform heat extraction.

[0154] In some embodiments, during sectioning of the ice tissue block (10s) by the tissue slicing unit (110), the tissue block is held in fixed XY position relative to the lower TEC assembly (100a) by frictional engagement between the lower TEC cold plate (100b) and the movable conductive base (lOj) of the cartridge (10). The frictional engagement is maintained by an axial preload force applied through the lower vertical Z-axis drive (lOOe), which is mounted on a stiff structural frame configured to react cutting forces transmitted through the frozen tissue block (10s) without permitting XY translation of the block during the cutting stroke. Because the tissue block (10s) is frozen and rigid, it transmits the cutting force from the blade (110a) into the movable conductive base (lOj) and thence into the lower TEC cold plate (100b); the coefficient of friction between (100b) and (lOj), multiplied by the axial preload from (lOOe),exceeds the in-plane component of the cutting force, so the tissue block (10s) remains stationary relative to the slicing-unit reference frame throughout the cutting stroke.

[0155] In further embodiments, the lower TEC cold plate (100b) further comprises a coupling element (100m) — for example, a collet-style segmented sleeve, a pressure-actuated elastomeric O-ring, an expanding mandrel, a hydraulic or pneumatic chuck, or a shape-memory-alloy ring — configured such that, after axial engagement of the lower TEC cold plate (100b) into an inner diameter of the movable conductive base (lOj) and after freezing of the tissue sample (5), the coupling element (100m) is actuated to change the effective outer diameter of the lower TEC cold plate (100b) to mechanically couple (100b) to (lOj) by a positive pressure fit at the inner diameter of (lOj). The coupling element (100m) supplements, or in some embodiments replaces, the frictionbased axial hold of the preloaded lower Z-axis drive (lOOe), ensuring rigid registration of the frozen tissue block (10s) to the lower TEC throughout the cutting stroke. The coupling element (100m) is actuated only after freezing is complete, so that the cartridge can be inserted, the lower TEC engaged, and the tissue frozen with the lower TEC cold plate (100b) at its native (uncoupled) diameter, and the positive coupling is then established prior to the first sectioning stroke.

[0156] In further embodiments, the platform comprises an external tissue-block coupling (lOOn) — a mechanical retainer that is separate from the lower TEC cold plate (100b), the lower copper cone (100k), and the movable conductive base (lOj) — and is configured to engage the frozen tissue block (10s) directly, or to engage the exterior of the disposable cartridge (10) containing the block, during sectioning to prevent the tissue block from moving relative to the slicing-unit reference frame. The external coupling (lOOn) may be implemented, without limitation, as a peripheral clamp or collar that descends over the upper face of the cartridge during the cutting stroke, an external retainer ring that grips the cartridge sides, a side-engaging fixture that wedges against the plastic insulating body (10a) of the cartridge, or a vacuum -actuated face plate that applies suction to the upper surface of the frozen tissue block (10s) at one or more peripheral contact points outside the diagnostic-critical sectioning region. The external coupling (lOOn) constitutes a third alternative — and may be combined with — the friction-based hold of (lOOe) and the inner-diameter pressure coupling of (100m) recited above.

[0157] In some embodiments, the thermoelectric freezing unit (100) implements a two-stage cascaded thermal architecture. In a first stage, two air-cooled chiller thermoelectric modules pre-cool a circulating liquid coolant to approximately zero degrees Celsius, rejecting heat to the ambient environment via ducted forced-air heatsinks. In a second stage, two tissue thermoelectric modules and one knife thermoelectric module operate with the pre-cooled liquid coolant on their hot sides, achieving cold-side temperatures of negative thirty to negative forty degrees Celsius for tissue TECs and approximately negative twenty degrees Celsius for the knife TEC (110b). In some embodiments, the cold-side temperature of the tissue thermoelectricmodules reaches as low as negative sixty degrees Celsius, and in certain embodiments as low as negative seventy degrees Celsius, when the hot side of the second-stage thermoelectric modules is held at approximately zero degrees Celsius by the pre-cooled liquid coolant from the first stage; such cold-side temperatures enable rapid freezing of the tissue specimen (5) and shorten the freezing-cycle contribution to the overall platform processing-time target. The cold plates of the tissue TECs and the knife TEC (110b) are connected in parallel via a distribution manifold with balanced port diameters, ensuring uniform coolant flow and thermal performance across all cold plates.

[0158] In some embodiments, the thermoelectric freezing unit (100) further comprises one or more thermally conductive coupling element s (100m) interposed between each thermoelectric cooler cold face and the corresponding contact surface of the cartridge assembly (10) to mediate heat transfer therebetween and to provide localized thermal storage. The thermoelectric freezing unit (100) accordingly comprises, without limitation, a lower coupling element (100k) interposed between the lower TEC cold plate (100b) and the movable conductive base (lOj) of the cartridge, and / or an upper coupling element (1001) interposed between the upper TEC cold plate (100g) and the upper face of the cartridge lid (lOw). In a preferred configuration, each coupling element (100m) comprises, without limitation, a truncated conical body (frustum) fabricated from high-purity copper, having a base diameter of approximately 50 mm dimensioned to substantially overlap the active area of the corresponding TEC cold face, a tip diameter of approximately 20 mm dimensioned to match the thermal contact footprint of the corresponding cartridge interface, and / or an axial height of approximately 20 mm.

[0159] The frustoconical geometry of each coupling element (100k, 1001) serves a dual purpose. First, the geometry provides an area transition from the larger TEC cold face to the smaller cartridge interface while maintaining a low conductive thermal resistance, on the order of approximately 0.07 °C / W given copper's thermal conductivity of approximately 385 W / (m K), such that the temperature drop across the element under operational heat loads (e.g., approximately twenty watts) is on the order of one to two degrees Celsius and is negligible relative to the overall freezing-cycle temperature span. Second, the substantial mass of the copper body (approximately 0.18 kg per cone in the foregoing embodiment) functions as a pre-cooled thermal reservoir, in some embodiments referred to as a "cold battery," wherein the coupling element (100m) is pre-conditioned to a sub-zero temperature (e.g., approximately negative fifty degrees Celsius) prior to tissue engagement, thereby storing on the order of several kilojoules of latent cooling capacity available for rapid extraction during the initial freezing transient. The stored thermal energy, in cooperation with continuous active cooling provided by the corresponding TEC, enables the assembly to overcome the latent-heat barrier of the phase-change zone (approximately zero degrees Celsius to negative five degreesCelsius) within a clinically acceptable interval, contributing to the overall platform processing-time target.

[0160] In some embodiments, the lower coupling element (100k) and the upper coupling element (1001) are pre-cooled in parallel during a platform pre-conditioning phase preceding cartridge insertion, such that both coupling element s (100m) are at or below the target sub-zero temperature when a freshly inserted cartridge is engaged, eliminating any cold-soak waiting period at the start of the freezing cycle.

[0161] The dimensions, geometry, and material of the coupling element s (100m) (100k, 1001) recited above are exemplary and non-limiting. In alternative embodiments, the base diameter, tip diameter, and axial height of either or both coupling element s (100m) may be varied to accommodate alternative TEC form factors, cartridge geometries, or target cooling profiles. In further alternative embodiments, the coupling element (100m) comprises one or more of: aluminum, silver, gold, or alloys thereof, or a composite material having an effective thermal conductivity of at least approximately 200 W / (m K). In still further alternative embodiments, the coupling element is configured with non-frustoconical geometry, including without limitation a stepped cylindrical profile, a parabolic taper, or a multi-stage tapered profile, provided that the dual function of area transition and pre-cooled thermal storage is preserved.

[0162] In some embodiments, the liquid coolant comprises a thirty to fifty percent solution of propylene glycol in deionized water, circulated at a flow rate of approximately 0.8 to 1.2 liters per minute through a reservoir of at least 1.5 liters capacity.

[0163] In some embodiments, the thermoelectric modules are driven by pure DC current only, with any pulse-width modulation (PWM) signal applied through a low-pass LC filter configured to reduce ripple to less than five percent of the DC value. Direct application of unfiltered PWM to the thermoelectric modules is specifically avoided, as current ripple causes thermal cycling of the TEC junctions and reduces service lifetime.

[0164] In some embodiments, the knife thermoelectric module is driven on a twelvevolt bus with a mandatory voltage clamp configured to limit the knife TEC (110b) voltage to a maximum of approximately 8.2 volts, implemented using a Zener diode voltage clamp. The voltage clamp protects against overvoltage events that would immediately destroy the knife TEC (110b). In some embodiments, the knife TEC cold plate (110b) measures approximately 20 x 40 mm and is configured to maintain the blade at approximately negative twenty degrees Celsius during and between sectioning strokes.

[0165] Referring also to FIG. 15 — a cross-sectional view of the slicing-unit gripper (110) holding the blade-and-insert sub-assembly (lOx) at the start of blade freezing, showing the knife thermoelectric cold plate (110b), the Z-axis stepper motor (110c), and the gripper stepper motor (1 lOf-GM) — , in some embodiments, the cutting blade (110a) of the autonomous sectioning subsystem is actively cooled to a temperaturesubstantially below the freezing point of the embedding medium (10g) to inhibit tissue adhesion to the blade, fouling of the cutting edge by frozen embedding medium (10g), and friction-induced surface melting at the cut interface. Said cooling is effected by a knife thermoelectric cooling module (100) thermally coupled to a high-conductivity cold plate (110b), preferably fabricated from copper and having dimensions on the order of 20 x 40 x 8 mm, which in turn engages a thermally conductive blade-receiving insert (HOi), preferably fabricated from aluminum and having dimensions on the order of 30 x 25 x 5 mm, configured to releasably retain the disposable microtome blade (110a).

[0166] In operation, the knife thermoelectric cooling module (100) maintains the cold plate (110b) at a tissue-class-dependent setpoint in the range of approximately negative fifteen to negative thirty-five degrees Celsius, with a preferred default of approximately negative twenty-five degrees Celsius. The setpoint is selected such that the blade (110a) temperature is at least approximately five degrees Celsius colder than the tissue-holder setpoint, ensuring that the net thermal flux during sectioning flows from the tissue section into the blade rather than the reverse. This thermal asymmetry is dictated by the negligible thermal mass of the resulting tissue section (typically five to ten micrometers in thickness, having a thermal capacity on the order of milligrams) relative to the blade and insert assembly, such that any heat flow from a warmer blade into the section would cause near-instantaneous local melting of the section and consequent adhesion failure during transfer to the slide.

[0167] In a further aspect, the cold plate (110b) is maintained at its operational setpoint continuously during cartridge processing, including during idle intervals between successive sectioning strokes and between successive specimen cartridges, such that the cold plate (110b) functions as a pre-cooled thermal reservoir. By virtue of said reservoir, when a blade and blade-receiving insert (llOi) at ambient or elevated temperature are introduced and grip-locked against the cold plate (110b), the assembly attains operational temperature primarily by thermal mixing with the pre-cooled reservoir, with the knife thermoelectric cooling module (100) providing only the residual cooling and steady-state load rejection (e.g., cutting friction, parasitic heat ingress). In typical embodiments, this configuration achieves a blade temperature within approximately five degrees Celsius of setpoint within seconds of grip-lock, substantially independently of the steady-state cooling capacity of the knife thermoelectric cooling module. This pre-cooled-reservoir approach contributes to the overall platform processing-time target by eliminating an extended blade pre-cooling step at the start of each sectioning cycle.

[0168] The dimensions, materials, and temperature ranges recited above for the cold plate (110b) and the blade-receiving insert (1 lOi) are exemplary and non-limiting. In alternative embodiments, the cold plate (110b) and the blade-receiving insert (1 lOi) may be fabricated from any suitable high-conductivity material, including, without limitation, without limitation copper, aluminum, silver, gold, and / or alloys thereof. In further alternative embodiments, the operational temperature setpoint of the cold plate(110b) may be varied to suit alternative tissue classes, alternative embedding-medium formulations, or alternative cutting-blade geometries, without departing from the scope of the present disclosure.

[0169] In some embodiments, the thermoelectric modules are mounted using a spring-loaded mechanism, such as a Belleville washer stack, configured to apply a controlled compression force to the thermal interface material between the TEC module and the cold plate. In some embodiments, the thermal interface material is a phase-change material configured to minimize contact resistance at the TEC-to-cold-plate interface.

[0170] In some embodiments, the thermoelectric freezing unit (100) is configured to freeze tissue sample s (5) ranging from approximately 0.3 x 0.3 x 0.3 mm to approximately 20 x 20 x 5 mm. The freezing volume is minimized by the cartridge assembly (10) design, and in some embodiments the total volume of freezing medium and tissue combined is less than approximately 5 mL.Tissue Characterization and Adaptive Freezing (TCAF) Subsystem

[0171] In some embodiments, the platform addresses a long-standing challenge in cryosectioning: a single freezing protocol cannot reliably handle the wide range of tissue specimen s (5) encountered in surgical pathology, because tissue thermal properties vary by an order of magnitude across tissue types — for example, between fatty breast tissue, parenchymal liver tissue, and dense muscle. Overdriven freezing of small or fatty specimens produces ice-crystal artifacts that destroy diagnostic morphology; underdriven freezing of dense or thick specimens leaves a soft tissue core that fragments under the blade and yields unusable sections. Conventional cryostats either rely on a single fixed cooling profile and require a trained histotechnologist to intervene when results are suboptimal, or require operator-supplied protocol selection with no in-process verification. Both approaches force operator-dependent quality control and are incompatible with autonomous, unsupervised intraoperative use. The TCAF subsystem of the present invention solves this problem with a three-layer hierarchical adaptive control architecture: it selects a candidate freezing profile from a stored thermophysical property set indexed by an operator-supplied tissue class, refines that profile using automatically measured tissue geometry acquired without added cycle time, and verifies the in-process cooling curve against an expected thermal signature, autonomously correcting deviations in real time. By combining a-priori tissue-class lookup, measured-geometry refinement, and observer-based real-time correction, TCAF eliminates the operator-dependent freezing-tune step that has historically prevented cryosectioning automation, enabling consistent section quality across the full range of tissues encountered in routine surgical pathology and freeing the system from the need for trained histotechnologist supervision during freezing.

[0172] In some embodiments, the platform implements a tissue characterization and adaptive freezing (TCAF) subsystem configured to adjust the freezing protocol to the specific thermophysical characteristics of each tissue specimen (5) prior to and duringfreezing. Referring to FIG. 11, the TCAF subsystem implements a three-layer hierarchical characterization architecture.

[0173] Layer 1 — Operator Tissue Class Input: Prior to cartridge insertion, the operator selects a tissue class from a predefined enumerated list via the user interface (230). In some embodiments, the enumerated list comprises ten or more tissue classes including one or more of: parenchymal tissue (liver, kidney), fatty breast, dense and / or fibrous breast, skin with subcutaneous fat, thin epidermal skin, lung, lymph node, muscle and / or soft tissue, bone and / or cartilage, and tissue fragments and / or curettage specimens. Each tissue class is associated with a pre-validated Tissue Thermal Property Set stored in firmware, comprising one or more of: unfrozen thermal conductivity (k unfrozen), frozen thermal conductivity (k frozen), unfrozen specific heat capacity (Cp unfrozen), frozen specific heat capacity (Cp frozen), tissue density (p), water mass fraction, effective latent heat, TEC setpoint temperature, target cooling ramp rate, minimum dwell time, and thermal equilibration criterion.

[0174] Layer 2 — Automated Geometry Measurement: In some embodiments, the platform automatically acquires two geometry parameters from each tissue specimen (5) with zero additional processing cycle time. A tissue footprint area (A tissue) is measured by the imaging sensor (120a), which in some embodiments comprises a 2D glob al -shutter CMOS imager of at least 1.2 megapixels that is dual -purposed to simultaneously decode the cartridge barcode and capture a top-down image of the tissue in the open cartridge. A color segmentation algorithm applied to the captured image extracts the tissue boundary and computes A tissue. A tissue thickness (L tissue) is measured by sensing the relative axial separation between the upper thermoelectric cooling element (100g) and the lower thermoelectric cooling element (100b) when both elements are in compressive contact with the closed cartridge assembly (10) during freezing. The position of each thermoelectric cooling element is monitored by a respective position encoder; in some embodiments, the lower thermoelectric cooling element (100b) is mounted on a movable axial stage of the freezing station and contacts the lower face of the cartridge through the movable conductive base (IQj), while in other embodiments the upper thermoelectric cooling element (100g) is mounted on a movable plunger (lOOh) that descends to contact the lid of the cartridge. In either embodiment, the tissue thickness L tissue is computed as the difference between the sensed separation distance of the upper and lower thermoelectric cooling elements with the cartridge clamped between them, and a stored reference distance corresponding to the cumulative thickness of the internal stack of cartridge components contacting the tissue and the thermoelectric cooling elements (the cumulative stack comprising, without limitation, one or more of the upper lid, the heat- conductive metal wall (lOn), the movable conductive base (1 Qj), and / or any thermal gap filler pad s (lOi) interposed in the thermal path). The stored reference distance is determined and saved by bringing the upper and lower thermoelectric cooling elements into contact with the cartridge assembly (10) in the absence of a tissue sample (5), recording the encoder positions, andpersisting the value in firmware. The thickness measurement is independent of the cartridge closure mechanism and applies equally to embodiments in which the cartridge is closed automatically by descent of an upper plunger and to embodiments in which the cartridge is closed manually by an operator prior to insertion. A tissue volume estimate (V tissue) is computed as the product of A tissue and L tissue. The 2D footprint measurement consistently overestimates volume for non-prismatic tissue geometries, producing a conservative overestimate of thermal mass, which represents a safe failure direction for freezing protocol selection.

[0175] Layer 3 — Thermal Response Observer (TRO): In some embodiments, a firmware module within the control unit (220) continuously monitors temperature sensor readings from the upper and lower TEC cold plate s (100b) at a sampling rate of at least ten hertz from the commencement of freezing. The TRO computes the observed cooling rate (dT / dt) in real time and compares it against the expected thermal signature for the selected tissue class and measured tissue geometry, the expected signature being generated from a parameterized one-dimensional thermal model using tissue classspecific thermophysical properties. If the observed cooling rate deviates from the expected profile by more than a threshold, in some embodiments plus or minus twenty-five percent, during the first five seconds of freezing, the TRO generates a tissue class mismatch signal and automatically corrects the active freezing profile to the bestmatching tissue class. All TRO computation executes concurrently with active freezing, adding no latency to the processing cycle. Referring to FIG. 11, the TRO operation is illustrated showing the observed cooling curve superimposed on the expected thermal signature and the deviation threshold triggering auto-correction.

[0176] In some embodiments, the cooling module (100) of the platform comprises multiple temperature sensors providing continuous real-time temperature feedback throughout the entire processing cycle. Specifically: a lower TEC NTC temperature sensor (lOOi) is mounted in a blind-drilled hole of approximately 1.5 mm diameter and 3 to 5 mm depth on the lower TEC cold plate (100b) with thermal epoxy fill; an upper TEC NTC temperature sensor (lOQj) is similarly mounted on the upper TEC cold plate (100g); a knife TEC (110b) NTC temperature sensor (1 lOh) is similarly mounted on the knife TEC (110b) cold plate (110b); and a coolant reservoir NTC temperature sensor (160d) is mounted in a T-fitting at the outlet of the liquid cooling reservoir (160b) of the TEC cooling liquid system (160). Each sensor comprises an NTC thermistor element of ten kilohms nominal resistance at twenty-five degrees Celsius. The control unit (220) samples each temperature sensor at a rate of at least ten hertz from cartridge insertion through final slide output, providing real-time thermal feedback for: (i) Thermal Response Observer (TRO) operation per Layer 3 of the TCAF protocol; (ii) bladereadiness verification prior to each sectioning stroke via knife sensor (1 lOh); and (iii) coolant temperature monitoring for stage- 1 chiller TEC control via reservoir sensor (160d).

[0177] In some embodiments, the control unit (220) implements a sensor-disconnect detection routine: if any temperature sensor (lOOi, lOOj, IlOh, 160d) reports an out-of-range value or fails to update within a defined timeout, the control unit (220) places the corresponding TEC into a fail-safe state, generates an operator alert via the user interface (230), logs the failure in the audit log of the control unit (220), and prevents initiation of any new sectioning or processing cycle until the failure is resolved. The fail-safe response is particularly critical for the knife TEC (110b), which is destroyed by overtemperature in the absence of voltage clamping; the sensor-disconnect routine provides a software-level safety layer in addition to the Zener voltage clamp recited in

[0126] ,Shell-Freeze Operating Mode

[0178] In some embodiments, the platform is operable in a Shell-Freeze operating mode configured to produce both a cryosectioned tissue specimen (5) suitable for immediate histological analysis and a preserved tissue core suitable for downstream molecular testing, from a single tissue specimen insertion. The Shell-Freeze mode addresses the clinical limitation that full-depth freezing destroys cellular architecture and degrades nucleic acid integrity, rendering fully frozen tissue unsuitable for next-generation sequencing (NGS) or companion diagnostic immunohistochemistry (IHC) assays that require nucleic acid integrity.

[0179] Referring to FIG. 55, in Shell-Freeze mode, dual-sided thermoelectric cooling is applied from both the upper and lower TEC cold plate s (100b), forming a frozen outer shell of defined depth surrounding an unfrozen tissue core. The OCT embedding medium (10g) surrounding the tissue perimeter also freezes rapidly, typically within one to two seconds of TEC engagement, forming a structurally continuous frozen cage around the tissue perimeter. This frozen OCT cage provides mechanical rigidity analogous to a fully frozen block, enabling stable sectioning from the frozen outer surface, while the tissue core remains unfrozen and thermally protected.

[0180] In some embodiments, the depth of the frozen outer shell is estimated in real time by a TRO Shell-Depth Estimator module executing within the control unit (220). The Shell-Depth Estimator applies a one-dimensional finite-difference thermal model parameterized by tissue class and tissue geometry measurements from the TCAF Layer 1 and Layer 2 inputs. Thermoelectric cooling is terminated when the Shell-Depth Estimator determines that the estimated frozen shell depth meets or exceeds a minimum sectionable threshold, in some embodiments 0.5 mm. Quantitative modeling results for representative tissue classes indicate that a 0.5 mm shell forms within approximately 1.6 to 1.9 seconds and a 1.0 mm shell within approximately 4.4 to 5.3 seconds in a 5 mm tissue block, providing a sectioning window of approximately 6 to 18 seconds before the tissue core temperature approaches zero degrees Celsius, depending on tissue class.

[0181] In some embodiments, the following safety mechanisms are applied during Shell-Freeze sectioning to prevent blade penetration into the unfrozen tissue core: (a) acumulative Z-axis advance limit is enforced on the blade assembly (110a), the limit being set as a fraction of the estimated frozen shell depth, in some embodiments fifty percent or less, preventing the blade from advancing into the core regardless of the number of sectioning strokes; (b) a force sensor (110g) monitors cutting resistance during each sectioning stroke, and the blade assembly is automatically retracted and a shell breach alert (SHELL BREACH) is generated if cutting resistance decreases by more than a defined threshold indicative of penetration past the frozen shell into the unfrozen core; and (c) an infrared surface temperature sensor (210c) monitors the cutting surface temperature before each stroke and triggers a cryogenic spray burst if the surface temperature rises above a defined threshold.

[0182] In some embodiments, the spray freezing system (210) operates in a mandatory continuous-assist mode during Shell-Freeze sectioning, with cryogenic spray applied at intervals of two seconds or less between sectioning strokes, maintaining the frozen shell at the cutting surface and replenishing the thermal margin consumed by the sectioning stroke.

[0183] In some embodiments, following completion of the sectioning phase in Shell-Freeze mode, the remaining tissue block comprising the unfrozen core is recovered via a dedicated tissue retrieval pathway and made available for immediate transfer to formalin fixative for FFPE processing. In some embodiments, the total time from completion of the last section to availability of the tissue block for fixation is sixty seconds or less, ensuring that the cold ischemia time budget for molecular integrity preservation is not exceeded.Tissue Slicing Unit (110) and Blade Alignment

[0184] In some embodiments, the tissue slicing unit (110) addresses two challenges that have historically prevented full automation of cryosectioning. First, precise blade-to-block angular alignment must be re-established for every tissue block, because thermal contraction of the embedding medium (10g) and small mechanical tolerances in cartridge seating produce angular errors that, if uncorrected, cause sections of non-uniform thickness or incomplete sectioning. Existing approaches rely either on manual angular adjustment by a trained histotechnologist — slow, skill-dependent, and incompatible with autonomous operation — or on optical surface profilometry sensors such as laser-based three-dimensional mapping, which add cost, calibration burden, and a vibration-sensitive optical alignment subject to drift. Second, blade crosscontamination between specimens has remained a residual contamination risk in clinical cryosectioning, particularly significant in oncological margin assessment where contaminating cells from a previous malignant specimen on a reused blade could produce false-positive findings on a subsequent benign margin. The mechanical blade alignment (MBA) subsystem of the present invention solves the alignment problem by using the optically flat reference surface (1 Of) of the cartridge assembly (10) itself as the alignment datum: the blade is engaged in a compliant grip, advanced into direct physical contact with the frozen block surface, allowed to self-align by mechanical compliance,and then locked passively by a self-locking lead-screw mechanism — eliminating the need for any optical sensor or operator alignment input while achieving alignment accuracy comparable to or better than laser profilometry at substantially lower cost and complexity. The integrated disposable blade (110a) insert further described in Section 6.2 solves the cross-contamination problem by ensuring that no blade element that has contacted one patient's tissue ever contacts another patient's tissue, the blade being discarded together with the cartridge and its tissue specimen (5) as a single-use unit. Together, MBA and the disposable blade (110a) insert (lOx) make autonomous, unsupervised, contamination-free cryosectioning achievable in a clinical workflow.

[0185] Referring to FIG. 21, in some embodiments the tissue slicing unit (110) comprises a blade assembly (110a), the tissue slicing unit (110) hereinafter also referred to as the "cutting module (110)", (110a), a knife thermoelectric cold plate (110b) for maintaining blade temperature, a Z-axis stepper motor (110c) for precise blade height control, a blade drive mechanism (1 lOd), a blade retraction mechanism (HOe), a blade housing and gripper assembly (1 lOf), and a force sensor (110g). The tissue slicing unit (110) further comprises, in some embodiments, a spray freezing system (210) with spray nozzle s (210b) (210a, 210b) and an infrared surface temperature sensor (210c) for cutting surface monitoring. A quality control camera (200) and quality control imaging sensor (200a) are positioned to inspect the tissue section following each sectioning stroke.

[0186] In some embodiments, the blade (110a) is a single-use surgical -grade blade configured for frozen tissue sectioning. In some embodiments, the blade is pre-loaded as an integrated component within the disposable cartridge assembly (10), as further described below. In alternative embodiments, the blade is a reusable platform component that is cleaned and replaced according to a maintenance schedule.Mechanical Blade Alignment (MBA) Subsystem — Preferred Embodiment

[0187] In some embodiments, blade alignment is performed by a mechanical blade alignment (MBA) subsystem integrated within the tissue slicing unit (110). The MBA subsystem uses the flat reference surface (lOf) of the cartridge assembly (10) as the alignment datum, exploiting the optical flatness of this surface (manufactured to <2 pm) to achieve precise blade-to-block parallelism by direct physical contact, without requiring optical profilometry sensors. Referring to FIG. 17 and FIG. 18, the MBA operates via a four-phase alignment cycle executed once per cartridge, prior to the first sectioning stroke.

[0188] Phase 1 — GRIP SOFT: The blade (110a) is loaded into the blade housing (1 lOf). A spring leaf (lOy) element (HOf-SL) within the blade housing provides initial clamping force sufficient to retain the blade against gravity while permitting angular compliance of approximately ±2° in the pitch axis. In this configuration the blade edge is free to rock relative to the housing, enabling self-alignment to a surface that is not perfectly parallel to the blade carrier.

[0189] Phase 2 — BLADE CONFORM: The Z-axis stepper motor (110c) lowers the blade toward the frozen tissue block (10s). The target Z position is computed from the known cartridge geometry, specifically the offset of the flat reference surface (lOf) from the cartridge holder datum (150a). The stepper advances the blade past this nominal target position by a configurable overshoot stroke, in some embodiments between 0.3 and 1.5 mm with a default of 0.5 mm, pressing the compliant blade edge against the frozen block surface with a contact force of five Newtons or less. The blade self-aligns to the actual surface plane of the frozen block regardless of any angular error between the block and the blade carrier, absorbed by the spring leaf (lOy) compliance. The force sensor (110g) provides confirmation of surface contact.

[0190] Phase 3 — GRIP LOCK: The gripper stepper motor (HOf-GM) drives the gripper jaw to a full-clamp position via a self-locking lead screw mechanism having a pitch angle less than its friction angle. A limit switch (HOf-LS) confirms attainment of the locked position. The motor is de-energized following lock confirmation, as the selflocking geometry of the lead screw maintains the clamping force, in some embodiments thirty Newtons or more, passively without continued motor energization. Elimination of motor energization during clamping reduces thermal dissipation in the cryogenic zone, benefiting knife TEC (110b) performance.

[0191] Phase 4 — SLICE READY: The Z-axis retracts by the overshoot distance plus the thickness of the first section, in some embodiments 0.010 mm (10 pm), positioning the blade parallel to the frozen block surface at the correct Z height for the first sectioning stroke. The system transitions to normal slicing operation.

[0192] In some embodiments, the MBA subsystem replaces the laser tissue mapping subsystem (190) described in an alternative embodiment. The laser tissue mapping subsystem (190), illustrated in FIG. 20, comprises, without limitation, a laser sensor (190a) and an illumination profiling system (190b) configured to construct a three-dimensional surface model of the frozen block for detection of tilt, Z-height origin determination, slicing region identification, and / or surface artifact detection. The MBA subsystem achieves equivalent alignment functions at lower cost and complexity by exploiting the geometric datum already inherent in the cartridge flat reference surface (lOf), which is manufactured to the optical flatness required for accurate thermal contact.

[0193] In some embodiments of the autonomous sectioning subsystem, the cutting blade (110a) and its blade-receiving insert (1 lOi) are releasably retained by the blade housing and gripper assembly (1 lOf) for the entire duration of sectioning of a given specimen block. The gripper assembly (1 lOf) executes exactly two grip transitions per cartridge lifecycle: a single extraction event at the commencement of sectioning, in which the blade-and-insert assembly is removed from a fresh-blade holster (lOt) provided within the disposable cartridge (10), and a single release event at the conclusion of sectioning. Throughout the intervening sectioning campaign, the gripper assembly (11 Of) maintains the blade (110a) in fixed thermal and geometric coupling to the cold plate (110b) andthe knife thermoelectric cooling module (100), without intervening release. Cutting is effected by translation of the specimen block past the stationary blade-and-gripper assembly, and depth advance for serial or multi-level sectioning is effected by motion of the gripper assembly (IlOf) along its Z-axis (110c) while the blade remains gripped, such that no ungrip-regrip cycle is required between successive cuts at successive depths.

[0194] The platform supports multiple alternative blade-disposal embodiments differing in the destination of the release event at conclusion of sectioning and in the corresponding cartridge architecture. Three such embodiments are described below; the embodiments are exemplary and non-limiting.

[0195] In a preferred embodiment ("Embodiment A" — production reference), the platform comprises a Waste Management System (240) configured to receive multiple categories of consumable waste generated during operation, including without limitation residual tissue fragments, depleted staining or fixation reagents, and at the conclusion of sectioning, the spent blade-and-insert assembly. Upon completion of sectioning, the blade housing and gripper assembly (IlOf) releases the blade-and-insert assembly directly into the Waste Management System (240), or into a chute, guide, or transport pathway leading thereto, such that the spent blade is co-located with other biohazard waste generated during the same processing cycle. The cartridge (10) in this embodiment comprises, without limitation, only a fresh-blade holster (lOt) without a corresponding cartridge- si de spent-blade receptacle (lOu), and / or is ejected from the platform after sectioning containing only residual tissue and the original specimen block. Advantages of this embodiment include: minimal per-cartridge manufacturing cost; consolidated sharps disposal with the platform's general waste handling; simplified cartridge handling at end of cycle; and reduced cartridge size and complexity.

[0196] In an alternative embodiment ("Embodiment B"), the cartridge (10) comprises both a fresh-blade holster (lOt) and a spent-blade receptacle (lOu) as distinct and spatially-separated features. The fresh-blade holster (lOt) is configured to releasably retain a sterile blade-and-insert assembly in geometric registration with the gripper assembly (IlOf) for precision extraction at start of cycle, whereas the spent-blade receptacle (lOu) is configured to receive and irreversibly retain the blade-and-insert assembly upon completion of sectioning. In a preferred form of Embodiment B, the spent-blade receptacle (lOu) comprises one or more geometric features selected from the group consisting of a one-way ramp, retention barbs, a sprung latch, and a closure cap, said features permitting insertion of the blade-and-insert assembly by the gripper assembly (IlOf) but resisting or preventing subsequent extraction. Upon ejection from the platform, the cartridge (10) thereby constitutes a unified biohazard-sharps consumable in which the contained blade is mechanically prevented from inadvertent or unauthorized re-deployment. By virtue of the two-receptacle architecture of Embodiment B, the lifecycle state of any cartridge — namely whether the cartridge is fresh and ready for sectioning, or spent and ready for disposal — is encoded in thephysical position of the blade-and-insert assembly within the cartridge (10), independently of any electronic, software, or supervisory state record, thereby providing a fail-safe indication of cartridge readiness that is robust against software fault, sensor failure, or loss of supervisory power.

[0197] In a further alternative embodiment ("Embodiment C" — hybrid), the cartridge (10) comprises, without limitation, a fresh-blade holster (lOt) and a minimal bladereceiving feature (lOv) that is not specifically configured for irreversible retention, and / or the platform comprises both a Waste Management System (240) and the cartridge-side blade-handling feature (lOv). The blade housing and gripper assembly (IlOf), under control of the platform's supervisory software executing on the main control unit (la) and / or the per-core control unit (220), releases the spent blade-and-insert assembly either into the Waste Management System (240) or into the cartridgeside blade-receiving feature (lOv), the selection being determined by one or more of: a configuration parameter stored in firmware, a deployment-context setting, a per-cycle operator selection input via the user interface (230), and an automatic selection responsive to platform state (e.g., capacity status of the Waste Management System (240)).

[0198] The foregoing transition sequence and disposal embodiments are exemplary and non-limiting. The blade housing and gripper assembly (1 lOf) may be configured to execute additional intermediate motions during the sectioning campaign, including without limitation translation between the cutting station, the slicing quality control station of the Slicing Quality Control System (200), and a section-transfer station, provided that the gripped state of the blade-and-insert assembly is maintained throughout. The spent-blade receptacle (lOu) of Embodiment B may be implemented using any mechanism providing functionally equivalent one-way retention. The hybrid feature (lOv) of Embodiment C may be implemented using any mechanism providing reversible blade containment. Combinations and variations of the foregoing embodiments are within the scope of the present disclosure.

[0199] In some embodiments, the blade-insert assembly (lOx) is part of the disposable cartridge (10) — held within the cartridge in the fresh-blade holster (lOt) at the start of cycle, and (in EMBODIMENT B) irreversibly retained in the spent-blade receptacle (lOu) at the end of cycle. The blade-insert assembly (lOx) is a reusable, thermally conductive carrier (e.g., aluminum, ~30 x 25 x 5 mm) that releasably retains the disposable microtome blade (110a). The blade-insert assembly (lOx) integrates an MBA spring leaf (lOy) — a compliant leaf-spring element that provides the alignment compliance underlying the Mechanical Blade Alignment function. When the slicing-unit gripper (1 lOf) closes on the blade-and-insert sub-assembly (110a + lOx), the spring leaf (lOy) accommodates manufacturing tolerances and seats the cutting edge of the blade (110a) in a precise, repeatable Z-position relative to the cartridge flat reference surface ( 1 Of); locked clamping is confirmed by the limit switch (1 lOf-LS).

[0200] In some embodiments, the blade-insert assembly (lOx) further comprises a section-receiving pivotable surface (lOz) on which the freshly cut tissue section comes to rest immediately after the cutting stroke. An antifold sheet (10z') overlies the sectionreceiving surface (lOz), constraining the freshly cut frozen section from curling, folding, or wrinkling during the brief residence time. When the Slicing Quality Control System (200) classifies the section as ACCEPT, the section is handed off to the tissue-to-slide transfer unit (120) by the normal accept path. When (200) classifies the section as REJECT, the control unit (220) commands a section-disposal flip actuator (HOj) integrated in the blade housing and gripper assembly (1 lOf). The flip actuator (1 lOj) engages a pivot interface on the cartridge-side section-receiving surface (lOz) and rotates (lOz) — together with the overlying antifold sheet (10z') and the rejected section — from a section-supporting orientation into a section-release orientation, so that the section and antifold sheet (10z') drop by gravity into the QC-reject compartment of the waste management system (240). On the next cycle, a fresh antifold sheet (10z') is presented with the next cartridge.Integrated Disposable Blade Insert in Cartridge

[0201] Referring to FIG. 16, in some embodiments the cartridge assembly (10) includes an integrated disposable blade insert (110a) pre-loaded within the cartridge. The blade insert (lOx) is a single-use element permanently attached to or received within the cartridge body (10a) such that the entire assembly — cartridge body, tissue specimen (5), and blade insert (lOx) — is discarded together following processing. This architecture eliminates the possibility of blade-to-blade cross-contamination between tissue specimens, as no blade element that has contacted patient tissue is reused.

[0202] Referring to FIG. 12, in some embodiments, cooling of the blade insert (lOx) is performed in parallel with cooling of the tissue specimen (5) during the freezing phase. Specifically, the tissue TECs (100b, 100g) cool the tissue block through the cartridge while the knife TEC (110b) simultaneously cools the blade insert (lOx) through its dedicated cold plate, both freezing operations proceeding independently and concurrently during the same cycle. The blade insert reaches its operating temperature, in some embodiments approximately negative twenty degrees Celsius, during the same time window that the tissue block reaches its target freezing temperature. This eliminates any separate blade pre-cooling step that would otherwise be required if the blade were a reusable platform component that needed to be pre-cooled independently.

[0203] Following the parallel freezing phase, the platform gripper assembly (IlOf) engages the blade insert (lOx) and the MBA alignment cycle proceeds as described in Section 6.1, with the MBA mechanism operating on the disposable blade (110a) insert in the same manner as it would on a reusable blade.Cross-Contamination Prevention Architecture

[0204] In some embodiments, the platform addresses a critical patient-safety challenge in surgical pathology: the risk that residual tissue, nucleic acid, or reagent carryoverfrom a prior specimen contaminates a subsequent specimen, producing false-positive findings or compromising downstream molecular assays. The risk is most acute in oncological margin assessment, where a trace of malignant DNA carried from one patient's specimen onto another patient's blade or cutting surface could be amplified, mistaken for residual disease at the margin, and lead to unnecessary additional tissue resection. Conventional cryosectioning workflows mitigate this risk through manual blade cleaning between specimens, periodic blade replacement, and chemical decontamination of the cryostat chamber — none of which is fully reliable, all of which require operator labor, and all of which fail to address the embedded ice block (10s) surfaces, blade housings, and tissue-contacting transfer paths that retain microscopic biological residues. The platform of the present invention solves this problem with a comprehensive single-use contamination prevention architecture in which every surface that contacts patient tissue is disposable, manufactured as part of the cartridge or slide consumable, and discarded together with the specimen at end of cycle. By eliminating reuse of any tissue-contacting surface between specimens, the architecture provides categorical contamination prevention that no clean-and-reuse protocol can match, removes the operator-dependent decontamination step from the workflow, and enables high-throughput, contamination-free serial processing of independent patient specimens with no inter-specimen reset time.

[0205] In some embodiments, the platform implements a comprehensive single-use contamination prevention architecture in which all surfaces that contact patient tissue are disposable and single-use. The architecture comprises the following disposable elements: (a) the cartridge body (10a), which contacts tissue and OCT embedding medium (10g); (b) the flat reference surface (lOf), which is an integral part of the disposable cartridge (10); (c) the blade insert (110a), which contacts the frozen tissue sections during sectioning; (d) the PTFE anti -fol ding sheet (10z') integrated in the cartridge lid (lOw), which contacts the cut tissue section; and (e) the consumable cover member (described in Section 10), which contacts the tissue section on the slide following transfer. In this architecture, no tissue-contacting surface is reused between specimens, eliminating the risk of specimen cross-contamination attributable to residual tissue, nucleic acid, or reagent carryover from previous specimens.

[0206] This comprehensive single-use architecture is particularly advantageous in oncological margin assessment applications, where contaminating DNA or tissue fragments from a previous malignant specimen could produce false-positive signals on a subsequent benign margin specimen, potentially leading to unnecessary additional tissue resection.Part 2: Transfer Unit Through Control UnitTissue-to-Slide Transfer Unit (120)

[0207] Referring to FIG. 22, in some embodiments the tissue-to-slide transfer unit (120) comprises an integrated barcode, the tissue-to-slide transfer unit (120) hereinafter alsoreferred to as the "sampling module (120)", and / or RFID scanning interface (120a) for cartridge and slide identification, a slide holder (120b) configured to support and optionally pre-heat one or more microscope slide s (125a), a slide cassette (120c) configured to dispense and store microscope slide s (125a), one or more microscope slide s (120d) onto which tissue sections are deposited, a Z-axis bracket (120e) and Z-axis motor (120f) cooperating to lower a slide onto the cut tissue section to effect adhesion transfer, ball plungers (120g) configured to assist slide registration and retention, a rotating axis and pinion mechanism (120h) configured to flip the slide following tissue transfer to present the tissue-bearing face in an orientation suitable for downstream staining and imaging, a transfer-unit base plate (120i) housing and supporting the foregoing components, and a slide-pushing solenoid ( 120j ) configured to dispense slides from the slide cassette (120c) into the slide holder (120b) in a controlled linear motion. The transfer unit (120) is configured to receive an individual tissue section that has been judged acceptable by the slicing quality control system (200) following each sectioning stroke, transfer the section in a substantially planar orientation onto the tissue-bearing face of a pre-positioned microscope slide ( 120d), and transport the slide to subsequent processing stations via the XY motion and positioning system (150).

[0208] In some embodiments, the tissue-to-slide transfer unit (120) further comprises one or more suction needles (120k) integrated into a slide-engagement head of the transfer unit. Each suction needle (120k) comprises a thin-bore lumen connectable to a vacuum source, the needle terminating at a contact tip configured to engage a peripheral region of a microscope slide (120d), and / or of a consumable slide assembly (125), at a contact location selected so as not to overlap the tissue-bearing region of the slide. The suction needles (120k) are operable in a holding mode, in which vacuum is applied through the lumen so as to retain the slide against the slide-engagement head, and a release mode, in which vacuum is removed. The control unit (220) actuates the suction needles (120k) into the holding mode (i) at the start of slide extraction from the slide cassette (120c), so as to retain the slide against the slide-engagement head as the slidepushing solenoid (120j) advances the slide out of the cassette and onto the slide holder (120b), and (ii) during the controlled descent of the slide-engagement head — driven by the Z-axis motor (120f) on the Z-axis bracket (120e) — toward the freshly cut tissue section presented at the cartridge tissue block, so as to maintain positional registration of the slide as the tissue-bearing face of the slide makes adhesion contact with the section. The suction needles (120k) are switched into the release mode after tissue-to-slide adhesion is established, permitting the slide — now bearing the transferred tissue section — to be flipped by the rotating axis and pinion mechanism (120h) and transported by the XY motion system (150) to the staining and imaging modules. In some embodiments, two or more suction needles (120k) are arranged in a pattern around the perimeter of the slide so as to balance holding force without contact with the tissuebearing region.

[0209] Referring to FIG. 28 — a cross-sectional view of slide-assembly placement, showing the barcode / RFID scanning interface (120a), the rotating axis and pinion (120h), and the Y-carriage plate (150c) — , in some embodiments, the transfer gripper assembly (120a) is further configured to actuate the consumable cover member (125b) associated with each microscope slide (125a), as further described in Section 9 below. The transfer gripper assembly (120a) comprises a rack-and-pinion mechanism configured to engage a rack element (125g) of the consumable cover member (125b) and translate the cover member (125b) from an open position, in which the tissuebearing face of the microscope slide (120d) is exposed for tissue section deposition, to a closed position, in which the cover member overlies the tissue-bearing face and forms a sealed envelope chamber ( 125f) enclosing the deposited tissue section. Actuation of the rack-and-pinion mechanism is performed automatically and immediately following deposition of the tissue section, minimizing the interval during which the tissue section is exposed to the ambient environment.

[0210] In some embodiments, Referring also to FIG. 23 — a cross-sectional view illustrating laser surface profiling by the laser tissue mapping subsystem (190) — an alternative embodiment to the slicing quality control system (200) — , (alternative laserprofiling embodiment), post-deposition slide-level inspection by the imaging module (140) or by an auxiliary slide-side sensor may be performed as a verification step downstream of the Slicing Quality Control System (200). The Slicing Quality Control System (200) and its operation are described separately in Section 8A below. References to slide-side QC in this Section 8 are limited to verification subsequent to tissue-to-slide adhesion and do not encompass the pre-transfer slicing QC functionality.Slicing Quality Control System (Pre-Transfer)

[0211] Referring also to FIG. 19 — a cross-sectional view illustrating cutting of a histological section, with the slicing quality control system (200) capturing the section — , In some embodiments, the platform addresses one of the principal obstacles to cryosectioning automation: the per-section accept / reject decision conventionally made by a trained histotechnologist who visually inspects each freshly cut section and decides whether it is of sufficient diagnostic quality to be transferred to a slide. Frozen sections are inherently prone to artifacts — tearing, compression, folding, ice-crystal cracking, blade-mark chatter, fragmentation, partial-thickness sectioning — and a single defective section transferred to a slide and then stained leads either to misdiagnosis or to a wasted full-cycle reprocess. Existing automated cryosectioning attempts route every cut section to a slide and rely on downstream pathologist review to catch defects, which wastes slides, reagents, time, and operator attention. The Slicing Quality Control System (200) of the present invention solves this problem by inspecting each section in situ at the cutting region, immediately after the sectioning stroke and before any transfer-arm engagement, using a high-resolution imaging sensor and one or more of computer vision, machine-learning, and convolutional -neural -network classifiers trained to recognize frozen- section artifacts. Sections judged acceptable are routed to amicroscope slide (125a) for the downstream stain-and-image cycle; sections judged defective are routed to the Waste Management System (240) without being transferred to a slide, and a re-slicing stroke is automatically triggered. By replacing the human-in-the-loop quality decision with an automated, in-process decision, the Slicing Quality Control System (200) enables truly autonomous operation, eliminates wasted downstream resources on defective sections, and provides quantitative, auditable persection quality metrics that conventional manual workflows cannot.

[0212] In some embodiments, the platform comprises a dedicated Slicing Quality Control System (200) configured to evaluate, the Slicing Quality Control System (200) hereinafter also referred to as the "quality control imaging arrangement (200)", the diagnostic suitability of each tissue section immediately after the section is cut and prior to any tissue-to-slide transfer operation. The Slicing Quality Control System (200) is functionally and logically distinct from the tissue-to-slide transfer unit (120). Each tissue section produced by the tissue slicing unit (110) is inspected by the Slicing Quality Control System (200) before the slide gripper assembly (120g) engages the section. Sections satisfying one or more diagnostic-quality criteria are routed by the tissue-to-slide transfer unit (120) onto a microscope slide (125a) for downstream staining and imaging. Sections failing one or more diagnostic-quality criteria are routed instead to the Waste Management System (240) without being transferred to a slide. The Slicing Quality Control System (200) thereby replaces the human-histotechnologist decision-making step that conventionally determines whether each freshly cut section is acceptable for further processing.

[0213] In some embodiments, the Slicing Quality Control System (200) comprises: a quality control complementary metal-oxide-semiconductor (CMOS) imaging sensor (200a) positioned with respect to the cutting region of the tissue slicing unit (110) such that each tissue section, immediately following the sectioning stroke and prior to transfer-arm engagement, is positioned within the field of view of the sensor; a Slicing Quality Control classifier module (200b) implemented as one or more image-processing modules executing on the control unit (220) and / or on a dedicated inference processing unit, the classifier module (200b) being configured to receive image data from the sensor (200a) and to compute one or more diagnostic-quality metrics on the imaged section; and an illumination source (200c) configured to illuminate the tissue section during image acquisition.

[0214] In some embodiments, the Slicing Quality Control classifier module (200b) implements one or more of: a computer vision algorithm, a classical image-processing algorithm, a machine learning classifier, and a convolutional neural network classifier, configured to detect one or more of the following sectioning artifacts in the imaged tissue section: tearing of the tissue section, compression of the tissue section, folding of the tissue section, ice-crystal cracking, presence of blade marks or chatter lines, incomplete sectioning, fragmentation, holes, and absence of tissue. In some embodiments, the classifier module (200b) is trained on a curated dataset of acceptableand defective sections of one or more tissue classes and outputs an acceptance score, a defect classification label, or both. The classifier module (200b) is functionally and architecturally distinct from the Al diagnostic engine (250) described in Section 12; the classifier module (200b) operates on a single cropped image of one freshly-cut tissue section to produce an acceptance / rej ection decision, whereas the Al diagnostic engine (250) operates on a stained whole-slide image to produce a malignancy and / or cancersubtype classification.

[0215] In some embodiments, the Slicing Quality Control System (200) further comprises one or more auxiliary inputs from the tissue slicing unit (110) and from the platform actuator subsystem, including: force-sensor data from the slicing unit (110) force sensor (110g) indicative of the cutting resistance encountered during the stroke, which is correlated with section quality, embedding-medium uniformity, and blade condition; positional feedback from the Z-axis position encoder of the slicing unit (110c) and from the slicing unit linear stage indicative of blade trajectory and stroke completion; and temperature data from the cutting region indicative of thermal conditions at the cutting surface. The control unit (220) and the classifier module (200b) fuse these auxiliary inputs with the image-derived classifier output to compute the diagnostic-quality decision.

[0216] In some embodiments, based on the diagnostic-quality decision, the control unit (220) actuates one or more of the following responses: (a) authorizing the tissue-to-slide transfer unit (120) to transfer the section to a microscope slide (125a) for adhesion, when the section is determined acceptable; (b) directing the tissue-to-slide transfer unit (120) or a dedicated waste actuator to deposit the section into the Waste Management System (240), when the section is determined unacceptable; (c) commanding the tissue slicing unit (110) to perform a repeat sectioning stroke when the prior section was unacceptable due to a recoverable cause; (d) generating an operator alert via the user interface (230) when the failure mode requires operator intervention; and (e) initiating an automated cleaning, blade-realignment, or recalibration routine when a defined number of consecutive sections fail the same defect criterion.

[0217] In some embodiments, the Slicing Quality Control System (200) may additionally perform a secondary slide-level quality verification on each section after adhesion to the microscope slide (125a), complementing the primary pre-transfer evaluation described above. Such secondary verification may use the same sensor (200a) at a different stage position, a separate slide-side imaging sensor, or the imaging module (140) operating in a low-magnification preview mode. The secondary verification provides a defense-in-depth check that the adhesion step has not introduced new artifacts (e.g., wrinkles or air gaps) but does not substitute for the primary pretransfer evaluation.

[0218] In some embodiments, the imaging optics of the Slicing Quality Control System (200) comprise a fixed focal length, macro-capable imaging lens optically matched to the pixel size of the sensor (200a). In some embodiments, the imaging lens comprises ahigh-resolution C-mount lens having a focal length of approximately sixteen to twenty-five millimeters and being configured to operate at a working distance of approximately fifty millimeters, optionally via a C-mount extension tube or by adjustment of a lens focus barrel. In some embodiments, the imaging lens is selected to be optically matched to a sensor pixel size of approximately two micrometers, such that no lens-induced blur is introduced into the diagnostic-quality classifier input. In some embodiments, the imaging lens is configured to be operated at an aperture stop of approximately f / 8 or f / 11, to maintain extended depth of field across folds, ridges, and surface nonuniformities of the tissue section.

[0219] In some embodiments, the illumination source (200c) of the Slicing Quality Control System (200) comprises a light-emitting diode (LED) ring illuminator coaxial with the imaging axis and configured to provide diffuse, shadow-free illumination of the tissue section. In some embodiments, to suppress specular reflection artifacts from moisture present on freshly cut frozen sections, the imaging lens is fitted with a linear polarizing filter and the LED ring illuminator (200c) is fitted with a linear polarizing sheet, the relative angular orientation of the polarizer and the analyzer being adjustable to substantially eliminate specular reflections from the imaged section. The crosspolarized illumination configuration enables the classifier module (200b) to evaluate the underlying tissue morphology rather than reflective glare features.

[0220] In some embodiments, the slide magazine (120b) stores multiple pre-loaded consumable slide assemblies, each comprising a microscope slide (125a) with an associated consumable cover member (125b). In some embodiments, the slide magazine has a capacity of ten or more slide assemblies, enabling unattended processing of multiple tissue sections from a single tissue block.Consumable Cover Member and Slide Assembly

[0221] Referring to FIG. 5 — a perspective schematic of a complete core unit configured with the staining module (130) using a consumable slide assembly with cover and the imaging module (140) — , FIG. 6 — a perspective schematic of a complete core unit configured with the alternative reusable-chamber staining variant (130') — , FIG. 24, FIG. 25, FIG. 26, FIG. 27, FIG. 29 — a cross-sectional view of placement of the slide assembly in the slides XY plate (150g) — , and FIG. 30 — a cross-sectional view illustrating disposal of the blade-and-insert sub-assembly (lOx) from the slicing unit (110) into the XY base plate (150b) waste path — , in some embodiments the platform employs a consumable slide assembly (125), the consumable slide assembly (125), the consumable slide assembly (125) hereinafter also referred to as the "histological slide (125)" with engageable "cover", comprising a microscope slide (125a) and a consumable cover member (125b) slidably mounted with respect to the microscope slide (125a). The consumable cover member (125b) is configured to translate between an open position (FIG. 25), in which the tissue-bearing face of the microscope slide (125a) is exposed for tissue section deposition, and a closed position (FIG. 27), in which the consumable cover member (125b) overlies the tissue-bearingface to form a sealed envelope chamber (125f) enclosing the tissue section. In some embodiments, the consumable slide assembly (125) further comprises a resilient sealing element (125c) integrated at the interface between the consumable cover member (125b) and the microscope slide (125a), the resilient sealing element (125c) comprising one or more of a circumferential rubber gasket, a thermoplastic elastomer ring, and a silicone sealing member, configured to form a fluid-tight seal of the sealed envelope chamber (125f) when the consumable cover member (125b) is in the closed position.

[0222] As used herein, the term "consumable cover member (125b)" is materialagnostic and encompasses any single-use, optically compatible cover element capable of forming a sealed chamber over the tissue-bearing face of the microscope slide (125a). In a preferred embodiment, the consumable cover member (125b) comprises a transparent polymethyl methacrylate (PMMA) cover. In alternative embodiments, the consumable cover member (125b) comprises one or more of: polystyrene, cyclic olefin copolymer (COC), polycarbonate, or other optically transparent, chemically compatible thermoplastic material. The consumable cover member (125b) is a single-use component discarded together with the microscope slide (120d) following imaging, such that no surface contacting patient tissue or staining reagents is reused between specimens.

[0223] In some embodiments, the consumable cover member (125b) comprises integrated inlet valve port (125d) and outlet valve port (125e), positioned at opposing ends of the sealed envelope chamber ( 125f). The inlet and outlet valve port s (125e) are configured to permit inflow and outflow of histological staining reagents into and from the sealed envelope chamber (125f) when the cover member (125b) is in the closed position. In some embodiments, the valve ports comprise self-sealing elastomeric septa configured to accept a staining reagent delivery needle or tube fitting with a leak-free seal.

[0224] In some embodiments, the sealed envelope chamber (125f) has a volume configured to minimize reagent consumption during staining. In some embodiments, the internal volume of the sealed envelope chamber (125f) is between 0.2 mL and 2.0 mL, and in certain embodiments approximately 0.5 mL, as compared to several milliliters consumed in conventional open-dish staining protocols. Minimization of the chamber volume reduces the volume of staining reagents required per specimen and decreases the diffusion distance for reagent delivery to the tissue section.

[0225] In some embodiments, the consumable cover member (125b) is further configured to serve as a permanent imaging coverslip. The cover member (125b) remains in the closed position during digital imaging of the stained tissue section, and the imaging module (140) acquires the image through the optically transparent cover member. In this configuration, no separate coverslipping step is required, eliminating the coverslipping substep from the tissue processing workflow. In some embodiments, the cover member has an optical thickness uniformity of one micrometer or less across the tissue-bearing area, sufficient to maintain focus consistency across the imaged field.

[0226] In some embodiments, the consumable cover member (125b) is translated from the open position to the closed position by the rack-and-pinion engagement, comprising the rack element (125g) and the pinion gear (125h) integrated within the transfer gripper assembly (120a). The rack element (125g) is formed integrally with the consumable cover member (125b), and the pinion gear (125h) is driven by a dedicated actuator within the transfer gripper assembly (1 lOf). Closure actuation is triggered by a signal from the control unit (220) immediately following confirmation of successful tissue section deposition by the quality control sensor (200a).Staining Module (130)Staining Module: Expanded (FLD-003A preferred / FLD-003B / FLD-002) Staining ModuleOverview and Design Objectives

[0227] The staining module (130) is configured to deliver one or more histological staining reagent sequences to tissue sections following transfer onto microscope slide s (125a), enabling rapid chromogenic visualization of tissue morphology for pathologist review or Al-assisted analysis. The staining module (130) of the present platform is designed to satisfy three concurrent requirements that are not addressed by prior-art staining instruments: first, compatibility with intraoperative timescales, requiring completion of a full staining sequence within sixty to ninety seconds; second, independence from trained operator intervention during the staining cycle; and third, the ability to deliver either or both of the two principal intraoperative staining modalities — hematoxylin and eosin (H&E) staining and rapid immunohistochemical (IHC) staining — to any staining chamber within the platform, optionally simultaneously, from a single reagent supply system. The following embodiments describe three alternative fluidic architectures satisfying these requirements to varying degrees. In each embodiment, all wetted surfaces in contact with staining reagents comprise one or more of: poly ether ether ketone (PEEK), Kalrez® perfluoroelastomer (FFKM), fluorinated ethylene propylene (FEP), ruby, sapphire, or high-density polyethylene (HDPE), selected for compatibility with all reagents used in H&E and IHC workflows including, without limitation, organic solvents such as xylene, alcohols, and / or chromogenic reagents.

[0228] In some embodiments, one or more reagent pump s (130g) of the staining module (130) comprise magnetically coupled gear pump s (130m) in which rotational torque is transmitted from an external motor to an internal pump rotor via a permanent magnet coupling, with no mechanical shaft penetrating the fluidic boundary. The elimination of a rotating shaft seal eliminates a primary source of reagent leakage and a primary maintenance failure mode, enabling the stated design target of seven years of maintenance-free operation without pump seal replacement. In some embodiments, the pump comprises PEEK gear elements with Kalrez O-ring seals and a 316L stainless steel pump body.

[0229] In some embodiments, non-return check valve s (130r) within the staining module (130) comprise a ruby ball element seated on a sapphire seat with a cracking pressure of one to three pounds per square inch (psi). The ruby-on-sapphire contact pair provides chemical resistance to all staining reagents, including strongly acidic and alkaline reagents, and wear resistance equivalent to or exceeding that of conventional PEEK-on-PEEK or steel-on-steel valve pairs, contributing to the maintenance-free design target.Preferred Embodiment — FLD-003A: Single Reagent Cartridge (130k) with Four-Way Distribution Valve (130o-B)

[0230] In a preferred embodiment, referring to FIG. 32, FIG. 33 — a top view of the staining plate (130y) with its heating elements (130h) engaged with the four staining chambers of the staining module (130) — , FIG. 34 — a top view of four consumable slide assemblies (125) placed in the slides XY plate (150g) after staining — , and FIG.59, the staining module (130) implements a single-cartridge, four-way distribution architecture (FLD-003A). A single reagent cartridge (130k) comprises multiple reagent reservoirs, in some embodiments six, individually associated with and selectively connectable by a reagent selection manifold (1301). The reagent selection manifold (1301) comprises a multi-port solenoid valve assembly configured to connect any one of the reagent reservoirs to a common reagent output rail while maintaining all other reservoir ports in a normally-closed state, thereby preventing cross-contamination between reagents.

[0231] The common reagent output rail connects to a magnetically coupled micro gear pump (130m) configured to deliver the selected reagent at a regulated flow rate. Downstream of the gear pump (130m), an inline filter (130n-B) assembly (130n) comprising a replaceable PEEK-fritted filter element of twenty micrometers pore size removes particulate matter, including any crystalline precipitates from hematoxylin solutions, that would otherwise score the gear pump surfaces if allowed to recirculate. In some embodiments, the gear pump (130m) and filter assembly (130n) are connected in series and positioned on the high-pressure side of the distribution valve (130o-B) to ensure filtered, metered flow to all chambers.

[0232] A chamber distribution valve (130o) is positioned downstream of the gear pump (130m) and filter assembly (130n). The chamber distribution valve (130o) is a four-port selector valve configured to direct the filtered reagent output to any one of multiple staining chambers (130p-1..4), in some embodiments a first staining chamber (130p-l), a second staining chamber (130p-2), a third staining chamber (130p-3), and a fourth staining chamber (130p-4). In some embodiments, the chamber distribution valve (130o) is a rotary solenoid selector or a four-port normally-closed solenoid manifold. Each staining chamber outlet is protected by a non-return check valve (130r) to prevent backflow and inter-chamber cross-contamination through the shared distribution valve (130o-B) during chamber dwell intervals. A waste scavenge pump (130q) providesactive evacuation of spent reagent from the staining chambers (130p-1..4) via the respective non-return check valve (130r) outlets.

[0233] The combination of the reagent selection manifold (1301) and the chamber distribution valve (130o) enables any staining protocol to be delivered to any staining chamber under software control, without requiring physical reconfiguration of the fluidic connections. The control unit (220) programs the staining sequence by specifying, for each reagent delivery step, the reagent identity (selection of the reagent selection manifold (1301)), the target chamber (selection of the chamber distribution valve (130o)), the delivery volume, and the dwell time. This architecture enables all four staining chambers (130p-1..4) to execute independent and dissimilar staining protocols — including a combination of H&E sequences and H4C antibody sequences — from a single reagent cartridge (130k).

[0234] In some embodiments, reagent delivery to each chamber is performed in a time-multiplexed manner. Because the dwell time for each staining reagent within the chamber — typically ranging from five to sixty seconds — is substantially longer than the time required to fill the chamber — typically less than one second at a flow rate of 0.5 to 1.0 mL per second — the gear pump (130m) is available to serve additional chambers during the dwell intervals of occupied chambers. The control unit (220) executes a scheduling algorithm that fills each chamber with the appropriate reagent for the current step of its protocol, then proceeds to serve the next chamber while the first dwell is in progress, returning to evacuate and refill the first chamber when its dwell is complete. In some embodiments, all four chambers complete an H&E staining sequence within ninety seconds of initiation using time-multiplexed delivery without any chamber waiting idle for more than two seconds at any point in the sequence.

[0235] In some embodiments, when the reagent selection manifold (1301) switches from a first reagent to a second reagent, a dead -volume purge step is automatically inserted by the control unit (220). The purge step directs the first several fill -volumes of new reagent through the pump and common rail and into the waste collection vessel, rather than into the staining chamber, until the entire dead volume of the common rail between the reagent selection manifold (1301) and the chamber distribution valve (130o) has been displaced by the new reagent. In some embodiments, the purge volume is at least three times the measured or estimated dead volume of the common rail segment, ensuring that the reagent delivered to the chamber does not contain carryover from the preceding reagent.

[0236] In some embodiments, the reagent reservoirs of the single reagent cartridge (130k) comprise, without limitation: a first reservoir containing a primary antibody solution for IHC; a second reservoir containing a secondary antibody or detection reagent for IHC; a third reservoir containing a chromogenic substrate such as 3,3'-diaminobenzidine (DAB); a fourth reservoir containing a hematoxylin solution; a fifth reservoir containing an eosin solution; and a sixth reservoir containing an aqueous wash buffer. The assignment of reagent identities to reservoir positions is configurable andstored in the firmware of the control unit (220), enabling the same fluidic hardware to support different staining panels by loading a different reagent cartridge (130k) and updating the firmware configuration.Alternative Embodiment A — FLD-003B: Dual Independent Fluidic Units

[0237] In an alternative embodiment, referring to FIG. 56 and FIG. 57, the staining module (130) implements a dual -independent-unit architecture (FLD-003B) comprising a first fluidic unit (130-A) and a second fluidic unit (130-B), each constituting a complete independent fluidic train and each associated with a respective reagent cartridge (130k).

[0238] The first fluidic unit (130-A) comprises a first reagent selection manifold (1301-A), a first magnetically coupled gear pump (130m-A), a first inline filter (130n-A), a first distribution valve (130o-A) and first waste scavenge pump (130q-A), connected to a first subset of staining chambers (130p-1..4), in some embodiments the first staining chamber (130p-l) and the second staining chamber (130p-2). The second fluidic unit (130-B) comprises a corresponding second set of components (1301-B, 130m-B, 130n-B, 130o-B, 130q-B), connected to a second subset of staining chambers (130p), in some embodiments the third staining chamber (130p-3) and the fourth staining chamber (130p-4). The two fluidic units share no fluid pathway, no pump, and no reagent reservoir.

[0239] The dual-unit architecture enables truly simultaneous and independent delivery of different reagents to chambers of the first and second subsets at the exact same instant, without scheduling constraints or purge delays between units. For example, the first fluidic unit (130-A) may deliver a primary antibody solution to the first and second staining chambers (130p-l, 13 Op-2) while the second fluidic unit (130-B) simultaneously delivers hematoxylin to the third and fourth staining chambers (130p-3, 130p-4), with zero inter-unit interference. This capability is particularly advantageous in cases requiring concurrent IHC and H&E analysis from the same surgical specimen.

[0240] In some embodiments, each reagent cartridge (130k) is operator-loadable as a single unit containing all reagents required for its associated protocol. In some embodiments, a first cartridge for the first fluidic unit (130-A) is pre-loaded with H&E reagents and a second cartridge for the second fluidic unit (130-B) is pre-loaded with IHC reagents specific to the tissue type and clinical application. The two cartridges may contain different reagent sets, including different primary antibodies for the IHC cartridge, enabling case-specific antibody selection by cartridge substitution without modifying the fluidic hardware.Alternative Embodiment B — FLD-002: Single-Pump Air-Push Architecture

[0241] In a further alternative embodiment, referring to FIG. 58, the staining module (130) implements a single-pump air-push architecture (FLD-002) that eliminates the waste scavenge pump (130q) of the foregoing embodiments and replaces it with a pneumatic line-clearing mechanism.

[0242] In this embodiment, multiple individual reagent selection solenoid valves (1301-1 through 1301-6) and an air vent solenoid valve (130s) and a prime bypass solenoid valve (130t) are all integrated on a single monolithic PEEK manifold block (130u). The monolithic manifold block (130u) eliminates inter-valve tubing segments, reducing total dead volume and platform footprint. The common outlet of the manifold block connects to the magnetically coupled gear pump (130m) and inline filter (130n-B) assembly (130n), and thence through a single non-return check valve (130r) to a distribution header serving all staining chambers (130p-1..4).

[0243] In this embodiment, staining chamber evacuation is performed by opening the air vent solenoid valve (130s), which admits sterile filtered air through a hydrophobic PTFE membrane air filter (130v) into the pump inlet, and operating the gear pump (130m) to drive the air through the common rail, check valve, and distribution header, displacing residual liquid reagent from all connected channels into the waste collection vessel. This air-push line clearing operation replaces the mechanical scavenge pump (130q-B) of other embodiments, reducing pump count and associated maintenance. In some embodiments, air-push clearing achieves clearance of at least three times the chamber volume of residual liquid within each staining cycle.

[0244] In this embodiment, the prime bypass solenoid valve (130t) is connected between the gear pump (130m) outlet and the waste collection vessel, bypassing the staining chambers (130p-1..4). During reagent switching, the prime bypass valve (130t) is opened and the preceding reagent is purged through the gear pump (130m) to waste until the dead volume between the selected reagent inlet and the pump outlet has been fully displaced, before the prime bypass valve (130t) is closed and the new reagent is directed to the chambers. This prevents reagent carryover into the staining chambers (130p) during protocol transitions.

[0245] In some embodiments, the FLD-002 architecture reduces the total component count of the staining fluidic circuit as compared to alternative architectures by eliminating the waste scavenge pump (130q) and per-chamber check valves, at the cost of reduced reagent delivery isolation between chambers, since all chambers share the single common distribution path without individual per-chamber inlet valves. In some embodiments, this architecture is preferred for H&E-only staining configurations, where all chambers execute the same protocol and per-chamber protocol independence is not required.Common Staining Sequence and Timing

[0246] In some embodiments, regardless of the fluidic architecture employed, the staining module (130) is configured to execute a complete rapid H&E staining sequence comprising, without limitation: a hematoxylin application step with a dwell time of fifteen to sixty seconds; one or more rinse steps; an eosin application step with a dwell time of five to thirty seconds; and a final rinse step, the total sequence being completed within ninety seconds or less from initiation. In some embodiments, an H4C staining sequence additionally comprises one or more of: an antigen retrieval step, a blockingstep, a primary antibody incubation step with a dwell time of fifteen to sixty seconds, a secondary antibody incubation step, a chromogenic substrate development step, and counterstaining steps.

[0247] In some embodiments, staining reagent flow rates, dwell times, and sequence steps are stored in a firmware-accessible staining protocol library within the control unit (220). The control unit (220) selects the appropriate protocol from the library based on the staining mode specified by the operator and the tissue class identified by the TCAF subsystem, and executes the selected protocol autonomously. In some embodiments, the staining protocol library comprises at least one H&E protocol and at least one IHC protocol, and in some embodiments multiple tissue-class-specific protocol variants within each category.

[0248] In some embodiments, the staining module (130) further comprises an inlet diza (130w) and an outlet diza (130x) configured to releasably engage, respectively, the inlet valve port (125d) and the outlet valve port (125e) of the consumable cover member (125b) of the consumable slide assembly (125). At the start of a staining step, the slideengagement head of the staining module (130) advances toward the consumable slide assembly (125) so that the inlet diza (130w) and the outlet diza (130x) simultaneously enter the inlet valve port (125d) and outlet valve port (125e) of the cover member (125b), establishing fluid-tight ingress and egress paths to the sealed envelope chamber (125f). Selected reagent flows from the cartridge (130k) through the reagent selection manifold (1301), the magnetically coupled gear pump (130m), the inline filter (130n), the chamber distribution valve (130o), and the inlet diza (130w) into the sealed envelope chamber (125f); spent reagent is aspirated through the outlet diza (130x) and routed by the waste scavenge pump (130q) to the waste management system (240). At the end of the step the slide-engagement head retracts; the self-sealing ports (125d, 125e) close behind the withdrawing diza, retaining residual reagent within the sealed chamber until the next ingress / egress event.

[0249] In some embodiments, following completion of a staining protocol, the staining module (130) is configured to introduce a replacement fluid into the sealed envelope chamber (125f) of the consumable slide assembly (125) through the inlet diza (130w), displacing residual staining reagent through the outlet diza (130x) to the waste management system (240). The replacement fluid is selected to (i) preserve the stained tissue section on the slide substrate (125a) against drying, oxidative degradation, and fluorophore fading; (ii) provide a refractive-index-matched, optically clear medium permitting high-resolution imaging by the imaging module (140) through the transparent cover member (125b); and (iii) be removable from the sealed envelope chamber (125f) by aspiration through the outlet diza (130x) under control of the waste scavenge pump (130q) in subsequent platform cycles. In some embodiments the replacement fluid is air or water. In a preferred embodiment, the replacement fluid is an aqueous glycerol / phosphate-buffered saline (PBS) solution in a ratio of about 70:30 v / v, optionally further comprising an anti-fade agent such as, without limitation, n-propyl gallate, DABCO, or an equivalent reactive-oxygen-species scavenger, the glycerol component providing both tissue preservation through reduced water activity and refractive-index matching for optical clarity, and the PBS component providing physiologically compatible buffering to maintain tissue and reagent integrity over the imaging interval. The aqueous glycerol / PBS replacement medium is configured to be removable through the outlet diza (130x) prior to disposal or to a subsequent staining or re-imaging cycle.

[0250] In some embodiments, the staining module (130) further comprises a staining plate (130y) carrying one or more heating elements (130h) and one or more sensors (130i) for closed-loop temperature regulation, with staining-plate inlet ports (130e) opening through the working face of the plate. In the alternative reusable-chamber embodiment (provisional baseline), the staining plate (130y) forms the lower wall of the reusable chamber together with (130e), the reagent distribution manifold (130c), and the evacuation pump (130f). In the preferred PCT consumable-slide embodiments, the staining plate (130y) is positioned below the consumable slide assembly (125) and provides protocol-controlled heating to the sealed envelope chamber (125f) through the slide substrate (125a / 120d) under closed-loop control of one or more sensors ( 13 Oi).

[0251] The platform comprises a shutter and entry management subsystem (180) comprising two independently-controlled shutters: a cartridge shutter (180a) and a slide shutter (180b). The cartridge shutter (180a) admits the disposable cartridge assembly (10) carrying the unfrozen tissue block to the cartridge holder (150a) of the XY motion system (150) — barcode / RFID identification, orientation validation against the cartridge groove (lOr) and flat reference surface (lOf), then motorized open / close. The slide shutter (180b) admits the consumable slide assembly (125), and / or the slide cassette (120c), to the slide holder (120b) of the tissue-to-slide transfer unit (120) — barcode / RFID identification through the transfer-unit scanning interface (120a), then motorized open / close. The cartridge shutter (180a) and the slide shutter (180b) are independently coordinated by the control unit (220), physically separating the cryogenic processing region (around the freezing unit (100) 100 and slicing unit (110) 110) from the slide-handling region (around the staining module (130) 130 and the imaging module (140) 140) and preventing cross-contamination between the two zones.

[0252] In some embodiments, each modular core tissue processing unit (lb) of a multicore platform is provided with its own dedicated staining module (130), each staining module (130) having its own reagent supply, pumps, valves, and chamber distribution architecture as recited herein. The per-core staining architecture eliminates inter-core scheduling conflicts and enables truly parallel staining of specimens across cores. In an alternative embodiment, two or more cores share a centralized reagent supply with per-core distribution valve (130o-B)s; both architectures are within the scope of the present disclosure.Imaging Module

[0253] Referring to FIG. 35 and FIG. 36, in some embodiments the imaging module (140) comprises a digital slide scanning system, the imaging module (140) being one embodiment of the "imaging module (140)" recited in the claims, configured to acquire high-resolution digital images of the stained tissue section. In some embodiments, the imaging module (140) implements a reverse scanning geometry in which the imaging objective (140a) is positioned below the microscope slide (125a), imaging the stained tissue section through the base of the slide.

[0254] In some embodiments, the imaging geometry of the imaging module (140) is configured such that the microscope slide (125a) is positioned tissue-bearing face upward and the imaging objective (140a) is positioned beneath the microscope slide (120d), the imaging objective (140a) imaging the tissue section through the substrate of the microscope slide (120d) from below. In some embodiments, the imaging objective (140a) comprises an objective lens fitted with a calibration correction collar adapted to compensate for spherical and chromatic aberrations introduced by an approximately one-millimeter-thick slide substrate, such that diffraction-limited optical performance is achieved through the slide substrate without requiring a separate cover glass between the tissue section and the imaging objective (140a). In such embodiments, no traditional glass coverslip is required for the imaging operation. In other embodiments employing a consumable cover member (125b), the cover member (125b) overlies the tissue section on the upward-facing side of the slide and is also imaged through; the cover member, in such embodiments, serves both as a sealed -chamber wall during staining and as an optically transparent imaging interface during imaging.

[0255] In some embodiments, the imaging module (140) comprises one or more of: a high-resolution CMOS imaging sensor (140b) of at least 10 megapixels effective area resolution; a motor-driven XY scanning stage (140c) configured to translate the slide in step-and-repeat fashion across the full tissue area; a Z-axis autofocus mechanism (140d) driven by a precision stepper motor; and an LED or laser illumination source (140e). In some embodiments, the imaging module (140) is configured to acquire a mosaic of overlapping field-of-view images and assemble them into a whole-slide digital image using a stitching algorithm executed by the control unit (220).

[0256] In some embodiments, the Z-axis autofocus mechanism (140d) executes a software Z-stacking algorithm configured to acquire multiple focal plane images at incremental Z positions and compute a composite focus-fused image, maintaining consistent sharpness across field curvature variations and tissue thickness nonuniformities. The Z-stacking algorithm operates concurrently with XY stage (150) translation, minimizing the total scan time.

[0257] In some embodiments, the imaging module (140) is configured to acquire a whole-slide image at a resolution equivalent to 20* or 40* optical magnification of a conventional brightfield microscope. The total imaging time for a single tissue section is, in some embodiments, sixty seconds or less at 20* equivalent resolution, contributing to the overall platform processing time target.Artificial Intelligence Diagnostic Engine

[0258] In some embodiments, the raw output of the Al diagnostic engine (250) comprises one or more of: a binary malignancy classification label; a confidence score associated with each classification; a tissue-of-origin or cancer subtype label with associated confidence; a spatial attention heatmap image co-registered to the wholeslide image; and a flag indicating whether the diagnostic confidence falls below a predefined threshold requiring mandatory human pathologist review. The raw output of the Al diagnostic engine (250) is provided as input to the Automated Diagnostic Report Generator (270), described below.Automated Diagnostic Report Generator (270)

[0259] In some embodiments, the platform further comprises an artificial intelligence (Al) diagnostic engine (250), the artificial intelligence diagnostic engine (250) hereinafter also referred to as the "image processing module (250)" or "Al model (250)". The Al diagnostic engine (250) is configured to receive a whole-slide digital image acquired by the imaging module (140) and to produce, for the tissue specimen (5) depicted in the image, one or more diagnostic indications, which may include, without limitation, a malignancy classification, a tissue-of-origin or cancer subtype classification, a per-region indication, a diagnostic confidence value, and a flag identifying images for which the diagnostic confidence falls below a defined threshold. The Al diagnostic engine (250) is, in some embodiments, implemented as a software module executing on one or more processors of the control unit (220) and / or on a dedicated inference processing unit; the internal architecture, training procedure, training corpus, and specific model parameters of the Al diagnostic engine (250) are not the subject of the present disclosure and may be selected by the implementer from among any suitable architecture, including without limitation classical computer-vision algorithms, machine-learning classifiers, convolutional neural networks, transformer architectures, vision foundation models, and any combination thereof. The total inference time of the Al diagnostic engine (250) is, in some embodiments, sixty seconds or less per slide, supporting the intraoperative time budget of the platform.

[0260] In some embodiments, the platform comprises an Automated Diagnostic Report Generator (270) configured to receive the raw output of the Al diagnostic engine (250), the whole-slide image data from the imaging module (140), and one or more items of specimen and patient metadata received from the user interface (230) and the cartridge identification subsystem, and to compose, in response thereto, a structured diagnostic report suitable for incorporation into a clinical information system. The Automated Diagnostic Report Generator (270) addresses the workflow gap between an Al inference output and a clinically usable report: a raw classification label and confidence score, by themselves, do not constitute a complete pathology report and cannot be filed in a clinical record without supplementary case-identification data, thumbnail and heatmap images, regulatory disclaimer language, and a structured data wrapper conforming toclinical interoperability standards. The Automated Diagnostic Report Generator (270) bridges this gap programmatically without operator transcription.

[0261] In some embodiments, the Automated Diagnostic Report Generator (270) outputs the structured diagnostic report in one or more of the following formats: a Health Level Seven Fast Healthcare Interoperability Resources (HL7 FHIR) DiagnosticReport resource for transmission to an electronic health record (EHR) system; a Digital Imaging and Communications in Medicine (DICOM) Structured Report (SR) object for transmission to a picture archiving and communication system (PACS); a Portable Document Format (PDF) document for human review or printout; and a comma-separated-values (CSV) or JavaScript Object Notation (JSON) record for archival or research-database ingestion. The structured report includes one or more of: case and specimen identifiers; the Al engine's diagnostic classification, subtype label, and confidence scores; an embedded thumbnail of the whole-slide image; an embedded thumbnail of the spatial attention heatmap; a confidence-below-threshold flag and recommended pathologist review pathway; the model identifier and version of the Al diagnostic engine (250) used to generate the output, supporting auditability; and a regulatory-status disclaimer indicating, where applicable, that the report is generated by an investigational Al system and requires confirmation by a board-certified pathologist before clinical action.Remote Pathologist Interface (260)

[0262] In some embodiments, the platform comprises a Remote Pathologist Interface (260) configured to securely transmit the whole-slide image, the spatial attention heatmap, the Al diagnostic engine (250) output, the Automated Diagnostic Report Generator (270) report, and any associated specimen metadata to a remote pathologist computing device via the network interface (245), and to receive, from the remote pathologist computing device, one or more of: a confirmation of the diagnostic classification, a modified or alternative diagnostic classification, an annotated overlay on the whole-slide image, a free-text comment, and an electronic signature for incorporation into the final structured report. The Remote Pathologist Interface (260) addresses the deployment scenario in which a board-certified pathologist is not physically located at the platform but is required to provide diagnostic confirmation, a scenario which is increasingly common as the platform is deployed in remote, off-hours, or under-resourced clinical settings.

[0263] In some embodiments, the Remote Pathologist Interface (260) presents to the remote pathologist a synchronized multi-pane viewer comprising one or more of: a high-resolution whole-slide-image pan-and-zoom viewer; the spatial attention heatmap superimposed on the whole-slide image with adjustable opacity; a side-by-side comparator for adjacent levels of the same specimen; the Al engine's diagnostic classification and confidence; the structured report from the Automated Diagnostic Report Generator (270) presented as a draft awaiting pathologist confirmation; and an annotation toolset for marking suspect regions and adding free-text comments. In someembodiments, the Remote Pathologist Interface (260) operates over an encrypted channel using one or more of Transport Layer Security (TLS) and Virtual Private Network (VPN) tunneling, in compliance with applicable health-data privacy requirements (e.g., the U.S. Health Insurance Portability and Accountability Act (HIPAA) and analogous regulations in other jurisdictions).

[0264] In some embodiments, the Remote Pathologist Interface (260), the network interface (245), the Automated Diagnostic Report Generator (270), and the Al diagnostic engine (250) are co-located within a single physical computing module of the control unit (220), sharing power, cooling, and bus infrastructure. The remote pathologist computing device is external to the platform housing and may comprise, without limitation, a workstation, tablet, and / or mobile device having appropriate viewing and authentication capabilities.Environmental Control Subsystem — Frost Mitigation Architecture

[0265] In some embodiments, the platform implements an environmental control subsystem configured to manage humidity and condensation within the cryogenic processing zones. In systems employing thermoelectric coolers operating at temperatures substantially below the dew point of the ambient environment, water vapor condensation and frost accumulation on cold surfaces — including cold plates, blade assemblies, and cartridge contact surfaces — is a persistent engineering challenge that, if unaddressed, degrades thermal contact efficiency, introduces ice crystal artifacts in tissue sections, and increases maintenance requirements. The environmental control subsystem of the present platform implements a four-layer frost mitigation architecture.

[0266] Referring to FIG. 31, the four-layer frost mitigation architecture comprises: Layer 1, a firmware-controlled thermal defrost cycle; Layer 2, active dehumidification implemented by one of two alternative approaches; Layer 3, optional mechanical surface protection during standby; and Layer 4, passive thermal insulation. Each layer addresses a distinct frost accumulation mechanism, and the layers operate in combination to provide comprehensive frost protection across all operating phases of the platform.

[0267] Layer 1 — Firmware-Controlled Defrost Cycle: In some embodiments, the control unit (220) executes a periodic inter-sample defrost cycle by reversing the polarity of the TEC drive current applied to one or more thermoelectric modules, temporarily operating the TEC in a heating mode that vaporizes accumulated frost from the cold plate surfaces. In some embodiments, the inter-sample defrost cycle comprises the following six sequential steps: (i) TEC polarity reversal for a defined defrost interval, in some embodiments five to thirty seconds; (ii) fan increase to evacuate evaporated moisture from the cryogenic zone; (iii) thermal soak at an intermediate positive temperature, in some embodiments plus five degrees Celsius, to ensure complete frost removal; (iv) purge of residual moist air; (v) restoration of normal TEC polarity; and (vi) thermal recovery to operating setpoint. The defrost cycle is executedbetween successive tissue specimen s (5), adding no processing time within a single specimen processing cycle.

[0268] Layer 2 A — Ionic Membrane Dehumidifier (preferred embodiment): In some embodiments, the environmental control subsystem comprises an ionic membrane dehumidifier (170b), such as a Rosahl M-2J1R unit or equivalent, positioned within the cryogenic zone enclosure. The ionic membrane dehumidifier operates by electrochemical moisture transport across a proton-exchange membrane, actively removing water vapor from the enclosed cryogenic zone without the use of mechanical refrigeration or desiccant replacement.

[0269] Layer 2B — Coolant-Loop Condensing Coil (alternative embodiment): In some embodiments, the environmental control subsystem employs the existing liquid coolant loop of the thermoelectric freezing unit (100) as a condensation surface for moisture removal. A dedicated condensing coil segment of the coolant loop, maintained at a temperature below the dew point of the cryogenic zone air, is positioned within the cryogenic zone enclosure. Water vapor in the zone air condenses on the condensing coil surface and is drained via a condensate drain to a collection reservoir external to the cryogenic zone. This architecture achieves active dehumidification of the cryogenic zone by repurposing the liquid cooling infrastructure already present in the thermoelectric freezing unit (100), without requiring any additional refrigeration component. In some embodiments, the condensing coil is implemented as a secondary pass of the liquid coolant manifold routed through the cryogenic zone air volume prior to connection to the tissue TEC cold plates.

[0270] Layer 3 — Mechanical Cold-Plate Sealing Covers (optional): In some embodiments, the platform further comprises removable mechanical covers configured to overlay the cold plate surfaces and the blade assembly (110a) during inter-sample standby intervals when no tissue is present in the cryogenic zone. The mechanical covers reduce the exposed surface area of cold metal parts in contact with ambient air, limiting the rate of moisture condensation during periods when the defrost cycle is not actively running. In some embodiments, the covers are automatically actuated by the control unit (220) upon transition to standby state and retracted upon initiation of a new specimen processing cycle.

[0271] Layer 4 — Passive Thermal Insulation: In some embodiments, all external surfaces of the cryogenic processing zone that are maintained below the ambient dew point are insulated with closed-cell elastomeric foam insulation material, in some embodiments Armaflex® or equivalent material of at least nine millimeters thickness. The passive insulation layer raises the outer surface temperature of the insulated assembly above the ambient dew point, preventing condensation and frost accumulation on exterior surfaces accessible to ambient air.

[0272] In some embodiments, the environmental control subsystem is configured with a selectable operating mode corresponding to one of five operational configurations: (i) standalone TEC defrost cycle only (Layer 1); (ii) TEC defrost cycle and ionicmembrane dehumidifier (Layers 1 and 2A); (iii) TEC defrost cycle and condensing coil (Layers 1 and 2B); (iv) any of configurations (i)-(iii) with mechanical cold-plate covers added (Layer 3); and (v) all active layers combined with passive insulation (Layers 1, 2A or 2B, 3, and 4). The selection among configurations is made based on ambient humidity conditions at the deployment site and the required operational duty cycle.Hardware Safety Interlock Chain

[0273] In some embodiments, the platform incorporates a hardware safety interlock chain configured to monitor critical system parameters and to remove power from one or more platform subsystems in the event that a monitored parameter exceeds a predefined safety threshold, independently of the firmware state of the control unit (220). The hardware interlock chain is implemented in hardware such that it remains operative even in the event of a firmware failure, ensuring that the platform fails to a safe state.

[0274] In some embodiments, the hardware safety interlock chain comprises one or more of the following elements: (a) a main power contactor (K-SAFETY) configured to disconnect all TEC and actuator power on activation of any safety interlock condition; (b) a liquid coolant flow switch configured to detect loss of coolant flow through the cooling loop and activate the K-SAFETY contactor if flow falls below a minimum threshold; (c) one or more Klixon-type thermal safety switches mounted on TEC cold plates and heat sinks, configured to open on exceedance of a maximum permissible temperature and activate the K-SAFETY contactor; (d) a coolant reservoir level switch configured to detect low coolant level and activate the K-SAFETY contactor; and (e) a drip tray liquid sensor configured to detect coolant leakage into the platform enclosure base and activate the K-SAFETY contactor.

[0275] In some embodiments, once the K-SAFETY contactor has been activated by any hardware interlock condition, it remains latched in the open (power-removed) state until a deliberate manual reset action is performed by an operator, preventing automatic restart following a safety event. In some embodiments, the hardware interlock chain further comprises one or more optical or electromechanical door interlock switches configured to prevent actuation of blade-drive and transfer mechanisms when any platform access panel is open.

[0276] In some embodiments, the platform further comprises an independent thermal management zone for the electronics enclosure, physically separated from the cryogenic processing zone by an insulating bulkhead. The electronics enclosure is maintained at a temperature above the dew point of the ambient environment at all times, preventing condensation on electronic components. Power supply units, motor drivers, and the main processor board are all located within the electronics enclosure.Control Unit

[0277] In some embodiments, the control unit (220) comprises, without limitation, one or more processors, associated memory, and / or firmware configured to coordinate thesequential and concurrent operation of all platform subsystems. In some embodiments, the control unit (220) implements a state machine architecture comprising multiple defined processing states, each corresponding to a phase of the tissue processing cycle. Transitions between states are governed by sensor inputs, timer events, and operator commands.

[0278] In some embodiments, the control unit (220) executes the following concurrent firmware modules during active tissue processing: (a) the TCAF module, responsible for tissue class management, geometry computation, and adaptive freezing profile generation as described in Section 4; (b) the Thermal Response Observer (TRO) module, responsible for real-time monitoring of the observed cooling curve and automatic profile correction, also described in Section 4; (c) the Shell-Depth Estimator module, active during Shell-Freeze operation as described in Section 5; (d) the blade alignment sequencer, coordinating the four-phase MBA cycle as described in Section 6; (e) the tissue transfer sequencer, coordinating tissue section pickup, slide deposition, and cover member (125b) closure as described in Sections 8 and 9; (f) the staining sequencer, coordinating reagent delivery through the consumable cover member (125b) as described in Section 10; (g) the imaging sequencer, coordinating XY stage (150) translation and Z-axis autofocus as described in Section 11; and (h) the Al inference scheduler, coordinating image data flow into and diagnostic output generation by the Al diagnostic engine (250) as described in Section 12.

[0279] In some embodiments, the control unit (220) is further configured to maintain a complete audit log of all sensor readings, control decisions, timing events, and diagnostic outputs associated with each tissue specimen (5) processed. The audit log is stored in non-volatile memory and is accessible to authorized service personnel for diagnostic purposes. In some embodiments, the audit log is transmitted together with the whole-slide image and diagnostic output to the remote pathologist interface (260) or clinical information system, providing complete chain-of-custody documentation for the processed specimen.

[0280] Referring to FIG. 37 — a cross-sectional view of slides collection by the user, showing the consumable slide assemblies (125), the slides XY plate (150g), and the slide shutter (180b) — , in some embodiments, the control unit (220) interfaces with the user interface (230) to receive operator inputs including, without limitation, tissue class selection, specimen identification, and / or processing mode selection. In some embodiments, the control unit (220) further interfaces with the network interface (240) for transmission of digital images, diagnostic outputs, and system status to a remote clinical information system. The network interface (245) is configured to support standard clinical interoperability protocols, including HL7 FHIR and DICOM, enabling integration with existing laboratory information management systems.

[0281] In some embodiments, the per-core user interface (230) is distinct from the platform-level main control unit (220) and software user interface (la). The per-core user interface (230) provides a status display, alert indicator, and minimal operator-interaction surface dedicated to the modular core tissue processing unit (lb) within which it is integrated. The platform -level main control unit (la) provides the primary operator-interaction surface for the platform as a whole, including, without limitation, cross-core scheduling, multi-core dashboard, and / or platform-shared subsystem control. The two interfaces operate in complementary fashion: per-core (230) for core-specific operator action; platform-level (la) for whole-platform orchestration.

[0282] In some embodiments, the control unit (220) is implemented on a single-board computer platform executing a real-time operating system, with processing-intensive inference tasks offloaded to a dedicated neural processing unit (NPU) or graphics processing unit (GPU) co-processor. In some embodiments, the control unit (220) further comprises a dedicated microcontroller for time-critical actuator and sensor management, operating independently of the main processor and communicating via a serial bus.

[0283] In some embodiments, the control unit (220) is configured with hardware suitable for real-time execution of the Al diagnostic engine (250) within the platform processing-time target. The hardware specification may comprise, without limitation, one or more of: a graphics processing unit and / or a neural processing unit having sufficient memory and compute capability for real-time inference on whole-slide images; a multi-core central processing unit; system random-access memory; nonvolatile solid-state storage; and a power supply sized to the platform's combined load. The specific selection of inference hardware and operating system is implementationdependent and may be selected from any combination of components meeting the platform processing-time target.

[0284] In some embodiments, the Al diagnostic engine (250) is configured to begin processing image data as the imaging module (140) acquires it, such that the diagnostic output is available substantially concurrently with completion of the whole-slide scan, supporting the platform's intraoperative time budget.

[0285] In some embodiments, the control unit (220) is housed in a medical-grade enclosure suitable for incorporation within the device chassis, the enclosure being compliant with applicable safety and electromagnetic compatibility standards including, without limitation, IEC 60601-1, and / or being configured for fanless or semi-passive cooling to avoid airborne particulate generation in the cryogenic and biological samplehandling zones. In some embodiments, the control unit (220) and the Al diagnostic engine (250) are co-located within a single physical computing module integrated within the platform housing, sharing power, cooling, and data-bus infrastructure, and exposing one or more network interface (245) connectors of the network interface (245) for communication with external clinical information systems.XY Motion and Positioning System (150)

[0286] Referring to FIG. 7 — a top view of a core unit with a single XY motion and positioning system (150) showing the cartridge holder (150a), XY base plate (150b), Y-carriage plate (150c), XY-carriage plate (150d), slide-flipping rack (150e), Y motor (150h), and X motor (150i) — and FIG. 8 — a top view of a core unit with the dual XY motion and positioning system (150') comprising the cartridge Y plate (150c1), the slides Y plate (150c"), the cartridge XY plate (150f), the slides XY plate (150g), and the respective cartridge X / Y motors (150i7150h') and slide X / Y motors (150i" / 150h") — , in some embodiments the platform comprises an XY motion and positioning system (150) constituting a dedicated subsystem responsible for transporting one or more of: the disposable cartridge assembly (10) before and after freezing, the ice tissue block (10s) following extraction from the cartridge, and the microscope slide s (125a) bearing transferred tissue sections, between the various processing stations of the platform — including, without limitation, the cartridge entry zone, the thermoelectric freezing unit (100), the tissue slicing unit (110), the tissue-to-slide transfer unit (120), the staining module (130), the imaging module (140), and the slide output zone. The XY motion and positioning system (150) is functionally and structurally distinct from the tissue slicing unit (110), the tissue-to-slide transfer unit (120), and the imaging module (140), each of which interfaces with but does not constitute the XY motion and positioning system (150).

[0287] In some embodiments, the XY motion and positioning system (150) comprises one or more of: a cartridge holder (150a) configured to receive and retain the disposable cartridge assembly (10) during transport, the cartridge holder (150a) further providing a defined alignment interface that engages a cartridge groove (lOr) of the cartridge assembly (10) to fix the cartridge in a known position relative to the freezing and slicing subsystems; an XY stage (150) base plate (150b) constituting the mechanical base that supports both X-axis and Y-axis movement; a Y-axis carriage plate (150c) translatable along a single linear degree of freedom relative to the XY stage (150) base plate (150b); an XY carriage plate (150d) translatable in two orthogonal degrees of freedom and supporting one or more of the cartridge holder (150a) and a slide holder (120b); and a rack element (150e) configured to engage a slide-flipping mechanism for inverting a microscope slide (120d) following tissue-to-slide transfer to present the tissue-bearing face of the slide in an orientation appropriate for downstream imaging.

[0288] In some embodiments, the XY motion and positioning system (150) comprises a single XY stage (150) assembly that handles both the cartridge assembly (10) and microscope slide (120d) transport in time-multiplexed fashion. In an alternative preferred embodiment, the XY motion and positioning system (150) comprises two physically and operationally independent XY stage (150) assemblies: a first XY stage assembly dedicated to the cartridge assembly (10) and the ice tissue block (10s), and a second XY stage assembly dedicated to the microscope slide s (125a). The dual-XY-stage embodiment enables the cartridge handling and slide handling operations to proceed in parallel rather than serially, which reduces the cumulative case processing time and increases throughput. In some embodiments, the second XY stage assembly is dedicated to slide transport between the staining module (130) and the imaging module(140), and is fitted with active thermal control configured to maintain the slides at a consistent temperature during staining and imaging.

[0289] In some embodiments, the XY motion and positioning system (150) is operated by stepper motors and / or servo motors with closed-loop position feedback provided by linear or rotary position encoders. In some embodiments, position feedback resolution is one micrometer or finer along each axis. The control unit (220) coordinates motion commands across the one or more XY stage (150) assemblies, optionally implementing a centralized scheduler that evaluates subsystem availability and dynamically routes cartridges and slides among available stations. In some embodiments, the centralized scheduler implements a real-time optimization engine configured to maximize utilization of the available XY stage s (150), robotic arms, and slide transfer mechanisms across one or more autonomous processing core unit s (lb) operating in parallel. [0212-F-A] In further detail of the dual-XY embodiment introduced in [0212-F], the dual XY motion and positioning system (150') comprises: a first Y-axis carriage plate (150c) dedicated to cartridge transport (150c1); a second Y-axis carriage plate dedicated to slide transport (150c"); a first XY carriage plate (150d) dedicated to cartridge transport (150f), translatable in two orthogonal degrees of freedom and supporting the cartridge holder (150a); and a second XY carriage plate dedicated to slide transport (150g), translatable in two orthogonal degrees of freedom and supporting one or more slide holders (120b). The two Y plates and two XY plates operate independently and in parallel, enabling truly simultaneous cartridge handling and slide handling without serial bottleneck. [0212-F-B] In some embodiments, the cartridge XY carriage plate (150f) is driven in the X-axis by a cartridge X-axis motor (150i') and in the Y-axis by a cartridge Y-axis motor (150h'); the slide XY carriage plate (150g) is driven in the X-axis by a slide X-axis motor (150i") and in the Y-axis by a slide Y-axis motor (150h"). The four motors operate independently and may execute simultaneously commanded motions in opposite directions or at different velocities, fully decoupling cartridge motion from slide motion. The control unit (220) of each modular core (lb) coordinates the four motors via a real-time motion controller. In single-XY embodiments employing one Y-axis carriage and one XY carriage, the corresponding motors are designated (150h) for the Y-axis motor and (150i) for the X-axis motor without primes.Waste Management System (240)

[0290] In some embodiments, the platform comprises, without limitation, a Waste Management System (240) responsible for the collection, segregation, containment, and / or disposal of consumables and byproducts generated during tissue processing operations. The Waste Management System (240) handles, without limitation, one or more of discarded tissue sections rejected by the slicing quality control system (200) prior to slide transfer; discarded slides; spent staining reagents and rinse fluids drained from the consumable cover member (125b); spent embedding medium (10g) overflow; tissue fragments produced during sectioning, including non-diagnostic dummy slicesintentionally produced to clear the blade or embedding medium; and post-processing cartridge assemblies and integrated disposable blade (110a) inserts after their final use.

[0291] In some embodiments, the Waste Management System (240) comprises a retractable waste bin (240) integrated into the platform chassis, the bin being configured for removal and disposal without compromising the sterility or containment of the internal environment of the platform. In some embodiments, the waste bin (240) further comprises one or more of: dedicated compartments or removable liners supporting segregation of different waste types — for example, a tissue-waste compartment, a reagent-waste compartment, and a slide-waste compartment; one or more fill-level sensors configured to monitor the cumulative waste volume in each compartment; and an electronic locking interface preventing inadvertent waste-bin removal during active processing. When a fill-level sensor reaches a defined threshold, the platform issues an alert via the user interface (230) prompting timely waste-bin replacement.

[0292] In some embodiments, the Waste Management System (240) is fluidically coupled to the staining module (130) via a dedicated drain line that conducts spent staining reagents, rinse buffers, and any aspirated chamber fluids from the consumable cover member (125b) to the appropriate compartment of the waste bin (240), optionally with segregation by reagent class. In some embodiments, the Waste Management System (240) is mechanically coupled to the slicing quality control system (200) and the tissue-to-slide transfer unit (120) by a controlled actuator pathway that deposits a tissue section judged unacceptable by the slicing quality control system (200) into the tissuewaste compartment of the waste bin (240) without first contacting any microscope slide (125a).

[0293] In some embodiments, the Waste Management System (240) further comprises, without limitation, an inspection interface enabling authorized service personnel to verify proper waste segregation, retrieve archival samples if requested by the operator, and / or confirm fill-level sensor calibration. By managing waste efficiently and maintaining hygienic separation between active and discarded materials, the Waste Management System (240) reduces contamination risk and supports uninterrupted, high-throughput operation.Multi-Core Parallel Processing Configuration

[0294] In some embodiments, the platform (1) comprises, without limitation, multiple autonomous processing core unit s (lb), each constituting a complete independent tissue processing system as described herein, housed within a common platform enclosure (lb) sharing utilities including a liquid cooling infrastructure, a reagent supply manifold, a waste collection system, and / or a common network interface (245). Each processing core unit (lb) is independently operable and controlled by its own control unit (220) instance, with a supervisory coordination layer managing shared utility allocation and output routing.

[0295] In some embodiments, a platform comprising two or more processing core unit s (lb) operating in parallel reduces the cumulative processing time for multi-sample surgical cases proportionally. For example, a platform comprising four processing core units is configured to process four tissue specimen s (5) simultaneously, reducing the total turnaround time for a four-specimen case from approximately forty minutes (four sequential specimens at approximately ten minutes each) to approximately ten minutes, equivalent to the processing time for a single specimen. This configuration directly addresses the clinical problem of extended patient anesthesia time in multi-sample oncological margin assessment cases described herein.

[0296] In some embodiments, the shared liquid cooling infrastructure of the multi-core platform comprises a central coolant reservoir and a central coolant pump serving all processing core unit s (lb) via a branched manifold. The coolant flow to each core unit is individually controllable via a dedicated flow valve, enabling selective activation and deactivation of individual core units without interrupting operation of other units.Thermal Architecture Addendum (THERM-001 Rev B)

[0297] In some embodiments, temperature sensors within the thermoelectric freezing unit comprise NTC thermistor elements of ten kilohms nominal resistance at twenty-five degrees Celsius, each mounted in a blind-drilled hole of approximately 1.5 mm diameter and 3 to 5 mm depth in the cold plate body, with the sensor element secured by thermally conductive epoxy filling the hole. This blind-hole mounting geometry ensures intimate thermal contact between the sensor element and the cold plate mass, providing a temperature measurement lag of less than 0.5 seconds. External surface-tape mounting of temperature sensors is specifically avoided, as tape mounting introduces a thermal lag of two to five seconds that causes control system overshoot and degrades freezing profile accuracy. All sensor readings are sampled at a rate of at least ten hertz consistent with the requirements of the TRO module described herein.

[0298] In some embodiments, the chiller thermoelectric module heatsinks are served by a dedicated forced-air duct that directs intake air from an external ambient port and exhausts heated air to a separate external port, with a minimum physical separation of fifty millimeters between the intake and exhaust ports within the platform enclosure. Recirculation of heated exhaust air back into the heatsink intake is specifically prevented by this duct geometry, as recirculation collapses the coefficient of performance of the chiller thermoelectric modules and can cause progressive thermal runaway. The duct is validated to maintain the chiller heatsink hot-side temperature below forty-five degrees Celsius at the maximum specified ambient operating temperature.

[0299] In some embodiments, the thermal interface material positioned between each thermoelectric module and its associated cold plate and heatsink surface comprises a phase-change material (PCM) pad configured to undergo a solid-to-liquid phase transition at approximately forty to sixty degrees Celsius, providing a bulk thermal conductivity of at least eight watts per meter-kelvin. The phase-change materialconforms to the micro-roughness features of both the thermoelectric ceramic face and the mating metal surface during the first thermal cycle of operation, minimizing interfacial contact resistance without requiring lapping or polishing of the mating surfaces. In some embodiments, the PCM pad is applied on both the cold and hot sides of each thermoelectric module, forming a six-element sandwich assembly of: heatsink base — PCM pad — thermoelectric module — PCM pad — cold plate, compressed by spring-loaded Belleville washer fasteners applying 150 to 300 PSI contact pressure, with fastener holes positioned within three millimeters of the thermoelectric module edge to prevent substrate bowing.

[0300] In some embodiments, the platform power supply is a medical-grade alternating current to direct current converter meeting the requirements of IEC 60601-1, rated at twenty-four volts DC output at a continuous capacity of at least 1200 watts, sized to accommodate the peak cold-boot transient electrical load of approximately 1088 watts arising from simultaneous near-maximum drive of the tissue thermoelectric modules and knife thermoelectric module together with auxiliary motor and control loads. The steady-state operating load during normal tissue processing is approximately 447 watts. Power is distributed on a twenty-four volt DC primary bus with secondary DC-DC converters providing twelve volts for the coolant pump, cooling fans, and knife thermoelectric module drive circuit, and five volts for the control electronics.Environmental Control Addendum (HUMID-001 Rev B)

[0301] In some embodiments of the coolant-loop condenser configuration (Layer 2B), the condenser heat exchanger is implemented as a dedicated aluminum fin array of approximately 50 * 50 * 25 mm thermally bonded to the exterior wall of the coolant reservoir (160b) or introduced into the coolant circuit via a T-fitting, with a forty millimeter low-speed fan positioned to circulate enclosure air across the fin array at a flow rate of approximately 0.3 to 0.6 cubic meters per hour. Moisture condensing on the fin surfaces falls by gravity into a sealed condensate tray positioned below the fin array and is conducted via a four millimeter inner diameter PTFE drain tube through the enclosure wall to the hot-side heatsink exhaust zone, where the approximately 480 watts of waste heat rejected by the chiller thermoelectric modules passively evaporates the condensate into the exhaust airstream, eliminating any need for a condensate pump or drain reservoir. In some embodiments, the coolant-loop condenser achieves an enclosure moisture extraction rate of fifty to one hundred twenty grams per day, which is twenty-five to fifty times the extraction rate of an ionic membrane dehumidifier of the type described herein, with a transient recovery time of ten to thirty seconds following a moisture ingress event.

[0302] In some embodiments, a self-defrost mechanism is implemented for the cold-fin condenser array to manage frost accumulation on the fin surfaces during periods when the coolant temperature is at or below zero degrees Celsius and enclosure humidity is elevated. In some embodiments, the self-defrost mechanism operates by periodically reducing condenser fan speed to zero for a dwell interval of twenty to sixty seconds,allowing the fin surface temperature to rise above zero degrees Celsius by thermal exchange with the surrounding enclosure air, melting any accumulated frost into liquid condensate that drains through the existing condensate management pathway. Fan operation resumes after the dwell interval. Frost accumulation onset is detected by the control unit (220) when the measured fin surface temperature falls more than two degrees Celsius below the coolant supply temperature, indicating the additional thermal mass of accumulated frost.

[0303] In some embodiments of the mechanical cold-plate sealing cover (Layer 3), the lower thermoelectric cold plate (100b) is covered between successive processing cycles by a sealing pad element integrated with the cartridge holder (150a) such that, as the cartridge holder translates away from the freeze station following cartridge ejection, the sealing pad automatically traverses over and rests upon the lower cold plate surface, enclosing a minimal air volume above the cold plate and preventing ambient moisture from accessing the cold surface during the inter-sample interval. The sealing pad is retracted automatically when the cartridge holder returns to the freeze station with the next cartridge, requiring no additional actuators, control signals, or cycle time. In some embodiments, the sealing pad contact surface comprises virgin polytetrafluoroethylene (PTFE) or hard-anodized aluminum, selected for a particle generation rate of fewer than one hundred particles per square centimeter per one thousand contact cycles for particles exceeding five micrometers in diameter, to protect the thermal interface zone of the cold plate.

[0304] In some embodiments, the TEC polarity-reversal defrost cycle (Layer 1) is executed at a reduced drive current of thirty to fifty percent of the rated full-load current, reducing the amplitude of the thermal stress cycle applied to the thermoelectric module solder joints relative to a full-current reversal, thereby extending thermoelectric module service lifetime. In some embodiments, the defrost cycle is terminated when the cold plate temperature reaches a configurable defrost termination temperature stored in firmware, with a default value of positive ten degrees Celsius, sufficient to melt accumulated frost and evaporate the resulting water film during a subsequent two to three second evaporation dwell phase. In some embodiments in which cycle time minimization is prioritized, the termination temperature is reduced to positive five degrees Celsius, reducing subsequent re-cooling time by approximately five to eight seconds, with any residual unevaporated water film absorbed by the active dehumidification layer. The defrost cycle executes in parallel with cartridge transport and scanning operations, adding a net elapsed time of approximately fifteen to twenty seconds to the inter-sample interval in the default configuration.

[0305] Those skilled in the art to which this invention pertains will readily appreciate that numerous changes, variations, and modifications can be made without departing from the scope of the invention, mutatis mutandis.

[0306] The technical features, elements, and steps disclosed throughout this specification - including the summary, the detailed description, and the drawings - areintended to be interpreted as modular components of a unified disclosure. While various features may be described in the context of specific embodiments for the sake of clarity and brevity, it is expressly intended that any single feature or group of features disclosed herein may be combined, in as far as reasonable to a person skilled in the art, with any other feature or group of features, regardless of whether they were originally presented in the same section or embodiment.

[0306] Each such combination is intended to be within the scope of this disclosure as if it were explicitly described in its combined form. The applicant hereby provides an explicit written description for various permutations of the disclosed elements, and the absence of a specific combination or permutation in the description should not be construed as a lack of support for such a combination. Unless otherwise indicated as being mutually exclusive or technically incompatible, all disclosed features are deemed to be interchangeable and / or combinable to achieve the objectives of the invention.

Claims

CLAIMS:

1. An automated biopsy platform comprising:a cooling module configured for receiving a tissue sample and lowering its temperature to form a cooled tissue sample;a cutting module configured for at least partially cutting a histological section of said cooled tissue sample;a sampling module configured for applying said histological section to a slide to form a histological slide; andan automated actuation mechanism associated with each of the cooling module, cutting module, and sampling module, and configured for automatically facilitating at least one of the following:transfer of said tissue sample to said cooling module;engagement between said cutting module and said cooled tissue sample; andapplication of said histological section to said slide.

2. An automated biopsy platform according to Claim 1, wherein said platform includes a housing accommodating at least said cooling module, said cutting module and said sampling module.

3. An automated biopsy platform according to Claim 2, wherein said housing comprises a sample inlet configured for introduction of a tissue sample into the automated biopsy platform.

4. An automated biopsy platform according to Claim 1, wherein the cooling module comprises a cooling arrangement configured for lowering the temperature of the tissue sample.

5. An automated biopsy platform according to Claim 4, wherein the cooling module is configured for lowering the temperature of the tissue sample to achieve at least partial freezing of the tissue sample.

6. An automated biopsy platform according to Claim 5, wherein the cooling module is configured for freezing the entire tissue sample.

7. An automated biopsy platform according to Claim 5, wherein the cooling module is configured for freezing a peripheral portion of the tissue sample while leaving a central portion thereof unfrozen.

8. An automated biopsy platform according to Claim 7, wherein said cooling module is configured for controlling the thickness of the peripheral portion of the tissue sample.

9. An automated biopsy platform according to any one of Claims 5 to 8 wherein the temperature of the frozen tissue sample is in the range of -10°C to -60°C.

10. An automated biopsy platform according to Claim 4, wherein the cooling module is associated with a tissue chamber configured for containing the tissue sample.

11. An automated biopsy platform according to Claim 10, wherein the tissue chamber is an individual chamber sized and shaped for accommodating a single tissue sample.

12. An automated biopsy platform according to Claim 10 or 11, wherein the cooling module is configured for cooling the tissue while the tissue is in the tissue chamber.

13. An automated biopsy platform according to Claim 10 or 11, wherein the tissue chamber is integrated into the automated biopsy platform.

14. An automated biopsy platform according to Claim 10 or 11, wherein the tissue chamber is an external unit introduced into the automated biopsy platform.

15. An automated biopsy platform according to Claim 10, wherein the automated biopsy platform further comprises an extraction mechanism configured for removing the cooled tissue sample from the tissue chamber.

16. An automated biopsy platform according to Claim 10, wherein said tissue chamber is configured for containing a thermal fluid.

17. An automated biopsy platform according to Claim 4, wherein the cooling module includes a monitoring unit configured for at least one of the following:i. assessing a size, a shape or a volume of the tissue within the tissue chamber;ii. assessing the temperature of the tissue within the tissue chamber; and iii. assessing the level of freezing of the tissue within the tissue chamber.

18. An automated biopsy platform according to Claim 17, wherein the cooling arrangement is associated with the monitoring unit and is configured for determining a cooling protocol based on the assessments of the monitoring unit.

19. An automated biopsy platform according to Claim 4, wherein the cooling arrangement is configured for cooling the tissue sample by conduction.

20. An automated biopsy platform according to Claim 19, wherein the cooling arrangement includes a thermoelectric cooling (TEC) unit.

21. An automated biopsy platform according to Claim 20, wherein the cooling module comprises two or more TEC units.

22. An automated biopsy platform according to Claim 21, wherein said cooling module comprises a first TEC unit and a second TEC unit, configured for cooling the tissue sample from two different directions.

23. An automated biopsy platform according to Claim 22, wherein the cooling module comprises an upper TEC assembly and a lower TEC assembly configured for bilateral compression of the tissue chamber between an upper thermal coupling and a lower thermal coupling.

24. An automated biopsy platform according to Claim 23, wherein the upper TEC assembly is carrier on an upper vertical Z-axis drive and the lower TEC assembly is carried on a lower vertical Z-axis drive, each Z-axis drive being operable independently.

25. An automated biopsy platform according to Claim 20, wherein the TEC is cooled using a secondary cooling system.

26. An automated biopsy platform according to Claim 25, wherein the secondary cooling system is a fluid cooling system.

27. An automated biopsy platform according to any one of Claims 4 to 26, wherein the cooling module further comprises one or more plungers configured to perform at least one of the following: (a) urge a cartridge lid into a closed position during descent of the upper TEC assembly, (b) lock a cartridge lid in a sealed configuration during a freezing dwell to preserve a sealed envelope chamber surrounding the tissue sample, and (c) release a cartridge lid on completion of the freezing dwell.

28. An automated biopsy platform according to Claim 1, wherein the cutting module comprises at least one blade configured for cutting a histological slice from the tissue sample, once cooled by the cooling module.

29. An automated biopsy platform according to Claim 28, wherein said blade is configured for removing a section of the tissue sample in order to form a planar surface of the tissue sample, appropriate for cutting a histological slice.

30. An automated biopsy platform according to Claim 29, wherein the automated biopsy platform also comprises a planing mechanism configured for creating a planar surface of the tissue sample appropriate for cutting a histological slice.

31. An automated biopsy platform according to Claim 30, wherein said planing mechanism comprises a planar surface configured for applying pressure to said tissue before or during cooling.

32. An automated biopsy platform according to Claim 28, wherein said cutting module is associated with a blade cooling arrangement configured for lowering the temperature of said at least one blade.

33. An automated biopsy platform according to Claim 32, wherein said at least one blade is configured for cutting two or more histological slices from the cooled tissue sample.

34. An automated biopsy platform according to Claim 33, wherein the blade cooling arrangement is configured for lowering the temperature of said at least one blade between subsequent cuts of histological slices.

35. An automated biopsy platform according to Claim 33, wherein the cooling module is configured for lowering the temperature of the tissue sample between subsequent cuts of histological slices.

36. An automated biopsy platform according to Claim 34 or 35, wherein said lowering of temperature is performed by spray cooling.

37. An automated biopsy platform according to Claim 28, wherein said at least one blade is disposable.

38. An automated biopsy platform according to Claim 37, wherein the automated biopsy platform is configured such that a blade is only used to cut a single tissue sample and is disposed thereafter.

39. An automated biopsy platform according to Claim 28, wherein said cutting module is associated with a stack of disposable blades.

40. An automated biopsy platform according to Claim 28, wherein the cutting module further comprises a section-receiving pivotable surface for receiving a histological slice after a cutting stroke, the section-receiving surface being pivotable about a flip axis between a section-supporting orientation and a section-release orientation.

41. An automated biopsy platform according to Claim 28, wherein said automatic biopsy diagnostic platform is configured for insertion therein of at least one external blade into the cutting module.

42. An automated biopsy platform according to Claim 41 , wherein said external blade comprises a flexible gripping portion configured for being held by a gripper of the cutting module.

43. An automated biopsy platform according to Claim 42, wherein said flexible gripping portion is configured for allowing the external blade to align with a planar surface of the tissue sample.

44. An automated biopsy platform according to Claim 28, wherein said cutting module comprises a control unit configured for controlling the movement of said at least one blade, at least during a cutting operation.

45. An automated biopsy platform according to Claim 44, wherein said control unit is configured for bringing said at least one blade in contact with the tissue sample, and monitor the resistance to the blade movement during a cutting operation.

46. An automated biopsy platform according to Claim 44 or 45, wherein the control unit is configured for verifying that said at least one blade is aligned with the cooled tissue sample before a cutting operation.

47. An automated biopsy platform according to Claim 44, wherein the control unit is associated with at least one imaging unit configured for obtaining visual data of the tissue sample before, during and after a cutting operation.

48. An automated biopsy platform according to Claim 47, wherein said visual data is used for quality control of the histological slice.

49. An automated biopsy platform according to Claim 48, wherein said quality control is configured for detecting folds and / or tears in the cut histological slice.

50. An automated biopsy platform according to Claim 44, wherein the control unit is configured for controlling the movement of said at least one blade to determine a thickness of the histological slice.

51. An automated biopsy platform according to Claim 28, wherein said at least one blade is configured for partially cutting the histological slice such that the histological slice remains attached to the tissue sample.

52. An automated biopsy platform according to Claim 51, wherein during a cutting operation said at least one blade is configured for sliding underneath the histological slice, and wherein said cutting module is configured for retracting said at least one blade after the cutting operation, leaving the histological slice on the tissue sample.

53. An automated biopsy platform according to Claim 28, wherein the cutting module comprises a slice scoop configured for receiving the at least partially cut histological slice therein during a cutting operation.

54. An automated biopsy platform according to Claim 53, wherein the slice scoop is angled to said at least one blade, allowing the at least partially cut histological slice to slide onto the scoop during a cutting operation.

55. An automated biopsy platform according to Claim 53, wherein said slice scoop is disposable.

56. An automated biopsy platform according to Claim 53, wherein said slice scoop is integrated with said at least one blade.

57. An automated biopsy platform according to Claim 1, wherein said sampling module comprises at least one slide configured for placing thereon a histological slice 58. An automated biopsy platform according to Claim 57, wherein said slide is provided with a barcode configured for being indexed according to said tissue sample.

59. An automated biopsy platform according to Claim 57, wherein said sampling module is configured for bringing said at least one slide into contact with the at least partially cut histological slice.

60. An automated biopsy platform according to Claim 59, wherein contact between said at least one slide and said at least partially cut histological slice causes attachment of the histological slice to said at least one slide.

61. An automated biopsy platform according to Claim 60, wherein said attachment is based on electrostatic forces.

62. An automated biopsy platform according to Claim 60 or 61, wherein, when the histological slice is still attached to the tissue sample, the sampling module is configured for distancing said at least one slide from the tissue sample in order to detach said partially cut histological slice from the tissue sample.

63. An automated biopsy platform according to Claim 57, wherein said at least one slide is engageable with a cover configured for covering the at least one slide and histological slice thereon.

64. An automated biopsy platform according to Claim 63, wherein said cover is configured for creating a closed chamber containing said histological slice.

65. An automated biopsy platform according to Claim 63, wherein said cover is slidable between a first, open position allowing attachment of the histological slide to said at least one slide, and a second, closed position in which it forms said closed chamber.

66. An automated biopsy platform according to Claim 63, 64 or 65, wherein said cover is integrated with said at least one slide.

67. An automated biopsy platform according to Claim 63, wherein said closed chamber comprises at least one inlet configured for introduction of a staining agent into said closed chamber and / or at least one outlet configured for egress of a staining agent from the closed chamber.

68. An automated biopsy platform according to Claim 67, wherein said at least one inlet and / or said at least one outlet is provided with a one-way valve.

69. An automated biopsy platform according to Claim 63, wherein said cover is made of a material allowing imaging of said histological slice through said cover.

70. An automated biopsy platform according to Claim 57, wherein said sampling module is provided with a stack of slides.

71. An automated biopsy platform according to Claim 70, wherein said sampling module further comprises a dispensing mechanism configured for drawing a slide from the stack and preparing it for engaging the tissue sample.

72. An automated biopsy platform according to Claim 1, wherein said automated biopsy platform further comprises a staining module configured for applying at least one staining agent to said histological slide to generate a stained histological slide.

73. An automated biopsy platform according to Claim 72, wherein the automated actuation mechanism is configured for bringing the histological slide into engagement with the staining module.

74. An automated biopsy platform according to Claim 72, wherein the histological slide comprises a closed chamber containing the histological slice, and wherein saidstaining module is configured for introducing said at least one staining agent into the closed chamber in order to stain the histological slice.

75. An automated biopsy platform according to Claim 74, wherein said closed chamber comprises at least one inlet configured for introduction of said at least one staining agent into said closed chamber and / or at least one outlet configured for egress of said staining agent from the closed chamber.

76. An automated biopsy platform according to Claim 75, wherein said at least one inlet and / or said at least one outlet is provided with a one-way valve.

77. An automated biopsy platform according to Claim 75, wherein said staining module is provided with a pump configured for introducing said at least one staining agent into the closed chamber under pressure.

78. An automated biopsy platform according to Claim 75, wherein said staining module is provided with at least one staining agent outlet configured for engaging with the at least one inlet of said closed chamber for provision of said at least one staining agent thereon.

79. An automated biopsy platform according to Claim 75, wherein said staining module is configured for removing a staining agent from the closed chamber either by introducing a different staining agent therein, or by introducing a replacement fluid into the closed chamber.

80. An automated biopsy platform according to Claim 73, wherein said replacement fluid is any one of the following: air, water, Aqueous glycerol, and PBS.

81. An automated biopsy platform according to Claim 72, wherein said staining module is provided with two or more staining agents, and includes a dispensing unit configured for controlling the release of each one of said two or more staining agents onto the slide.

82. An automated biopsy platform according to Claim 81, wherein said dispensing unit is configured for determining a staining protocol determining at least one of the following: dispensing order of, dispensing duration of, temperature of or mixture of said two or more staining agents.

83. An automated biopsy platform according to Claim 82, wherein said staining protocol is determined according to the tissue sample introduced into the automated biopsy platform.

84. An automated biopsy platform according to Claim 76, wherein the staining module is configured to terminate a staining sequence with a final reagent step in which a retention reagent is delivered into a sealed chamber of the slide.

85. An automated biopsy platform according to Claim 84, wherein the retention reagent remains within the sealed chamber to provide one or more of: facilitation of subsequent slide handling, preservation of histological integrity of the tissue section, optical index-matching between the cover member and the slide substrate during imaging by the imaging module, and prevention of tissue dehydration during the interval between staining and imaging.

86. An automated biopsy platform according to Claim 1, wherein said automated biopsy platform further comprises an imaging module configured for obtaining at least one image of said stained histological slide.

87. An automated biopsy platform according to Claim 86, wherein said automated actuation mechanism is configured for transferring a stained histological slide from said staining module to said imaging module.

88. An automated biopsy platform according to Claim 86, wherein the imaging module is configured for obtaining said at least one image through a transparent cover of the stained histological slide.

89. An automated biopsy platform according to Claim 86, wherein said at least one image is a high resolution image.

90. An automated biopsy platform according to Claim 86, wherein said automated biopsy platform further comprises an image processing unit configured analyzing said at least one image and, based on a computer model, extract at least one pathological parameter therefrom.

91. An automated biopsy platform according to Claim 86, wherein said analysis is performed using an Al model.

92. An automated biopsy platform according to Claim 1, wherein said automated biopsy platform further comprises an analysis module configured for receiving input data of the histological slice from an imaging module, analyzing said input data and determining at least one pathological characteristic of the histological slice.

93. An automated biopsy platform according to Claim 92, wherein said at least one pathological characteristic includes the presence of cancer.

94. An automated biopsy platform according to Claim 93, wherein said analysis module is further configured, upon determining the existence of cancer, to perform a classification of the type of cancer into at least two different sub-groups.

95. An automated biopsy platform according to Claim 94, wherein said analysis module is configured for determining, within any one of said at least two sub-groups, a specific sub-type of cancer.

96. An automated biopsy platform according to Claim 1, wherein said automated biopsy platform is configured for receiving a cartridge containing therein the tissue sample.

97. An automated biopsy platform according to Claim 96, wherein said automated biopsy platform comprises a hatch for introduction of said cartridge.

98. An automated biopsy platform according to Claim 96, wherein the automated actuation mechanism is configured for transferring said cartridge from said hatch to said cooling module, and for bringing said cartridge into engagement with the cutting module.

99. An automated biopsy platform according to Claim 96, wherein cartridge defines a cavity configured for receiving therein the tissue sample.

100. An automated biopsy platform according to Claim 99, wherein said cartridge is provided with a lid configured for transposing between a first, open position, allowing introduction of the tissue sample into the cavity, and a second, closed position, in which the tissue sample is sealed within the cartridge.

101. An automated biopsy platform according to Claim 100, wherein said lid is formed with a planar surface configured for applying pressure to the tissue sample at least in said second, closed position, thereby deforming the tissue sample into having at least one planar surface.

102. An automated biopsy platform according to claim 101, wherein said cartridge comprises a pressure mechanism configured for pushing the tissue sample against the lid in order to facilitate forming said planar surface.

103. An automated biopsy platform according to Claim 102, wherein said pressure mechanism comprises a pressure plate biased towards the lid.

104. An automated biopsy platform according to Claim 103, wherein said pressure plate is perforated.

105. An automated biopsy platform according to Claim 96, wherein the cartridge is provided with a thermal fluid in which said tissue sample is configured for being submerged.

106. An automated biopsy platform according to Claim 96, wherein the cartridge includes an identification code configured for being associated with the tissue sample placed therein.

107. An automated biopsy platform according to Claim 96, wherein the cartridge is made of a low thermal resistance material, and wherein, when engaged with the cooling module, allows lowering the temperature of the tissue sample contained therein.

108. An automated biopsy platform according to Claim 107, wherein the cartridge is configured for engagement with a first and a second TEC of the cooling module for the purpose of cooling the tissue sample.

109. An automated biopsy platform according to Claim 100, wherein said lid is removable to allow access to said tissue sample.

110. An automated biopsy platform according to Claim 96, wherein the cartridge further comprises an extraction mechanism configured for at least partially extracting the tissue sample from cartridge cavity.

111. An automated biopsy platform according to Claim 110, wherein the extraction mechanism utilizes, at least in part, the pressure mechanism.

112. An automated biopsy platform according to Claim 110 or 111, wherein the automated biopsy platform is configured for gradually extracting a cooled tissue sample from said cavity for the purpose of a cutting operation.

113. An automated biopsy platform according to Claim 96, wherein said cartridge comprises a geometric design facilitating alignment of the cartridge when introduced into the automated biopsy platform and / or through subsequent transitions of the cartridge within the automated biopsy system.

114. An automated biopsy platform according to Claim 96, wherein said cartridge is disposable.

115. An automated biopsy platform according to Claim 96, wherein said cartridge is integrated with at least one blade engageable with said cutting module.

116. An automated biopsy platform according to Claim 115, wherein said cutting module includes a grip configured for gripping said at least one blade.

117. An automated biopsy platform according to Claim 116, wherein said at least one blade is detachable from said cartridge, at least during a cutting operation.

118. An automated biopsy platform according to Claim 116, wherein said blade is capable of performing a cutting operation of the tissue sample without being detached from the cartridge.

119. An automated biopsy platform according to Claim 117 or 118, wherein said automated actuation mechanism is configured for bringing said at least one blade into engagement with said grip.

120. An automated biopsy platform according to Claim 115, wherein both said cartridge and said at least one blade are disposable.

121. An automated biopsy platform according to Claim 115, wherein the cartridge and the at least one blade are configured for being cooled simultaneously.

122. An automated biopsy platform according to Claim 121, wherein said cartridge and said at least one blade are designed and shaped such that the cartridge is configured for being cooled by said cooling module while said at least one blade is configured for simultaneously being cooled by a cooling mechanism of said cutting module.

123. An automated biopsy platform according to Claim 96, wherein said cartridge comprises an anti-fold arrangement configured for preventing folding of the tissue sample within a cavity of the cartridge.

124. An automated biopsy platform according to Claim 96, wherein the cartridge further comprises an anti-fold sheet overlying a section-receiving surface and configured to constrain a freshly cut histological section from curling, folding, or wrinkling and to flip together with the section-receiving surface about the flip axis.

125. An automated biopsy platform according to Claim 1, wherein the automated biopsy platform further comprises a waste disposal bin configured for containing any disposable items, staining agents and / or biological samples which have been disposed of during operation of the automated biopsy platform.

126. An automated biopsy platform according to Claim 125, wherein said disposable includes at least one blade and / or at least one cartridge.

127. An automated biopsy platform according to Claim 1, wherein said automated biopsy platform is configured for outputting a sealed and stained histological slide.

128. An automated biopsy platform according to Claim 127, wherein said sealed and stained histological slide is indexed.

129. An automated biopsy platform according to Claim 128, wherein said indexing corresponds to the indexing of a cartridge containing the original tissue sample.

130. An automated biopsy platform according to Claim 1, wherein said automated biopsy platform utilizes a disposable cartridge configured for containing the tissue sample, and at least one disposable blade configured for cutting the cooled tissue sample such that the cartridge and the at least one blade come into contact with a single tissue sample, thereby reducing the risk of cross-contamination.

131. An automated biopsy platform according to Claim 1, wherein said automated biopsy system comprises one or more imaging devices configured for monitoring the process along the platform, said monitoring including at least any one of the following:a. alignment of the tissue sample within the cooling module;b. size, shape or volume of said tissue sample;c. a cutting operation by the cutting module; andd. quality of the histological slice.

132. An automated biopsy platform according to Claim 1, wherein said automated actuation mechanism comprises a transport arrangement configured for displacing the tissue sample and / or a container containing the tissue sample along the x, y and z axes.

133. An automated biopsy platform according to Claim 1, wherein the automated biopsy system further comprises a heat regulation unit configured for controlling the cooling of any thermal element within the platform in order to provide frost mitigation.

134. An automated biopsy platform according to Claim 1, wherein said platform is completely autonomous.

135. An automated biopsy platform according to Claim 134, wherein the automated biopsy platform comprises an inlet for introducing said tissue sample, and is configured for performing cooling, cutting, slide application and analysis of the histological slide without the intervention of a human user.

136. An automated biopsy platform according to Claim 135, wherein the analysis of a tissue sample within the platform does not exceed 45 minutes.

137. An automated biopsy platform according to Claim 136, wherein the analysis of a tissue sample within the platform is between 8-20mins.

138. An automated biopsy platform according to Claim 1, wherein the automated biopsy platform further comprises a processing unit associated at least with said cooling module, said cutting module, said sampling module and said automated actuation mechanism.

139. An automated biopsy platform according to Claim 138, wherein the processing unit is further associated with at least one of: a staining module, and imaging module and an analysis module of the automated biopsy platform.

140. An automated biopsy platform according to Claim 138 or 139, wherein the processing unit is configured for regulating the operation of any module within the automated biopsy system.

141. An automated biopsy platform according to Claim 1, wherein the automated biopsy system further comprises a user interface.

142. An automated biopsy platform according to Claim 141, wherein the user interface is configured for providing a user with at least one of the following indications:i. indication of a pathological analysis of the tissue sample;ii. indication on the stage of the process within the platform;iii. indication of an error; andiv. operation instructions.

143. An automated biopsy platform according to Claim 1, wherein said automated biopsy platform constitutes part of a modular system including two or more automated biopsy platforms.

144. An automated biopsy platform according to Claim 143, wherein said two or more automated biopsy platforms are configured for operating in parallel.

145. A method for analyzing a tissue sample using the automated biopsy platform of Claim 1, said method comprising the steps of:receiving a tissue sample;transferring the tissue sample to a freezing module;lowering the temperature of the tissue sample in the freezing module to form at least a partially frozen tissue sample;engaging the frozen tissue sample by a cutting module to at least partially cut a histological section of said frozen tissue sample;collecting said histological section by a collecting module and applying it to a slide to form a histological slide;applying a marking material to said histological slide by a staining module in order to generate a stained histological slide; andusing an imaging module, obtaining at least one image of said dyed histological slide.

146. An automated biopsy platform comprising:a cooling module configured for receiving a tissue sample and lowering its temperature to form a cooled tissue sample;a cutting module configured for at least partially cutting a histological section of said cooled tissue sample;a sampling module configured for applying said histological section to a slide to form a histological slide;a staining module configured for applying at least one staining agent to said histological slide to generate a stained histological slide;an imaging module configured for obtaining at least one image of said stained histological slide;an image processing module configured for processing said at least one image and providing at least one pathological indication relating to said tissue sample; andan automated actuation mechanism associated with each of the cooling module, cutting module, and sampling module, and configured for automatically facilitating at least one of the following:transfer of said tissue sample to said cooling module;engagement between said cutting module and said cooled tissue sample; and application of said histological section to said slide;engagement between the histological slide and the staining module; transport of the stained histological slide to said imaging module; and output of said stained histological slide.

147. A disposable cartridge for introduction into an automated biopsy platform according to Claim 1, wherein said cartridge defines a cavity configured for receiving therein the tissue sample.

148. A disposable cartridge according to Claim 147, wherein said cartridge is provided with a lid configured for transposing between a first, open position, allowing introduction of the tissue sample into the cavity, and a second, closed position, in which the tissue sample is sealed within the cartridge.

149. A disposable cartridge according to Claim 148, wherein said lid is formed with a planar surface configured for applying pressure to the tissue sample at least in said second, closed position, thereby deforming the tissue sample into having at least one planar surface.

150. A disposable cartridge according to claim 149, wherein said cartridge comprises a pressure mechanism configured for pushing the tissue sample against the lid in order to facilitate forming said planar surface.

151. A disposable cartridge according to Claim 150, wherein said pressure mechanism comprises a pressure plate biased towards the lid.

152. A disposable cartridge according to Claim 151, wherein said pressure plate is perforated.

153. A disposable cartridge according to Claim 147, wherein the cartridge is provided with a thermal fluid in which said tissue sample is configured for being submerged.

154. A disposable cartridge according to Claim 147, wherein the cartridge includes an identification code configured for being associated with the tissue sample placed therein.

155. A disposable cartridge according to Claim 147, wherein the cartridge is made of a low thermal resistance material, and wherein, when engaged with a cooling module, allows lowering the temperature of the tissue sample contained therein.

156. A disposable cartridge according to Claim 155, wherein the cartridge is configured for engagement with a first and a second TEC of the cooling module for the purpose of cooling the tissue sample.

157. A disposable cartridge according to Claim 147, wherein said lid is removable to allow access to said tissue sample.

158. A disposable cartridge according to Claim 157, wherein the cartridge further comprises an extraction mechanism configured for at least partially extracting the tissue sample from cartridge cavity.

159. A disposable cartridge according to Claim 158, wherein the extraction mechanism utilizes, at least in part, the pressure mechanism.

160. A disposable cartridge according to Claim 147, wherein said cartridge comprises a geometric design facilitating alignment of the cartridge when introduced into the automated biopsy platform and / or through subsequent transitions of the cartridge within the automated biopsy system.

161. A disposable cartridge according to Claim 147, wherein said cartridge is integrated with at least one blade engageable with said cutting module.

162. A disposable cartridge according to Claim 161, wherein said cutting module includes a grip configured for gripping said at least one blade.

163. A disposable cartridge according to Claim 162, wherein said at least one blade is detachable from said cartridge, at least during a cutting operation.

164. A disposable cartridge according to Claim 163, wherein said blade is capable of performing a cutting operation of the tissue sample without being detached from the cartridge.

165. A disposable cartridge according to Claim 163 or 164, wherein said automated actuation mechanism is configured for bringing said at least one blade into engagement with said grip.

166. A disposable cartridge according to Claim 161, wherein both said cartridge and said at least one blade are disposable.

167. A disposable cartridge according to Claim 161, wherein the cartridge and the at least one blade are configured for being cooled simultaneously.

168. A disposable cartridge according to Claim 167, wherein said cartridge and said at least one blade are designed and shaped such that the cartridge is configured for being cooled by said cooling module while said at least one blade is configured for simultaneously being cooled by a cooling mechanism of said cutting module.

169. A disposable cartridge according to Claim 147, wherein said cartridge comprises an anti-fold arrangement configured for preventing folding of the tissue sample within a cavity of the cartridge.